Analysis of some Pharmaceuticals utilizing Sequential Injection  and Differential Electrolytic Potentiometry by Eldaw, Atta Elmanan
University of Khartoum 
The Graduate College 
Medical and Health Studies Board 
 
 
 
 
 
 
Analysis of some Pharmaceuticals utilizing Sequential Injection 
and Differential Electrolytic Potentiometry 
 
 
 
 
By 
Atta Elmanan Eldaw Ibrahim 
 B. Pharm. (U of K) 1986   
 
 
  
 
A thesis submitted in fulfillment for the requirements of master in 
Pharmaceutical Chemistry 
 
 
 
Supervisor 
Professor Kamal Eldin Eltayeb Ibrahim 
PhD 
Professor of Pharmaceutical Chemistry 
U of K 
 
External supervisor 
Professor Abdalla Abu-Alkibash 
Professor of Chemistry 
KFUPM 
 
 
 
 
2009 
  ﺍﻟﻤﺴﺘﺨﻠﺹ
  
   ﺍﻷﻫﺩﺍﻑ
ﺃﺩﻭﻴﺔ ﻜﻠﻭﺭﻓﻴﻨﺎﺭﻤﻴﻥ ﻤﻠﻴﺎﺕ ﻭ ﻓﻴﺭﺍﺒﺎﻤﻴـل ﺓ ﻜﺴﺩﻤﻥ ﺃﻫﺩﺍﻑ ﻫﺫﻩ ﺍﻟﺩﺭﺍﺴﺔ ﻋﻤل ﻁﺭﻕ ﺸﺎﻤﻠﺔ ﻷ 
ﺒﺎﺴـﺘﺨﺩﺍﻡ ﺨﺎﺼـﻴﺔ  ﺒﻭﺍﺴﻁﺔ ﺒﻴﺭﻤﻨﺠﻨﺎﺕ ﺍﻟﺒﻭﺘﺎﺴﻴﻭﻡ ﻓﻲ ﻭﺠﻭﺩ ﺤﻤﺽ ﺍﻟﻜﺒﺭﻴﺘﻴﻙ  ﻜﻠﻭﺭﻴﺩ ﺍﻟﻬﺎﻴﺩﺭﻭﺠﻴﻥ 
 ﻓﻲ ﻭﺠﻭﺩ ﺤﻤﺽ ﺍﻟﺴﻴﺭﻴﻡ ﺍﻟﺭﺒﺎﻋﻲ ﺒﻭﺍﺴﻁﺔ ﺠﻴﻥﻬﺎﻴﺩﺭﻭﻜﻠﻭﺭﻴﺩ ﺍﻟ ﻭ ﺒﺭﻭﻤﻴﺜﺎﺯﻴﻥ ﺍﻟﺤﻘﻥ ﺍﻟﻤﺘﻌﺎﻗﺏ ﺍﻟﻁﻴﻔﻲ
 ﻭ ﻜﺫﻟﻙ ﺍﺘﺸﺎﺀ ﻭ ﺘﺭﻜﻴﺏ ﺃﻨﺎﺒﻴﺏ ﻤﺘﻔﺭﻋـﺔ ﻤﻼﺌﻤـﺔ ﻭ ﺒﻨﻅﺎﻡ ﻓﺭﻕ ﺍﻟﺠﻬﺩ ﺍﻟﻜﻬﺭﺒﺎﺌﻲ ﺍﻟﺘﻔﺎﻀﻠﻲ  ﺍﻟﻜﺒﺭﻴﺘﻴﻙ
ﺘﻁﺒﻴﻕ  ﺍﻟﻤﺜﻠﻰ ﻭ ﻅﺭﻭﻑ ﺍﻟﺘﺤﻠﻴل ﻋﻥ ﺍﻟﺒﺤﺙﻋﻤل ﺒﺭﺍﻤﺞ ﻤﻨﺎﺴﺒﺔ ﻟﻠﺘﺤﻜﻡ ﺒﻬﺫﻩ ﺍﻟﻁﺭﻕ ﺍﻟﺠﺩﻴﺩﺓ ﺇﻀﺎﻓﺔ ﺇﻟﻰ 
 ﻓﻘﻁ ﻭ ﺘﻘﻴﻴﻡ ﻤـﺩﻯ ﺍﻟﺤﻘﻥ ﺍﻟﻤﺘﻌﺎﻗﺏ ﺍﻟﻁﻴﻔﻲ   ﻟﻁﺭﻴﻘﺔ ل ﺍﻟﻅﺭﻭﻑ ﺍﻟﻤﺼﻔﻭﻓﺎﺕ ﺍﻟﻜﻴﻤﻴﺎﺌﻴﺔ ﻟﻠﻭﺼﻭل ﻷﻓﻀ 
  .         ﻭ ﺘﻜﺭﺍﺭ ﻭ ﺘﻜﻠﻔﺔ ﻫﺫﻩ ﺍﻟﻁﺭﻕ ﻭ ﺃﺨﻴﺭﺍ ﻤﻘﺎﺭﻨﺘﻬﺎ ﻤﻊ ﺩﺴﺘﻭﺭ ﺍﻷﺩﻭﻴﺔ ﺍﻟﺒﺭﻴﻁﺎﻨﻲﺩﻗﺔ ﻭ ﻤﺼﺩﺍﻗﻴﺔ
ﺍﻷﻭل ﻫﻭ ﺍﺴﺘﺨﺩﺍﻡ ﺘﻘﻨﻴﺔ ﺍﻟﺘﺤﻠﻴل ﺒﺎﻟﺤﻘﻥ ﺍﻟﻤﺘﻌﺎﻗﺏ ﻷﺩﻭﻴﺔ ، ﻁﺭﻭﺤﺔ ﺘﻡ ﻋﻤل ﻨﻅﺎﻤﻴﻥ ﻓﻲ ﻫﺫﻩ ﺍﻷ
ﻭ ﺍﻵﺨـﺭ ﻫـﻭ ، ﻴﺭﺍﺒﺎﻤﻴل ﻜﻠﻭﺭﻴﺩ ﺍﻟﻬﺎﻴﺩﺭﻭﺠﻴﻥ ﻓﻲ ﺍﻟﻤﺴﺘﺤﻀﺭﺍﺕ ﺍﻟﺩﻭﺍﺌﻴـﺔ ﻜﻠﻭﺭﻓﻴﻨﺎﺭﻤﻴﻥ ﻤﻠﻴﺎﺕ ﻭ ﻓ 
ﺠﻴﻥ ﻓـﻲ ﺍﺴﺘﺨﺩﺍﻡ ﺍﻟﻤﻌﺎﻴﺭﺓ ﺒﻨﻅﺎﻡ ﻓﺭﻕ ﺍﻟﺠﻬﺩ ﺍﻟﻜﻬﺭﺒﺎﺌﻲ ﺍﻟﺘﻔﺎﻀﻠﻲ ﻟﻌﻘﺎﺭ ﺒﺭﻭﻤﻴﺜﺎﺯﻴﻥ ﻜﻠﻭﺭﻴﺩ ﺍﻟﻬﺎﻴﺩﺭﻭ 
  .ﺍﻟﻤﺴﺘﺤﻀﺭﺍﺕ ﺍﻟﺩﻭﺍﺌﻴﺔ
  
  ﻤﻨﻬﺠﻴﺔ ﺍﻟﺒﺤﺙ
ﺘﻘـﻭﻡ ﻫـﺫﻩ . ﻴـﺔ ﻗﺘﺼﺎﺩﻴﺔ ﻭ ﺫﺍﺘ ﺇ، ﺴﺭﻴﻌﺔ، ﺠﺩﻴﺩﺓﻗﴼ ﺘﻌﺘﺒﺭ ﻁﺭﻕ ﺍﻟﺘﺤﻠﻴل ﺒﺎﻟﺤﻘﻥ ﺍﻟﻤﺘﻌﺎﻗﺏ ﻁﺭ 
ﺘﻌﺘﻤﺩ ﻁﺭﻴﻘﺘﺎ ﺘﺤﻠﻴل . ﺍﻟﻁﺭﻕ ﺍﻟﺠﺩﻴﺩﺓ ﺒﺎﺴﺘﺨﺩﺍﻡ ﺨﺎﺼﻴﺔ ﺍﻟﺤﻘﻥ ﺍﻟﻤﺘﻌﺎﻗﺏ ﺍﻟﻁﻴﻔﻲ ﻭ ﺍﻟﻤﺼﻔﻭﻓﺎﺕ ﺍﻟﻜﻴﻤﻴﺎﺌﻴﺔ
ﻜﻠﻭﺭﻓﻴﻨﺎﺭﻤﻴﻥ ﻤﻠﻴﺎﺕ ﻭ ﻓﻴﺭﺍﺒﺎﻤﻴل ﻜﻠﻭﺭﻴﺩ ﺍﻟﻬﺎﻴﺩﺭﻭﺠﻴﻥ ﻋﻠﻰ ﺃﻜﺴﺩﺘﻬﻤﺎ ﺒﻭﺍﺴﻁﺔ ﺒﻴﺭﻤﻨﺠﻨﺎﺕ ﺍﻟﺒﻭﺘﺎﺴـﻴﻭﻡ 
 ﺍﻟﺒﻴﺭﻤﻨﺠﻨـﺎﺕ ﻋﻨـﺩ ﻁـﻭل ﻤﺘﺼﺎﺹﺇﻓﻲ ﻭﺠﻭﺩ ﺤﻤﺽ ﺍﻟﻜﺒﺭﻴﺘﻴﻙ ﻭ ﺭﺼﺩ ﻤﻘﺩﺍﺭ ﺍﻟﻨﻘﺼﺎﻥ ﺍﻟﻨﺎﺘﺞ ﻓﻲ 
ﻜﻤﺎ ﺘﻡ ﺘﻁﺒﻴﻕ ﺍﻟﻤﺼﻔﻭﻓﺎﺕ ﺍﻟﻜﻴﻤﻴﺎﺌﻴﺔ ﻟﻠﻭﺼﻭل ﻷﻓﻀل ﺍﻟﻅﺭﻭﻑ ﻭ ﻫﻲ ﻁـﺭﻕ ،  ﻨﺎﻨﻭﻤﺘﺭ 645ﻤﻭﺠﻲ 
ﺨﺘﻴﺎﺭ ﺘﺭﻜﻴﺯ ﺍﻟﺤﻤﺽ ﻭ ﺘﺭﻜﻴـﺯ ﺇﻜﺫﻟﻙ ﺘﻡ . ﺴﺘﺠﺎﺒﺔ ﺍﻟﺴﻁﺢ ﻭ ﺘﺄﺜﻴﺭ ﺍﻟﻌﻭﺍﻤل ﻜﺄﺠﺯﺍﺀ ﻤﻥ ﺘﺤﻠﻴل ﺍﻟﺘﻐﻴﺭ ﺇ
 ﻓـﻲ ﻫـﺫﺍ 32ﺘﺨﺩﺍﻡ ﺍﻟﻌﺎﻤـل ﺴﺇﻭ ﺘﻡ ، ﺍﻟﺒﻴﺭﻤﻨﺠﻨﺎﺕ ﻭ ﻭﻗﺕ ﺍﻟﺘﺤﻠﻴل ﻜﻌﻭﺍﻤل ﻤﺅﺜﺭﺓ ﻓﻲ ﻜﻔﺎﺀﺓ ﺍﻟﺘﺤﻠﻴل 
ﺴﺘﺠﺎﺒﺔ ﺍﻟﺴﻁﺢ ﻭ ﺍﻥ ﺘﺄﺜﻴﺭ ﺇﺍﻟﺘﺤﻠﻴل ﻭﻭﺠﺩ ﻤﻥ ﺘﻘﺩﻴﺭ ﺘﺄﺜﻴﺭ ﺍﻟﻌﻭﺍﻤل ﻭ ﺍﻟﺘﺄﺜﻴﺭﺍﺕ ﺍﻟﻤﺘﺩﺍﺨﻠﺔ ﻓﻲ ﺘﻭﺍﻓﻕ ﻤﻊ 
  .ﺘﺭﻜﻴﺯ ﺍﻟﺒﻴﺭﻤﻨﺠﻨﺎﺕ ﻭﻭﻗﺕ ﺍﻟﺘﺤﻠﻴل ﺍﻜﺒﺭ ﻤﻥ ﺘﺄﺜﻴﺭ ﺘﺭﻜﻴﺯ ﺍﻟﺤﻤﺽ
  ﻁﺭﻴﻘﺔ ﺍﻟﺘﺤﻠﻴل ﺒﻭﺍﺴﻁﺔ ﻓﺭﻕ ﺍﻟﺠﻬﺩ ﺍﻟﻜﻬﺭﺒﺎﺌﻲ ﺍﻟﺘﻔﺎﻀﻠﻲ ﻤﻥ ﺍﻟﻁﺭﻕ ﺍﻟﺠﺩﻴﺩﺓ ﺤﻴـﺙ ﺃﻥ ﺘﻌﺘﺒﺭ
ﺃﻏﻠﺏ ﺍﻟﺒﺎﺤﺜﻴﻥ ﻴﺴﺘﺨﺩﻡ ﻁﺭﻕ ﺍﻟﺘﺤﻠﻴل ﺍﻟﺘﻘﻠﻴﺩﻴﺔ ﺒﻭﺍﺴﻁﺔ ﻓﺭﻕ ﺍﻟﺠﻬﺩ ﺍﻟﻜﻬﺭﺒﺎﺌﻲ ﺒﺩﻭﻥ ﺘﻴﺎﺭ ﻭ ﺒﺎﺴـﺘﺨﺩﺍﻡ 
 ﻗﻁﺒﻴﻥ ﻤﺘﻁـﺎﺒﻘﻴﻥ ﻤـﻥ ﺴﺘﺨﺩﺍﻡﺇﻗﻁﺏ ﻗﻴﺎﺴﻲ ﻭ ﺁﺨﺭ ﻋﻤﻠﻲ ﺒﻴﻨﻤﺎ ﺍﻟﻤﻌﺎﻴﺭﺓ ﻓﻲ ﺘﻔﺎﻋﻼﺕ ﺍﻷﻜﺴﺩﺓ ﻴﻤﻜﻨﻨﺎ 
 ﻫـﺫﻩ ﺴـﺘﺨﺩﺍﻡ ﺇﻡ ﻭ ﻗﺩ ﺘ . ﺍﻟﺒﻼﺘﻴﻥ ﻟﻘﻴﺎﺱ ﻓﺭﻕ ﺍﻟﺠﻬﺩ ﺍﻟﻜﻬﺭﺒﺎﺌﻲ ﺍﻟﺘﻔﺎﻀﻠﻲ ﻓﻲ ﻭﺠﻭﺩ ﺘﻴﺎﺭﻜﻬﺭﺒﺎﺌﻲ ﻗﻠﻴل 
ﺄﻜﺴﺩﺘﻪ ﺒﻭﺍﺴـﻁﺔ ﺒ ﺠﻴﻥ ﻓﻲ ﺍﻟﻤﺴﺘﺤﻀﺭﺍﺕ ﺍﻟﺩﻭﺍﺌﻴﺔ ﻋﻘﺎﺭ ﺒﺭﻭﻤﻴﺜﺎﺯﻴﻥ ﻜﻠﻭﺭﻴﺩ ﺍﻟﻬﺎﻴﺩﺭﻭ ﺍﻟﻁﺭﻴﻘﺔ ﻟﺘﺤﻠﻴل 
  . ﻗﻴﺎﺱ ﻓﺭﻕ ﺍﻟﺠﻬﺩ ﻭ ﺍﻟﺤﺠﻡ ﺍﻟﻨﺎﺘﺠﻴﻥ ﻤﻥ ﻫﺫﻩ ﺍﻟﻤﻌﺎﻴﺭﺓ ﻓﻲ ﻭﺠﻭﺩ ﺤﻤﺽ ﺍﻟﻜﺒﺭﻴﺘﻴﻙ ﻭ ﺍﻟﺴﻴﺭﻴﻡ ﺍﻟﺭﺒﺎﻋﻲ
  
  
  ﺍﻟﻨﺘﺎﺌﺞ
 3-01×1 ﻤﻴﻜﺭﻭﻟﻴﺘﺭ ﻤـﻥ 53ﻟﻘﺩ ﻭﺠﺩ ﺃﻥ ﺃﻓﻀل ﻅﺭﻭﻑ ﺍﻟﺘﺤﻠﻴل ﺍﻟﻜﻤﻲ ﻟﻜﻠﻭﺭﻓﻴﻨﺎﺭﻤﻴﻥ ﻫﻲ 
 ﺩﻗﺎﺌﻕ 4 ﻤﻭل ﻟﻜل ﻟﺘﺭ ﻤﻥ ﺍﻟﺒﻴﺭﻤﻨﺠﻨﺎﺕ ﻭ 3-01×1 ﻤﻴﻜﺭﻭﻟﻴﺘﺭ ﻤﻥ  03ﻤﻭل ﻟﻜل ﻟﺘﺭ ﻤﻥ ﺍﻟﺤﻤﺽ ﻭ 
 ﻤﻴﻜﺭﻭﻟﻴﺘﺭ ﻟﻜل ﺜﺎﻨﻴـﺔ ﻟﺘﻌﻁـﻲ 52 ﻤﻴﻜﺭﻭﻟﻴﺘﺭ ﻤﻥ ﻜﻠﻭﺭﻓﻴﻨﺎﺭﻤﻴﻥ ﻭ ﻤﻌﺩل ﺍﻨﺴﻴﺎﺏ 03ﻭﻗﺕ ﺘﺤﻠﻴل ﻭ 
 ﺍﻟﻰ 02ﻁﻲ ﻤﻥ   ﻭ ﻤﺩﻯ ﺨ( 8999.0)ﻭ ﻤﻌﺎﻤل ﺍﺭﺘﺒﺎﻁ ( )4600.0 +C6100.0 = Rﻤﻌﺎﺩﻟﺔ ﺘﻌﻴﻴﺭ 
 .  ﺠﺯﺀ  ﻤﻥ ﺍﻟﻤﻠﻴﻭﻥ051
 ﻤﻭل ﻟﻜـل 3-01×1 ﻤﻴﻜﺭﻭﻟﻴﺘﺭ ﻤﻥ 53 ﻭ ﺃﻥ ﺃﻓﻀل ﻅﺭﻭﻑ ﺍﻟﺘﺤﻠﻴل ﺍﻟﻜﻤﻲ ﻟﻔﻴﺭﺍﺒﺎﻤﻴل ﻫﻲ 
 ﻤﻭل ﻟﻜل ﻟﺘﺭ ﻤﻥ ﺍﻟﺒﻴﺭﻤﻨﺠﻨﺎﺕ ﻭ ﺩﻗﻴﻘﺘﺎﻥ ﻭﻗﺕ ﺘﺤﻠﻴل 3-01×2 ﻤﻴﻜﺭﻭﻟﻴﺘﺭ ﻤﻥ  03ﻟﺘﺭ ﻤﻥ ﺍﻟﺤﻤﺽ ﻭ 
 ﺜﺎﻨﻴـﺔ ﻟﺘﻌﻁـﻲ ﻤﻌﺎﺩﻟـﺔ ﺘﻌﻴﻴـﺭ            ﻤﻴﻜﺭﻭﻟﻴﺘﺭ ﻟﻜل 52 ﻤﻴﻜﺭﻭﻟﻴﺘﺭ ﻤﻥ ﻓﻴﺭﺍﺒﺎﻤﻴل ﻭ ﻤﻌﺩل ﺍﻨﺴﻴﺎﺏ 03ﻭ 
  ﺠﺯﺀ ﻤﻥ 002 ﺍﻟﻰ 05ﻭ ﻤﺩﻯ ﺨﻁﻲ ﻤﻥ  ( 8799.0)ﻭ ﻤﻌﺎﻤل ﺍﺭﺘﺒﺎﻁ ( )500.0 +C8100.0 = R
  .ﺍﻟﻤﻠﻴﻭﻥ
ﺒﻨﻅﺎﻡ ﻓﺭﻕ ﺍﻟﺠﻬﺩ ﺍﻟﻜﻬﺭﺒﺎﺌﻲ ﺍﻟﺘﻔﺎﻀﻠﻲ ﻋﻠﻰ ﺃﻜـﺴﺩﺘﻪ ﺘﺒﻨﻰ ﻁﺭﻴﻘﺔ ﺍﻟﺘﺤﻠﻴل ﺍﻟﻜﻤﻲ ﻟﺒﺭﻭﻤﻴﺜﺎﺯﻴﻥ 
ﺱ ﻓﺭﻕ ﺍﻟﺠﻬﺩ ﻭ ﺍﻟﺤﺠﻡ ﺍﻟﻨﺎﺘﺠﻴﻥ ﻤﻥ ﻫـﺫﻩ ﻗﻴﺎ ﻓﻲ ﻭﺠﻭﺩ ﺤﻤﺽ ﺍﻟﻜﺒﺭﻴﺘﻴﻙ ﻭ ﺍﻟﺴﻴﺭﻴﻡ ﺍﻟﺭﺒﺎﻋﻲ ﺒﻭﺍﺴﻁﺔ 
ﺍﻟﻤﻌﺎﻴﺭﺓ ﻭ ﻤﻥ ﺜﻡ ﺭﺴﻡ ﻤﻨﺤﻨﻴﺎﺕ ﺍﻟﻤﻌﺎﻴﺭﺓ ﺍﻟﻤﺨﺘﻠﻔﺔ ﺒﺎﺴﺘﺨﺩﺍﻡ ﻓﺭﻕ ﺍﻟﺠﻬﺩ ﺍﻟﻨﺎﺘﺞ ﻭ ﺤﺠﻡ ﺍﻟﺴﻴﺭﻴﻡ ﺍﻟﺭﺒﺎﻋﻲ 
ﻤـﻥ ﹰ ﻭﺍﺤﺩﺍﹰ ﻭ ﻟﻘﺩ ﻭﺠﺩ ﺃﻥ ﺠﺯﺀﺍ ، ﺍﻟﻼﺯﻡ ﻻﺘﻤﺎﻡ ﺍﻟﻤﻌﺎﻴﺭﺓ ﺜﻡ ﺩﺭﺍﺴﺔ ﺍﻟﻨﺘﺎﺌﺞ ﻭ ﻋﻤل ﺍﻟﺤﺴﺎﺒﺎﺕ ﺍﻟﻼﺯﻤﺔ 
 ﻋﻠﻰ ﺃﻓﻀل ﻅﺭﻭﻑ ﺍﻟﺘﺤﻠﻴل ﻭﻭﺠﺩ ﺃﻥ . ﻤﻥ ﺍﻟﺴﻴﺭﻴﻡ ﺍﻟﺭﺒﺎﻋﻲ ﹰ ﺍﺤﺩﺍﻭﹰ ﺍﻟﺒﺭﻭﻤﻴﺜﺎﺯﻴﻥ ﻗﺩ ﺘﻔﺎﻋل ﻤﻊ ﺠﺯﺀﺍ 
 3-01×5 -  3-01×1ﺘﺭﻜﻴﺯ ﺍﻻﻟﻜﺘﺭﻭﻻﻴﺕ ﺍﻟﻤﻌﺎﻀﺩ ﻭ ﻫﻭ ﺤﻤﺽ ﺍﻟﻜﺒﺭﻴﺘﻴﻙ ﻴﺘﺭﺍﻭﺡ ﺒﻴﻥ : ﻨﺤﻭ ﻤﺎ ﻴﻠﻲ 
ﻭ ﺘﻴـﺎﺭ ،  ﻤﻭل ﻟﻜـل ﻟﺘـﺭ 3-01×1 - 5-01×5ﺘﺭﻜﻴﺯ ﺍﻟﺴﻴﺭﻴﻡ ﺍﻟﺭﺒﺎﻋﻲ ﻴﺘﺭﺍﻭﺡ ﺒﻴﻥ  ، ﻤﻭل ﻟﻜل ﻟﺘﺭ 
  . ﻤﻴﻜﺭﻭﻟﻴﺘﺭ ﻟﻜل ﺜﺎﻨﻴﺔ02ﺎﺏ ﺍﻨﺴﻴ ﻤﺎﻴﻜﺭﻭﺃﻤﺒﻴﺭ ﻭ ﻤﻌﺩل 5ﻤﺘﺭﺩﺩ 
  
  ﺍﻟﺨﻼﺼﺔ
ﻟﻘﺩ ﻭﺠﺩ ﺃﻥ ﺍﻟﻁﺭﻕ ﺍﻟﺠﺩﻴﺩﺓ ﺫﺍﺕ ﺩﻗﺔ ﻭ ﻤﺼﺩﺍﻗﻴﺔ ﻋﻨﺩ ﻤﻘﺎﺭﻨﺘﻬـﺎ ﺒﻨﺘـﺎﺌﺞ ﺩﺴـﺘﻭﺭ ﺍﻷﺩﻭﻴـﺔ 
ﺍﻟﺒﺭﻴﻁﺎﻨﻲ ﻭ ﻜﺫﻟﻙ ﻓﻴﻤﺎ ﻴﺘﻌﻠﻕ ﺒﺴﺭﻋﺘﻬﺎ ﻭ ﻤﻌﺎﻟﺠﺘﻬﺎ ﻟﻠﻌﻴﻨﺎﺕ ﻭ ﺘﻭﻓﻴﺭﻫﺎ ﻟﻠﻜﻭﺍﺸﻑ ﻭ ﻤﺤﺎﻓﻅﺘﻬـﺎ ﻋﻠـﻰ 
  .ﺍﻟﺩﻗﺔ ﻭ ﺍﻟﻤﺼﺩﺍﻗﻴﺔ ﺍﻟﻰ ﹰﺍﻟﺒﻴﺌﺔ ﻭ ﺃﻴﻀﺎ ﻤﻥ ﻨﺎﺤﻴﺔ ﺍﻟﺫﺍﺘﻴﺔ ﻭ ﺍﻻﻨﺘﻘﺎﺌﻴﺔ ﺍﻀﺎﻓﺔ
 ﻁﺭﻴﻘﺔ ﺍﻟﺘﺤﻠﻴل ﺒﻭﺍﺴﻁﺔ ﻓﺭﻕ ﺍﻟﺠﻬﺩ ﺍﻟﻜﻬﺭﺒﺎﺌﻲ ﺍﻟﺘﻔﺎﻀﻠﻲ ﺍﻟﺠﺩﻴﺩﺓ ﻋﺎﻟﻴﺔ ﺍﻟﺤـﺴﺎﺴﻴﺔ ﻤـﻊ ﺘﻌﺘﺒﺭ
ﺒﺘﻐﻴﺭ ﺘﺭﻜﻴﺯ ﺍﻻﻟﻜﺘﺭﻭﻻﻴﺕ ﺍﻟﻤﻌﺎﻀـﺩ ﻟﻬـﺫﺍ ﹰ ﻭ ﻟﻜﻨﻬﺎ ﻗﺩ ﺘﺘﺄﺜﺭ ﻜﺜﻴﺭﺍ ، ﺩﺭﺠﺎﺕ ﻜﺸﻑ ﻤﻨﺨﻔﻀﺔ ﺍﻟﺤﺩﻭﺩ 
ﻬﺎ ﻤﻥ ﻫـﺫﻩ ﺍﻟﻁﺭﻴﻘـﺔ ﻭ ﻟﻘﺩ ﻭﺠﺩ ﺃﻥ ﺍﻟﻨﺘﺎﺌﺞ ﺍﻟﻤﺘﺤﺼل ﻋﻠﻴ . ﻴﺠﺏ ﻀﺒﻁﻪ ﺒﻌﻨﺎﻴﺔ ﺘﺎﻤﺔ ﻟﻀﻤﺎﻥ ﺍﻟﺘﻜﺭﺍﺭ 
ﺩﻗﻴﻘﺔ ﻭ ، ﻴﻤﻜﻥ ﻤﻘﺎﺭﻨﺘﻬﺎ ﺒﺘﻠﻙ ﺍﻟﻤﻨﺼﻭﺹ ﻋﻠﻴﻬﺎ ﻓﻲ ﺩﺴﺘﻭﺭ ﺍﻷﺩﻭﻴﺔ ﺍﻟﺒﺭﻴﻁﺎﻨﻲ ﻤﻊ ﻤﻴﺯﺓ ﻜﻭﻨﻬﺎ ﺍﻗﺘﺼﺎﺩﻴﺔ 
  .  ﺫﺍﺕ ﻤﺼﺩﺍﻗﻴﺔ ﻭ ﺸﺒﻪ ﺫﺍﺘﻴﺔ
 
   
               
Abstract 
 
Objectives 
 The objectives of this study is to perform comprehensive procedures for 
the oxidation of  chlorpheniramine maleate and verapamil hydrochloride by 
permanganate in sulphuric acid media utilizing sequential injection analysis 
(SIA) and promethazine hydrochloride by cerium IV in acid medium using 
differential electrolytic potentiometry (DEP). To construct SIA and DEP 
manifolds suitable for these methods of assay. To establish appropriate 
programs to control the newly adopted methods. To search for the optimum 
conditions for these assay methods, to conduct a chemometric optimization for 
the SIA methods, to evaluate the accuracy, precision, repeatability, robustness 
and cost of the newly adopted method, and finally to validate the newly 
adopted methods by comparison with the BP standard methods. 
In this thesis two systems were studied, the first was sequential injection 
analysis (SIA) technique for the assay of chlorpheniramine maleate and 
verapamil hydrochloride in pharmaceuticals formulations, and the second was 
DEP (differential electrolytic potentiometry) for the assay of promethazine 
hydrochloride in pharmaceutical formulations. 
 
Methodology 
SIA methods were novel, robust, cost-effective and fully automated. The 
newly adopted methods utilized sequential injection analysis with 
spectrophotometry and chemometric approaches. The methods for the assay of 
chlorpheniramine and verapamil were based on their oxidation by 
permanganate in sulfuric acid medium and their consequent spectrophotometric 
measurement of the absorbance at wavelength 546 nm. The methods were 
optimized chemometrically with surface response and estimation of effects 
factorial design ANOVA approaches. This method was applied for factors 
which presumably have potential effects on the efficiency of the methods, such 
as acid and permanganate concentrations and delay time. A 23 factorial design 
chemometric method was applied, that from the estimation of effect factors, the 
main and interaction effect factors were found to be in agreement with the 
surface response. These findings indicate that the concentration of 
permanganate and delay time have a greater effect on response than acid 
concentration. 
DEP method is considered new since researchers are still using the 
traditional potentiometry at zero current with standard and working electrodes. 
In DEP for redox titration two identical platinum electrodes at low current are 
used. The assay of promethazine hydrochloride was based on its oxidation by 
cerium (IV) in sulfuric acid medium and consequent measurement of the 
potential difference and recording the volume of cerium (IV) needed to 
complete the titration. 
 
Results 
In the chlorpheniramine maleate assay, the optimum operating 
conditions were found to be 35µl of 1×10-3 mol l-1 sulfuric acid, 30µl of 1×10-3 
mol l-1 permanganate, 4 minutes delay time and 30µl of chlorpheniramine with 
a flow rate of 25µl s-1. Beer, s law was obeyed in the concentration range of 20 
– 150 ppm with regression calibration equation (R=0.0016C+0.0064) and 
correlation coefficient of 0.9998. 
In the verapamil hydrochloride assay, the optimum operating conditions 
were found to be 35µl of 1×10-3 mol l-1 sulfuric acid, 30µl of 2×10-3 mol l-1 
permanganate, 2 minutes delay time and 30µl of verapamil with a flow rate of 
25µl s-1. Beer, s law was obeyed in the concentration range of 50 – 200 ppm 
with regression calibration equation (R=0.0018C+0.005) and correlation 
coefficient 0.9978. 
In DEP different titration curves of volume of cerium (IV) against 
potential were drawn. The results obtained were studied and the necessary 
calculations were made. It was found that one part of promethazine reacts with 
one part of cerium (IV). The optimum working conditions were as follows for 
supporting electrolyte concentration sulfuric acid, ranges from 1×10-3mol l-1-
5×10-3mol l-1, cerium (IV) concentration ranges from 5×10-5 mol l-1-1×10-3 mol 
l-1, DC current of 5µA and flow rate of 20µl s-1.  
 
Conclusion 
The developed SIA methods were found to be accurate and reproducible 
when the results were statistically compared with the results obtained by the 
official standard methods with respect to sample handling, reagents saving, 
environmental hazardous, automation, precision and accuracy. 
The developed DEP method was found to be highly sensitive with lower 
detection limits and seemed to be largely affected by the variation of 
supporting electrolyte concentrations which may affect repeatability and should 
be carefully adjusted. The results obtained from DEP method were comparable 
to those of the official BP methods, with the advantages of being economical, 
accurate, precise and partially automated.  
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II 
  ﺍﻟﺨﻼﺼﺔ
  
ﺍﻷﻭل ﻫﻭ ﺍﺴﺘﺨﺩﺍﻡ ﺘﻘﻨﻴﺔ ﺍﻟﺘﺤﻠﻴل ﺒﺎﻟﺤﻘﻥ ﺍﻟﻤﺘﻌﺎﻗﺏ ﻷﺩﻭﻴـﺔ ، ﻁﺭﻭﺤﺔ ﺘﻡ ﻋﻤل ﻨﻅﺎﻤﻴﻥ ﻓﻲ ﻫﺫﻩ ﺍﻷ 
ﻭ ﺍﻵﺨﺭ ﻫﻭ ﺍﺴﺘﺨﺩﺍﻡ ، ﻜﻠﻭﺭﻓﻴﻨﺎﺭﻤﻴﻥ ﻤﻠﻴﺎﺕ ﻭ ﻓﻴﺭﺍﺒﺎﻤﻴل ﻜﻠﻭﺭﻴﺩ ﺍﻟﻬﺎﻴﺩﺭﻭﺠﻴﻥ ﻓﻲ ﺍﻟﻤﺴﺘﺤﻀﺭﺍﺕ ﺍﻟﺩﻭﺍﺌﻴﺔ 
ﻟﻬﺎﻴـﺩﺭﻭﺠﻴﻥ ﻓـﻲ ﺍﻟﻤﻌﺎﻴﺭﺓ ﺒﻨﻅﺎﻡ ﻓﺭﻕ ﺍﻟﺠﻬﺩ ﺍﻟﻜﻬﺭﺒﺎﺌﻲ ﺍﻟﺘﻔﺎﻀـﻠﻲ ﻟﻌﻘـﺎﺭ ﺒﺭﻭﻤﻴﺜـﺎﺯﻴﻥ ﻜﻠﻭﺭﻴـﺩ ﺍ 
  .ﺍﻟﻤﺴﺘﺤﻀﺭﺍﺕ ﺍﻟﺩﻭﺍﺌﻴﺔ
ﺘﻘﻭﻡ ﻫﺫﻩ ﺍﻟﻁﺭﻕ . ﻗﺘﺼﺎﺩﻴﺔ ﻭ ﺫﺍﺘﻴﺔ ﺇ، ﺴﺭﻴﻌﺔ، ﺠﺩﻴﺩﺓﻗﴼ ﺘﻌﺘﺒﺭ ﻁﺭﻕ ﺍﻟﺘﺤﻠﻴل ﺒﺎﻟﺤﻘﻥ ﺍﻟﻤﺘﻌﺎﻗﺏ ﻁﺭ 
ﺘﻌﺘﻤـﺩ ﻁﺭﻴﻘﺘـﺎ ﺘﺤﻠﻴـل . ﺍﻟﺠﺩﻴﺩﺓ ﺒﺎﺴﺘﺨﺩﺍﻡ ﺨﺎﺼﻴﺔ ﺍﻟﺤﻘﻥ ﺍﻟﻤﺘﻌﺎﻗﺏ ﺍﻟﻁﻴﻔﻲ ﻭ ﺍﻟﻤﺼﻔﻭﻓﺎﺕ ﺍﻟﻜﻴﻤﻴﺎﺌﻴـﺔ 
ﻴﻥ ﻋﻠﻰ ﺃﻜﺴﺩﺘﻬﻤﺎ ﺒﻭﺍﺴﻁﺔ ﺒﻴﺭﻤﻨﺠﻨﺎﺕ ﺍﻟﺒﻭﺘﺎﺴﻴﻭﻡ ﻓﻲ ﻜﻠﻭﺭﻓﻴﻨﺎﺭﻤﻴﻥ ﻤﻠﻴﺎﺕ ﻭ ﻓﻴﺭﺍﺒﺎﻤﻴل ﻜﻠﻭﺭﻴﺩ ﺍﻟﻬﺎﻴﺩﺭﻭﺠ 
ﻤﺘﺼﺎﺹ ﺍﻟﺒﻴﺭﻤﻨﺠﻨﺎﺕ ﻋﻨﺩ ﻁـﻭل ﻤـﻭﺠﻲ ﺇﻭﺠﻭﺩ ﺤﻤﺽ ﺍﻟﻜﺒﺭﻴﺘﻴﻙ ﻭ ﺭﺼﺩ ﻤﻘﺩﺍﺭ ﺍﻟﻨﻘﺼﺎﻥ ﺍﻟﻨﺎﺘﺞ ﻓﻲ 
ﺴـﺘﺠﺎﺒﺔ ﺇﻜﻤﺎ ﺘﻡ ﺘﻁﺒﻴﻕ ﺍﻟﻤﺼﻔﻭﻓﺎﺕ ﺍﻟﻜﻴﻤﻴﺎﺌﻴﺔ ﻟﻠﻭﺼﻭل ﻷﻓﻀل ﺍﻟﻅﺭﻭﻑ ﻭ ﻫﻲ ﻁﺭﻕ ،  ﻨﺎﻨﻭﻤﺘﺭ 645
ﺨﺘﻴﺎﺭ ﺘﺭﻜﻴﺯ ﺍﻟﺤﻤﺽ ﻭ ﺘﺭﻜﻴﺯ ﺍﻟﺒﻴﺭﻤﻨﺠﻨﺎﺕ ﺇﻜﺫﻟﻙ ﺘﻡ . ﺭﺍﻟﺴﻁﺢ ﻭ ﺘﺄﺜﻴﺭ ﺍﻟﻌﻭﺍﻤل ﻜﺄﺠﺯﺍﺀ ﻤﻥ ﺘﺤﻠﻴل ﺍﻟﺘﻐﻴ
 ﻓﻲ ﻫﺫﺍ ﺍﻟﺘﺤﻠﻴل ﻭﻭﺠﺩ ﻤـﻥ 32ﺴﺘﺨﺩﺍﻡ ﺍﻟﻌﺎﻤل ﺇﻭ ﺘﻡ ، ﻭ ﻭﻗﺕ ﺍﻟﺘﺤﻠﻴل ﻜﻌﻭﺍﻤل ﻤﺅﺜﺭﺓ ﻓﻲ ﻜﻔﺎﺀﺓ ﺍﻟﺘﺤﻠﻴل 
ﺴﺘﺠﺎﺒﺔ ﺍﻟﺴﻁﺢ ﻭ ﺍﻥ ﺘﺄﺜﻴﺭ ﺘﺭﻜﻴﺯ ﺍﻟﺒﻴﺭﻤﻨﺠﻨﺎﺕ ﺇﺘﻘﺩﻴﺭ ﺘﺄﺜﻴﺭ ﺍﻟﻌﻭﺍﻤل ﻭ ﺍﻟﺘﺄﺜﻴﺭﺍﺕ ﺍﻟﻤﺘﺩﺍﺨﻠﺔ ﻓﻲ ﺘﻭﺍﻓﻕ ﻤﻊ 
  .ﻤﻥ ﺘﺄﺜﻴﺭ ﺘﺭﻜﻴﺯ ﺍﻟﺤﻤﺽﻭﻭﻗﺕ ﺍﻟﺘﺤﻠﻴل ﺍﻜﺒﺭ 
 ﻤﻭل 3-01×1 ﻤﻴﻜﺭﻭﻟﻴﺘﺭ ﻤﻥ 53ﻟﻘﺩ ﻭﺠﺩ ﺃﻥ ﺃﻓﻀل ﻅﺭﻭﻑ ﺍﻟﺘﺤﻠﻴل ﺍﻟﻜﻤﻲ ﻟﻜﻠﻭﺭﻓﻴﻨﺎﺭﻤﻴﻥ ﻫﻲ 
 ﺩﻗﺎﺌﻕ ﻭﻗـﺕ 4 ﻤﻭل ﻟﻜل ﻟﺘﺭ ﻤﻥ ﺍﻟﺒﻴﺭﻤﻨﺠﻨﺎﺕ ﻭ 3-01×1 ﻤﻴﻜﺭﻭﻟﻴﺘﺭ ﻤﻥ  03ﻟﻜل ﻟﺘﺭ ﻤﻥ ﺍﻟﺤﻤﺽ ﻭ 
ﻴﺔ ﻟﺘﻌﻁـﻲ ﻤﻌﺎﺩﻟـﺔ  ﻤﻴﻜﺭﻭﻟﻴﺘﺭ ﻟﻜل ﺜﺎﻨ 52 ﻤﻴﻜﺭﻭﻟﻴﺘﺭ ﻤﻥ ﻜﻠﻭﺭﻓﻴﻨﺎﺭﻤﻴﻥ ﻭ ﻤﻌﺩل ﺍﻨﺴﻴﺎﺏ 03ﺘﺤﻠﻴل ﻭ 
  051 ﺍﻟـﻰ 02ﻭ ﻤﺩﻯ ﺨﻁﻲ ﻤـﻥ   ( 8999.0)ﻭ ﻤﻌﺎﻤل ﺍﺭﺘﺒﺎﻁ ( )4600.0 +C6100.0 = Rﺘﻌﻴﻴﺭ 
 .ﺠﺯﺀ  ﻤﻥ ﺍﻟﻤﻠﻴﻭﻥ
 ﻤﻭل ﻟﻜل ﻟﺘﺭ 3-01×1 ﻤﻴﻜﺭﻭﻟﻴﺘﺭ ﻤﻥ 53 ﻭ ﺃﻥ ﺃﻓﻀل ﻅﺭﻭﻑ ﺍﻟﺘﺤﻠﻴل ﺍﻟﻜﻤﻲ ﻟﻔﻴﺭﺍﺒﺎﻤﻴل ﻫﻲ 
 03ﻗﻴﻘﺘﺎﻥ ﻭﻗﺕ ﺘﺤﻠﻴل ﻭ  ﻤﻭل ﻟﻜل ﻟﺘﺭ ﻤﻥ ﺍﻟﺒﻴﺭﻤﻨﺠﻨﺎﺕ ﻭ ﺩ3-01×2 ﻤﻴﻜﺭﻭﻟﻴﺘﺭ ﻤﻥ  03ﻤﻥ ﺍﻟﺤﻤﺽ ﻭ 
 = R ﻤﻴﻜﺭﻭﻟﻴﺘﺭ ﻟﻜل ﺜﺎﻨﻴﺔ ﻟﺘﻌﻁﻲ ﻤﻌﺎﺩﻟﺔ ﺘﻌﻴﻴﺭ           52ﻤﻴﻜﺭﻭﻟﻴﺘﺭ ﻤﻥ ﻓﻴﺭﺍﺒﺎﻤﻴل ﻭ ﻤﻌﺩل ﺍﻨﺴﻴﺎﺏ 
  ﺠـﺯﺀ ﻤـﻥ 002 ﺍﻟـﻰ 05ﻭ ﻤﺩﻯ ﺨﻁﻲ ﻤﻥ  ( 8799.0)ﻭ ﻤﻌﺎﻤل ﺍﺭﺘﺒﺎﻁ ( )500.0 +C8100.0
  .ﺍﻟﻤﻠﻴﻭﻥ
ﺘﺎﺌﺞ ﺩﺴﺘﻭﺭ ﺍﻷﺩﻭﻴﺔ ﺍﻟﺒﺭﻴﻁﺎﻨﻲ ﻟﻘﺩ ﻭﺠﺩ ﺃﻥ ﺍﻟﻁﺭﻕ ﺍﻟﺠﺩﻴﺩﺓ ﺫﺍﺕ ﺩﻗﺔ ﻭ ﻤﺼﺩﺍﻗﻴﺔ ﻋﻨﺩ ﻤﻘﺎﺭﻨﺘﻬﺎ ﺒﻨ 
ﻭ ﻜﺫﻟﻙ ﻓﻴﻤﺎ ﻴﺘﻌﻠﻕ ﺒﺴﺭﻋﺘﻬﺎ ﻭ ﻤﻌﺎﻟﺠﺘﻬﺎ ﻟﻠﻌﻴﻨﺎﺕ ﻭ ﺘﻭﻓﻴﺭﻫﺎ ﻟﻠﻜﻭﺍﺸﻑ ﻭ ﻤﺤﺎﻓﻅﺘﻬﺎ ﻋﻠﻰ ﺍﻟﺒﻴﺌﺔ ﻭ ﺃﻴـﻀﺎ 
  . ﺍﻟﻰ ﺍﻟﺩﻗﺔ ﻭ ﺍﻟﻤﺼﺩﺍﻗﻴﺔﹰﻤﻥ ﻨﺎﺤﻴﺔ ﺍﻟﺫﺍﺘﻴﺔ ﻭ ﺍﻻﻨﺘﻘﺎﺌﻴﺔ ﺍﻀﺎﻓﺔ
ﻴـﺙ ﺃﻥ   ﻁﺭﻴﻘﺔ ﺍﻟﺘﺤﻠﻴل ﺒﻭﺍﺴﻁﺔ ﻓﺭﻕ ﺍﻟﺠﻬﺩ ﺍﻟﻜﻬﺭﺒﺎﺌﻲ ﺍﻟﺘﻔﺎﻀﻠﻲ ﻤﻥ ﺍﻟﻁﺭﻕ ﺍﻟﺠﺩﻴـﺩﺓ ﺤ  ﺘﻌﺘﺒﺭ
ﺃﻏﻠﺏ ﺍﻟﺒﺎﺤﺜﻴﻥ ﻴﺴﺘﺨﺩﻡ ﻁﺭﻕ ﺍﻟﺘﺤﻠﻴل ﺍﻟﺘﻘﻠﻴﺩﻴﺔ ﺒﻭﺍﺴﻁﺔ ﻓﺭﻕ ﺍﻟﺠﻬﺩ ﺍﻟﻜﻬﺭﺒﺎﺌﻲ ﺒﺩﻭﻥ ﺘﻴـﺎﺭ ﻭ ﺒﺎﺴـﺘﺨﺩﺍﻡ 
 ﻗﻁﺒـﻴﻥ ﻤﺘﻁـﺎﺒﻘﻴﻥ ﻤـﻥ ﺴﺘﺨﺩﺍﻡﺇﻗﻁﺏ ﻗﻴﺎﺴﻲ ﻭ ﺁﺨﺭ ﻋﻤﻠﻲ ﺒﻴﻨﻤﺎ ﺍﻟﻤﻌﺎﻴﺭﺓ ﻓﻲ ﺘﻔﺎﻋﻼﺕ ﺍﻷﻜﺴﺩﺓ ﻴﻤﻜﻨﻨﺎ 
  .ﺍﻟﺒﻼﺘﻴﻥ ﻟﻘﻴﺎﺱ ﻓﺭﻕ ﺍﻟﺠﻬﺩ ﺍﻟﻜﻬﺭﺒﺎﺌﻲ ﺍﻟﺘﻔﺎﻀﻠﻲ ﻓﻲ ﻭﺠﻭﺩ ﺘﻴﺎﺭﻜﻬﺭﺒﺎﺌﻲ ﻗﻠﻴل
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 ﻓـﻲ ﻭﺠـﻭﺩ ﺍﻟﺴﻴﺭﻴﻡ ﺍﻟﺭﺒـﺎﻋﻲ ﻋﻠﻰ ﺃﻜﺴﺩﺘﻪ ﺒﻭﺍﺴﻁﺔ ﺘﺒﻨﻰ ﻁﺭﻴﻘﺔ ﺍﻟﺘﺤﻠﻴل ﺍﻟﻜﻤﻲ ﻟﺒﺭﻭﻤﻴﺜﺎﺯﻴﻥ 
ﻗﻴﺎﺱ ﻓﺭﻕ ﺍﻟﺠﻬﺩ ﻭ ﺍﻟﺤﺠﻡ ﺍﻟﻨﺎﺘﺠﻴﻥ ﻤﻥ ﻫﺫﻩ ﺍﻟﻤﻌﺎﻴﺭﺓ ﻭ ﻤﻥ ﺜـﻡ ﺭﺴـﻡ ﻤﻨﺤﻨﻴـﺎﺕ ﺤﻤﺽ ﺍﻟﻜﺒﺭﻴﺘﻴﻙ ﻭ 
ﺭﺍﺴـﺔ ﺍﻟﻤﻌﺎﻴﺭﺓ ﺍﻟﻤﺨﺘﻠﻔﺔ ﺒﺎﺴﺘﺨﺩﺍﻡ ﻓﺭﻕ ﺍﻟﺠﻬﺩ ﺍﻟﻨﺎﺘﺞ ﻭ ﺤﺠﻡ ﺍﻟﺴﻴﺭﻴﻡ ﺍﻟﺭﺒﺎﻋﻲ ﺍﻟﻼﺯﻡ ﻻﺘﻤﺎﻡ ﺍﻟﻤﻌﺎﻴﺭﺓ ﺜﻡ ﺩ 
ﹰ ﻤﻥ ﺍﻟﺒﺭﻭﻤﻴﺜﺎﺯﻴﻥ ﻗﺩ ﺘﻔﺎﻋل ﻤﻊ ﺠـﺯﺀﺍ ﹰ ﻭﺍﺤﺩﺍﹰ ﻭ ﻟﻘﺩ ﻭﺠﺩ ﺃﻥ ﺠﺯﺀﺍ ، ﺍﻟﻨﺘﺎﺌﺞ ﻭ ﻋﻤل ﺍﻟﺤﺴﺎﺒﺎﺕ ﺍﻟﻼﺯﻤﺔ 
ﺘﺭﻜﻴﺯ ﺍﻻﻟﻜﺘﺭﻭﻻﻴـﺕ :  ﻋﻠﻰ ﻨﺤﻭ ﻤﺎ ﻴﻠﻲ ﺃﻓﻀل ﻅﺭﻭﻑ ﺍﻟﺘﺤﻠﻴل ﻭﻭﺠﺩ ﺃﻥ . ﻤﻥ ﺍﻟﺴﻴﺭﻴﻡ ﺍﻟﺭﺒﺎﻋﻲ ﹰ ﻭﺍﺤﺩﺍ
ﻴـﺯ ﺍﻟـﺴﻴﺭﻴﻡ ﺘﺭﻜ،  ﻤﻭل ﻟﻜل ﻟﺘـﺭ 3-01×5 -  3-01×1ﺍﻟﻤﻌﺎﻀﺩ ﻭ ﻫﻭ ﺤﻤﺽ ﺍﻟﻜﺒﺭﻴﺘﻴﻙ ﻴﺘﺭﺍﻭﺡ ﺒﻴﻥ 
 ﻤـﺎﻴﻜﺭﻭﺃﻤﺒﻴﺭ ﻭ ﻤﻌـﺩل 5ﻭ ﺘﻴﺎﺭ ﻤﺘـﺭﺩﺩ ،  ﻤﻭل ﻟﻜل ﻟﺘﺭ 3-01×1 - 5-01×5ﺍﻟﺭﺒﺎﻋﻲ ﻴﺘﺭﺍﻭﺡ ﺒﻴﻥ  
  . ﻤﻴﻜﺭﻭﻟﻴﺘﺭ ﻟﻜل ﺜﺎﻨﻴﺔ02ﺍﻨﺴﻴﺎﺏ 
 ﻁﺭﻴﻘﺔ ﺍﻟﺘﺤﻠﻴل ﺒﻭﺍﺴﻁﺔ ﻓﺭﻕ ﺍﻟﺠﻬﺩ ﺍﻟﻜﻬﺭﺒﺎﺌﻲ ﺍﻟﺘﻔﺎﻀﻠﻲ ﺍﻟﺠﺩﻴﺩﺓ ﻋﺎﻟﻴﺔ ﺍﻟﺤـﺴﺎﺴﻴﺔ ﻤـﻊ ﺘﻌﺘﺒﺭ
ﺒﺘﻐﻴﺭ ﺘﺭﻜﻴﺯ ﺍﻻﻟﻜﺘﺭﻭﻻﻴﺕ ﺍﻟﻤﻌﺎﻀﺩ ﻟﻬﺫﺍ ﻴﺠﺏ ﹰ ﻭ ﻟﻜﻨﻬﺎ ﻗﺩ ﺘﺘﺄﺜﺭ ﻜﺜﻴﺭﺍ ، ﺩﺭﺠﺎﺕ ﻜﺸﻑ ﻤﻨﺨﻔﻀﺔ ﺍﻟﺤﺩﻭﺩ 
ﻭ ﻟﻘﺩ ﻭﺠﺩ ﺃﻥ ﺍﻟﻨﺘﺎﺌﺞ ﺍﻟﻤﺘﺤﺼل ﻋﻠﻴﻬﺎ ﻤﻥ ﻫـﺫﻩ ﺍﻟﻁﺭﻴﻘـﺔ ﻴﻤﻜـﻥ . ﻀﺒﻁﻪ ﺒﻌﻨﺎﻴﺔ ﺘﺎﻤﺔ ﻟﻀﻤﺎﻥ ﺍﻟﺘﻜﺭﺍﺭ 
ﺩﻗﻴﻘـﺔ ﻭ ﺫﺍﺕ ، ﻤﻘﺎﺭﻨﺘﻬﺎ ﺒﺘﻠﻙ ﺍﻟﻤﻨﺼﻭﺹ ﻋﻠﻴﻬﺎ ﻓﻲ ﺩﺴﺘﻭﺭ ﺍﻷﺩﻭﻴﺔ ﺍﻟﺒﺭﻴﻁﺎﻨﻲ ﻤﻊ ﻤﻴﺯﺓ ﻜﻭﻨﻬﺎ ﺍﻗﺘﺼﺎﺩﻴﺔ 
 .  ﻤﺼﺩﺍﻗﻴﺔ ﻭ ﺸﺒﻪ ﺫﺍﺘﻴﺔ
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Abstract 
 
In this thesis two systems were studied, the first was sequential injection 
analysis (SIA) technique for the assay of chlorpheniramine maleate and 
verapamil hydrochloride in pharmaceuticals formulations, and the second was 
DEP (differential electrolytic potentiometry) for the assay of promethazine 
hydrochloride in pharmaceutical formulations. 
SIA methods were novel, robust, cost-effective and fully automated. The 
newly adopted methods utilized sequential injection analysis with 
spectrophotometry and chemometric approaches. The methods for the assay of 
chlorpheniramine and verapamil were based on their oxidation by permanganate 
in sulfuric acid medium and their consequent spectrophotometric measurement 
of the absorbance at wavelength 546 nm. The methods were optimized 
chemometrically with surface response and estimation of effects factorial design 
ANOVA approaches. This method was applied for factors which presumably 
have potential effects on the efficiency of the methods, such as acid and 
permanganate concentrations and delay time. A 23 factorial design chemometric 
method was applied, that from the estimation of effect factors, the main and 
interaction effect factors were found to be in agreement with the surface 
response. These findings indicate that the concentration of permanganate and 
delay time have a greater effect on response than acid concentration. 
In the chlorpheniramine maleate assay, the optimum operating conditions 
were found to be 35µl of 1×10-3 mol l-1 sulfuric acid, 30µl of 1×10-3 mol l-1 
permanganate, 4 minutes delay time and 30µl of chlorpheniramine with a flow 
rate of 25µl s-1. Beer, s law was obeyed in the concentration range of 20 – 150 
ppm with regression calibration equation (R=0.0016C+0.0064) and correlation 
coefficient of 0.9998. 
In the verapamil hydrochloride assay, the optimum operating conditions 
were found to be 35µl of 1×10-3 mol l-1 sulfuric acid, 30µl of 2×10-3 mol l-1 
permanganate, 2 minutes delay time and 30µl of verapamil with a flow rate of 
25µl s-1. Beer, s law was obeyed in the concentration range of 50 – 200 ppm with 
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regression calibration equation (R=0.0018C+0.005) and correlation coefficient 
0.9978. 
The developed SIA methods were found to be accurate and reproducible 
when the results were statistically compared with the results obtained by the 
official standard methods with respect to sample handling, reagents saving, 
environmental hazardous, automation, precision and accuracy. 
DEP method is considered new since researchers are still using the 
traditional potentiometry at zero current with standard and working electrodes. 
In DEP for redox titration two identical platinum electrodes at low current are 
used. The assay of promethazine hydrochloride was based on its oxidation by 
cerium (IV) in sulfuric acid medium and consequent measurement of the 
potential difference and recording the volume of cerium (IV) needed to complete 
the titration. Different titration curves of volume of cerium (IV) against potential 
were drawn. The results obtained were studied and the necessary calculations 
were made. It was found that one part of promethazine reacts with one part of 
cerium (IV). The optimum working conditions were as follows for supporting 
electrolyte concentration sulfuric acid, ranges from 1×10-3mol l-1-5×10-3mol l-1, 
cerium (IV) concentration ranges from 5×10-5 mol l-1-1×10-3 mol l-1, DC current 
of 5µA and flow rate of 20µl s-1.  
The developed DEP method was found to be highly sensitive with lower 
detection limits and seemed to be largely affected by the variation of supporting 
electrolyte concentrations which may affect repeatability and should be carefully 
adjusted. The results obtained from DEP method were comparable to those of 
the official BP methods, with the advantages of being economical, accurate, 
precise and partially automated.  
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CHAPTER ONE 
INTRODUCTION
 2
1.1 Principles of Flow injection (FI) techniques 
All flow injection techniques are based on the injection of a liquid sample 
into a moving, non-segmented carrier stream of a suitable liquid. The injected 
sample form a zone, which is then transported to a detector that records a desired 
physical parameter as it is continuously changing due to the passage of the 
sample material through a flow cell. 
Since it is introduced in the year 1974, FI technique has grown 
dramatically and undergone a lot of modifications and developments, and it is 
classified into three generations; the first generation is flow injection analysis 
(FIA), the second generation is sequential injection analysis (SIA), and the third 
one is bead injection analysis-lab-on-valve (BIA-LOV). The following sections 
briefly describe the main principles, features and the developments of the 
technique as well as its advantages and limitations. 
 
1.1.1 Flow injection analysis (FIA)  
Ruzicka and Hansen in Denmark as well as, Steward in the US created 
the flow injection analysis (FIA) technique for the automation of chemical 
procedures [1, 2].The introduction of this technique revolutionized the concept 
of automation in chemical analysis by allowing instrumental measurements to be 
carried in the absence of physical and chemical equilibrium [3-7]. FIA became 
popular since it automates routine procedures with reduction in sample 
consumption and providing high sampling rates, in addition to its use in other 
areas of chemical analysis, such as the study of kinetic and mechanistic aspects 
of chemical reactions and the development of new chemical, enzymatic and 
immunological procedures. 
The FIA method combines several analytical functions for a method 
performed in a flowing stream and under computer control, in a time of 15-60 
seconds with the volume of a sample in microliters with a simple hardware and 
high precision of about 0.5% (R. S. D.) with relatively little waste and broad 
concentration range form ppb to %(w/v). A FIA method can be divided into 
three stages. Figure 1.1 shows the components of the FIA manifold. The first 
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stage and the second are the heart of FIA, while the third one is based on 
conventional technology. All stages are performed in sequence in a flowing 
carrier stream pumped through a narrow bore tubing of 0.5 mm I.D. The first 
step is the injection of a measured sample into a flowing carrier stream (injected 
sample volumes are 50 to 200 µL, while a typical sampling frequency is 60 
injections/ hour). Samples are injected by means of a two-position valve with a 
fixed internal volume (loop). The valve is furnished with a bypass that allows the 
loop to be filled while the carrier stream is passing through the valve. The 
second stage is a sample processing in which the analyte is transformed into 
species that can be detected and have its concentration manipulated into a range 
that is compatible with the detector. The third one is the detection where the 
analyte or one of its derivatives produces a response that can be reliably 
quantified. 
 FIA has also been used as a “front end” or solution handling system, for 
an entire range of spectroscopic and electrochemical instruments, since it offers 
sample pretreatment, matrix removal and automated recalibration of different 
detectors. FIA can be easily configured with almost all spectroscopic techniques 
including UV/VIS spectrophotometry, fluorescence, chemiluminescence, atomic 
absorption spectrophotometry, atomic emission spectrophotometry and 
nephelometry. In addition, electrochemical measurements like potentiometry, 
voltammetry, polarography and conductimetry. FIA as an analytical tool rapidly 
and automatically performs methods with less sample and reagent consumption 
[4]. 
 
 
 
Figure 1.1: single stream FIA manifold 
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1.1.2 Sequential injection analysis (SIA) [7-15] 
Following the general applications of computers in the routine laboratory 
work, it was possible to cover up the deficiencies of the FIA technique in 
autonomy, given that automatic control of the different electric components in 
the mountings was possible. In that way, a second generation of flow analysis 
was proposed by Ruzicka and Marshal in 1990, designated as sequential 
injection analysis (SIA) [8]. As with the FIA, this is a non-segmented continuous 
flow technique based on the same principles of controlled dispersion and 
reproducible manipulation of the FIA concept, but whose mode of functioning is 
based on the concept of programmable flow. A basic SIA system (figure 1.2) 
consists of a bi-directional propulsion device, a holding coil, a multiposition 
selection valve, a detector, tubing adequate for unifying all different components 
of the system and a microcomputer.  
          
 
Figure 1.2: Basic SIA manifold; RC is reaction coil; R1 and R2 are reagents  
 
This component makes the synchronized control of the propulsion device 
and the multiposition selection valve possible in such a way to define the volume 
and direction of stream of the different solutions. In a typical analytical cycle, 
precise volumes of sample and reagents are sequentially aspirated through the 
multiposition selection valve to the holding coil. By commutation of the 
selection valve and by inversing the direction of the stream, a zone is created 
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(composed of the overlapping sample and reagents zones) for which the radial 
and axial dispersion processes also contribute. When the overlapping zone is 
directed to the detector, a transient signal is obtained of a magnitude 
proportional to the concentration of the species under study. 
       The introduction of SIA marked a new era in the development of flow 
analysis. Compared with FIA, SIA economically uses fewer reagents and 
reduces waste generation, because a permanent flow of carrier solution ceases to 
be necessary, so that the reagents and samples are used in a more efficient way, 
since only volumes necessary are processed. SIA can undertake analytical 
measurements on a large scale because of its high sampling rate (although the 
rates are less compared with FIA). SIA can easily be applied in the kinetic 
studies of chemical reactions, since the factors that affect the precision of the 
volumes and reaction times are rigorously controlled, [16, 17]. The experimental 
parameters can be altered and controlled easily by computer. Knowing the flow 
rate profiles and the selection of both time/flow rate using just one propulsion 
unit, makes these systems simple, robust and stable in the long term. The 
simplicity in configuration does not require significant reconfigurations, so any 
alteration in experimental conditions such as injection volume, reaction type, 
sample dilution or sample/reagent relation can be achieved by changing the 
instruction introduced by the computer keyboard. The versatility shown by SIA 
makes it possible to automate various steps of analytical procedures, for 
example: sample dilution [18], automatic calibration [19], liquid-liquid 
extraction [20], gas-liquid diffusion [21], dialysis and on-line digestion. 
In the course of 17 years, SIA has demonstrated itself to be a powerful 
and versatile instrument for the automation of different analytical procedures. 
This technique has been associated with a large variety of detectors including 
UV/VIS spectrophotometry, fluorescence, turbidimetry, chemiluminescence, 
atomic absorption spectrophotometry, mass spectrometry with radio-frequency 
plasma, atomic emission spectrophotometry, and electrochemical measurements 
like potentiometry, voltammetry, polarography and conductimetry. It has been 
applied in diverse areas of chemistry like, environmental, pharmaceutical, food 
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and beverages, biotechnology, radiochemical and metallurgic, kinetic studies of 
chemical reactions and chemometric studies. 
 
1.1.3 Sequential injection analysis-lab-on-valve (SIA-LOV)  
In order to overcome the drawbacks (handling of hazardous chemicals, in 
reagent-limited assays or waste production as a critical parameter) a new 
generation of flow injection analysis techniques namely sequential injection 
analysis-lab-on-valve (SI-LOV) was introduced. The LOV system potentially 
offers facilities of allowing any kind of chemical and physical process, including 
fluidic and microcarrier bead control, homogenous reaction, , liquid-solid 
extraction, and in-valve, real time optical detection of various reaction processes 
with optical fibers . SIA-LOV has already proved to be an attractive, effective 
front end to various detection devices with microminiaturized sample processing 
along with improved efficiency and ruggedness. Figure 1.3 shows a typical 
micro SIA-LOV system with a close-up of the multi-purpose flow cell 
configured for real-time measurement of absorbance [22, 23]. 
 
 
Figure 1.3: A typical micro SIA-Lab-On-Valve 
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1.1.4 Sequential injection chromatography (SIC)  
A new generation of sequential injection analysis (SIA) called sequential 
injection chromatography (SIC) has already been introduced as a good 
alternative of high performance liquid chromatography (HPLC) for fast analysis 
of simple samples. The benefits of this flow method are automation, 
miniaturization and low sample and mobile phase consumption. The 
implementation of short monolithic chromatographic column into SIA opens 
new areas for on-line chromatographic separation of multi-compound sample in 
low-pressure flow system, with the advantage of programmable flow and 
possibility of sample manipulation. The potentials of SIC and its comparison 
with HPLC for the determination of pharmaceuticals was discussed, but recent 
trends focused on separation with SIC. 
Sequential injection chromatography (SIC) has been successfully applied 
in the analysis of relatively simple multi-component samples, mainly in the field 
of pharmaceutical analysis. Sequential injection chromatography is built on 
classical SIA manifold (in our case FIAlab® 3000 or FIAlab® 3500 analyzers 
equipped with syringe pump). Chromatographic part is represented by short 
(usually 25 or 50mm of length) commercially available monolithic column (with 
or without monolithic pre column 5 or 10mm length) placed between multi-
position valve and Z flow cell of detector (Figure 1.4) [24]. 
 
  
Figure 1.4: Sequential injection chromatography (SIC) 
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1.1.5 Bead injection analysis (BIA)  
Bead injection analysis (BIA), as a third generation of FI techniques, first 
introduced by Ruzicka in 2000, has a programmable flow to handle precise 
volumes of suspended micro beads to perform such physical or chemical 
processes for analytes. Beads can be used as a removable solid surface in many 
analytical applications. It is very practical to use beads in a flow based system, 
where beads can easily be moved in and out of the system using a flowing 
stream of reagent(s). The use of beads for sample pretreatment, such as 
preconcentration, isolation, and separation, and for accommodation of chemical 
reactions has attracted increasing interest. The development and applications of 
the BI technique coupled with a lower cost first-generation FI technique is a 
good alternative to other expensive systems. In its simplest form, microspheres 
are injected into a conduit, where they can be trapped at a selected location, then 
the sample zone is injected and perfused through the beads where sample 
components react with functional groups on bead surfaces, and retained analytes 
are detected by spectroscopy. Analyte molecules may also be eluted for 
detection downstream. The unique features of bead injection are high precision 
of bead delivery, absence of carryover and fast-automated renewal of the 
reactive solid phase that is delivered in uniform composition throughout a series 
of measurements (figure 1.5) [25]. 
 
Figure 1.5: Bead injection analysis (BIA) 
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1.2 Dispersion in FI technique 
Any injection analyzer requires for its successful operation to have the 
capability to bring about the sample and the reactants together and allow them to 
be mixed and react in a reproducible manner. In this respect flow conditions 
should be maintained constant for specific period of time, and as long as flow-
rate is kept constant the sample may be injected into the system at any time, so 
what happens to one sample happens exactly to any other sample regardless to 
when the sample is injected into the carrier stream. To fulfill the above, strict 
control of the flow rate must be maintained throughout the entire analysis 
process. [5]. 
In FIA the sample is completely surrounded by reagents, while in SIA the 
sample and reagent zones are sequentially staked and moved along the 
instrument, the zones penetrate each other and become interdispersed. The 
penetration degree has been measured and defined to help understand zone 
dispersion. These include: D (dispersion); S1/2 (volume required to reach 
dispersion of 2 at the peak maximum); P (degree of zone penetration). [26]. 
Gubeli et al [27] have observed that increasing the sample volume up to 
S1/2 enhanced the sensitivity. However, beyond that volume (S1/2) there was no 
improvement.  
Marshal and van Staden [28] evaluated the precision and zone penetration 
to determine the effect of tubing diameter, reactor geometry and pump speed. 
Their conclusion showed that tubing with internal diameter of 0.8 or 1.5 mm 
gave improved precision without excessive decrease in zone penetration 
compared with that of 0.5mm. They found that knitted reactors were interfered 
to straight tubing with respect to axial dispersion, while the effect of pump speed 
was little as the flow rate changed due to its sinusoidal nature. 
Clardera et al [29] studied the effect of ionic strength, flow rate and 
reactor and holding coils dimensions on the S1/2 value and they found that the 
length and the inner diameter have some influence, but each system should be 
optimized separately.  
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1.3 Applications of SIA to pharmaceutical analysis 
The FIA technique contributes largely to the development of automation 
in pharmaceutical analysis and its advantages are well documented. 
Pharmaceutical applications of FIA were summarized in a monograph [30] and 
updated elsewhere [31, 32]. The introduction of SIA has awakened the interest 
and the need for the automation in the pharmaceutical area. Two review articles 
dedicated to pharmaceutical analysis have been published [33,34], applying 
sequential analysis to a wide variety of matrices, solid (tablets, capsules), liquids 
(suspensions, solutions, emulsions), pastes (ointments, creams) and covering 
different active ingredients. Taking advantages of the economy of reagents and 
high sampling rates, most of these applications are used to determine the active 
ingredients for the quality control of pharmaceuticals. Other applications used its 
robustness and elevated efficiency to monitor the production of pharmaceutical 
compounds and for their dissolution assays. 
 
1.3.1 Automated analysis of drug formulations 
Determination of the active ingredients of pharmaceuticals is one of the 
main quality control tests, so the method used must be selective, precise and 
accurate, since additive substances are also present, (filers, binders, suspending 
agents and preservatives). SIA technique shows a great satisfaction for these 
requirements. The most recent review was published by Pimenta et al, [34] and it 
is summarized in table 1.1 for optical detection methods and table 1.2 for 
electrochemical detection methods. 
  
1.3.1.1 Spectrophotometry 
The majority of the determinations of active ingredient in pharmaceuticals 
belong to a group of spectrophotometric ones, and most of them are based on 
chromogenic reactions or on the specific characteristics of light absorption by 
analytes. The configuration of the SIA is normal, simple and requires the 
selection of the nature and volume to adapt to one or more chromogenic reagents 
and the detection with spectrophotometers. The chromogenic reactions for drugs 
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include among other procedures metal ion chelation reactions for the 
determination of organic compounds or metal ion components, redox reactions, 
ion pairing, charge transfer complex formation reactions. 
 
1.3.1.2 Fluorescence and Chemiluminescence 
In Fluorimetry, the procedures involve elevated selectivity, and it is more 
sensitive than that of the spectrophotometric ones by lowering the interference of 
the matrix and by the proportionality between the intensity of the radiation 
source and the analytical signal measured. 
Chemiluminescent processes are classified into two groups, one in which 
the analyte itself is the emission specie through the direct action of strong 
oxidizing agents (mainly permanganate and CeIV). The other covers indirect 
methods through which the analyte interferes (as a catalizer, inhibitor, etc.) in 
the oxidation of the chemiluminescent precursors such as luminal, lucigenine, 
etc. The latter are called (classics). The current interests focus on liquid phase 
analytical chemiluminescence to find new chemiluminescent reactions directly 
on the analyte. 
 
1.3.1.3 Electrochemistry 
Electrochemical methods are favorable with flow analysis due to their 
sensitivity, controllable selectivity, precision and accuracy, simplicity with easy 
signal handling and automation. However the sensors are difficult to develop and 
the interaction between the sensors and the liquid tested lead to poor stability 
and reproducibility of the active electrode surface. These problems can be 
overcome by the rigorous selection of the experimental conditions. The sensors 
used with SIA gave robust, portable low-cost and high-throughput systems. SIA 
systems with voltammetric, potentiometric and amperometric detection are 
found in the literature (table 1.2). 
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A review of SI techniques applied to pharmaceutical analysis [34] 
Table 1.1 Optical detection methods  
Analyte Matrix Detection method   Linear range R.S.D. %  Sample Ref. 
           frequency h-1   
Alendronic  Tablets Spect. determ.*at (240 nm) 1.0-60.0 mg/l 3 60 [35] 
acid  Fluori. det.¤ (λex340;λem455nm)     0.13-10 mg/l 2 30 [35] 
       
Ambroxol Capsules Spect. determ.*at (213 nm)  2-100 µg/ml 0.5-5.4 7 [36] 
hydrochloride Tablets      
       
p-Aminobenz-  Sunscreens          Spect. determ.*at (500 nm)  0-25 µg/l 2.0- 6.0 13.8 [37] 
oic acid Lotain&sunmilk   Spect. determ.*at (434 nm) 0-20 µg/l 3.0-7.0 13 [38] 
       
Amincaproic Pharmaceutical Fluori. det.¤(λex350;λem450nm)     4x10-7-6x10-5mol/l      <2.0       40 [39] 
acid  formulations      
       
Amoxycillin Tablets  Spect. determ.*at (250 nm) 10-120mg/l 6.0-9.0 20 [40] 
 Tablets  Spect. determ.*at (210-340 nm)       0-60mg/l               1.3 25 [41] 
       
 Benzocaine Injections     Oxidation of drug bypermang-  0.5-25 mg/l <3.8  120 [42] 
    nate in acidic medium,      
  chemiluminiscence (≥390nm)     
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Benzo-  Sunscreens  Spect. determ.*at (286 nm) 10-120 µg/l 1.0-12.0 20 [43] 
 phenone-4       
       
 Bismuth  Tablets & caps  Spect. determ.*at (548 nm) 0.0-75 mg/l  1.1 72 [44] 
       
Bopindolol Tablets  Spect. determ.*at (264 nm) 1-10 µg/ml  <1 40 [45] 
       
Boric acid  Eye solutions Complexation between D- 0-12mg/l <0.6  30 [46] 
  sorbitol and boric acid, then     
  acid-base reaction      
   Spect. determ.*at (520 nm)     
       
Boric acid  Eye solutions Fluori.det.¤ (λex313;λem360nm)   8-350 µg/l 2.7 55 [47] 
 mineral waters      
       
Bromazepam Tablets Complexation reaction of  5x10-4-1.5x10-3mol/l <1.2 36 [48] 
  bromazepam with iron(II) in HCl     
   Spect. determ.*at (585 nm)     
       
Bromazepam Tablets Complexation with iron(II), 300-1100 mg/l 0.3 3 [49] 
   Spect. determ.*at (585 nm)     
    chemometric optimization          
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Calcium Tablets; Complexation with cresol- 0-20 mg/l <1.4 43 [50] 
 drinking water phthalein comlexone;      
   Spect. determ.*at (578 nm)     
       
Captopril Tablets  Spect. determ.*at (400 nm) 2x10-4-1.4x10-3mpl/l >2 60 [51] 
       
Captopril Tablets  Spect. determ.*at (535 nm) 20-1000mg/l 1.2 60 [52] 
       
Ciprofloxacin Tablets Complexation with iron(III), 50-500 mg/l <0.9 60 [53] 
 Infusion  Spect. determ.*at (447 nm)     
       
Diclofenac Tablets Fluorimetric determination, 1x10-5-1x10-4 mol/l <0.6 32 [54] 
 Injections (λex305-95nm;λem430-70nm)      
 Suppositories      
       
Doxycycline Capsules;   Spect. determ.*at (213 nm) 2-100 µg/ml 0.5 6 [36] 
 Tablets      
       
Etilefrine Pharmaceutical  Spect. determ.*at (503 nm) 1-20 mg/l <2.7 80 [55] 
hydrochloride formulations      
       
Fenoterol Syrups  Spect. determ.*at (505 nm) 0.5-40mg/l 1.8 60 [56] 
hydrochloride             
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Indomethacin Capsules;  Fluorimetric determination, 4x10-7-1x10-5mol/l <1.2 30 [57] 
 Tablets (λex350 nm;λem450nm)     
 ext. release caps      
       
Iodide Tablets; drops;  Spect. determ.*at (410 nm) 0.002-0.5 mg/l <3.6 15 [58] 
 Drinking water      
       
Iodide Tablets  Spect. determ.*at (600 nm) 0.1-6 µg/l >2 80 [59] 
       
Iron (III) Capsules;   Spect. determ.*at (667 nm) 100-1000 mg/l <1 8 [60] 
 Tablets      
 Pharm. products  Spect. determ.*at (667 nm) 0.30-80.00 mg/l <0.8 30 [56] 
       
Iron (II)  Pharmaceutical  Spect. determ.*at (523 nm) 5.0-40.0 mg/l 3.0-4.0 100 [61] 
 formulations      
       
 Tablets; caps;  Spect. determ.*at (515 nm) 1-60 mg/l <2.5 24 [62] 
  natural water      
       
 Multi-vitamin   Spect. determ.*at (512 nm) 0.25-5.0mg/l 0.7-1.6 40 [63] 
 Tablets      
 Pharm.       
  products  Spect. determ.*at (667 nm) 0.15-100.00 mg/l <1.3 30 [64] 
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Isoxsuprine Tablets  Spect. determ.*at (507 nm) 1-60 mg/l 1.4-1.6 60 [65] 
hydrochloride       
       
Lisinopril Tabs & caps Fluorimetric determination,   0.3-10.00 mg/l 2 60 [66] 
  (λex346;λem455nm)        
       
Norfloxacin Tablets Complexation with iron(III), 50-400 ppm <0.9 60 [53] 
   Spect. determ.*at (430 nm)     
       
Magnesium Tablets  Spect. determ.*at (570 nm) 0-2.0 mg/l 0.7-1.9 80 [67] 
       
Metoclo- Tablets  Spect. determ.*at (495 nm) 13-130 µg/ml§ 2.32 40 [68] 
pramide       
   Spect. determ.*at (495 nm) 3-42 µg/ml¢  2.78 18 [68] 
       
Naproxen Tablets Fluorimetric determination,  4x10-7-1x10-5mol/l <2.1 70 [69] 
  (λex280;λem356nm)     
       
Oxybenzone Milk; oil;  Spect. determ.*at (376 nm) 840 µg/l 3.0-8.0 24 [70] 
 lotions      
 Lipsticks  Spect. determ.*at (376 nm) 840 µg/l 6.0-12.0 24 [71] 
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Oxprenolol Tablets Oxidation with Ce(IV),  50-400 ppm 0.88 120 [72] 
   Spect. determ.*at (480 nm)     
       
Paracetamol Tablets  Oxidation by hexacyanoferrate- 0-60 mg/l 1.2 27 [73] 
  (III) and reaction with phenol      
  in the presence of ammonia,     
   Spect. determ.*at (630 nm)     
 Tablets;   400-1000;  3 60 [74] 
 suspensions;  Spect. determ.*at (430 nm) 50-500 mg/l    
 syrup  200-1000;  4 15 [74] 
   1000-2500mg/l    
       
Perphenazine Synthetic Complexation with Pd(II), 50-500 mg/l <1 50 [75] 
 samples  Spect. determ.*at (560 nm)     
       
Phenylbenz- Sunscreen  Spect. determ.*at (300 nm) 50-80 µg/l 1.0-6.0 20 [43] 
imidazole sprays      
sulphonic acid       
       
Piroxicam Capsules;  Fluorimetric determination,      
 Tablets (λex358;λem615nm)    0.1-1 ppm >3.8 60 [76] 
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Procaine Injections Oxidation by permanganate 0.5-50 mg/l <3.8 120 [42] 
hydrochloride  chemiluminescence (≥390nm)      
       
Promethazine Tablets; elixir   Complexation with Pd(II), 50-400 mg/l 0.92 200 [77] 
 syrup  Spect. determ.*at (540 nm)     
       
Promethazine Tablets Chemiluminescence (200-750) 1.6x10-5-1.9x10-3mol/l 0.75 180 [78] 
       
Sulpha- Standard Oxidation by permanganate 0.015-1.50 mmol/l <2.3 120 [79] 
nilamide solutions chemiluminescence (≥390nm)      
       
Sulpha- Eye drops Oxidation by permanganate 0.012-1.20 mmol/l <2.3 120 [79] 
cetamide  chemiluminescence (≥390nm)      
       
Sulphathiazole Standard Oxidation by permanganate 0.009-0.92 mmol/l <2.3 120 [79] 
 solutions chemiluminescence (≥390nm)      
       
Sulpha- Standard Oxidation by permanganate 0.035-0.87 mmol/l <2.3 120 [79] 
dimidine solutions chemiluminescence (≥390nm)      
       
Sulpha- Tablets Oxidation by permanganate 0.009-0.88 mmol/l <2.3 120 [79] 
furazole  chemiluminescence (≥390nm)      
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Sulphametho- Standard Oxidation by permanganate 0.019-0.95 mmol/l <2.3 120 [79] 
xypyridazine solutions chemiluminescence (≥390nm)      
       
Sulpha- Tablets Oxidation by permanganate 0.010-1.00 mmol/l <2.3 120 [79] 
guanidine  chemiluminescence (≥390nm)      
       
Tetracaine Standard Oxidation by permanganate 0.2-25 µg/ml <3.8 120 [42] 
hydrochloride solutions chemiluminescence (≥390nm)      
       
 Powder  Spect. determ.*at (572 nm) 25-300 µg/ml  2.07 40 [68] 
       
Trimperazine Synthetic Complexation with Pd(II), 50-400 ppm <1 50 [75] 
 samples  Spect. determ.*at (515 nm)     
       
Trimethoprim Tablets Oxidation by permanganate 0.5-100 µg/ml <1 120 [80] 
  chemiluminescence (370nm)     
       
Warfarin Spiked Fluorimetric determination,  0.1-1 µg/ml 1.5 180 [81] 
 samples (λex310;λem385nm)     
       
Vitamin B1 Multivitamins Fluorimetric determination,  0.06-8.0 µg/ml 1 30 [82] 
 tabs & syrups;  (λex385;λem433nm)     
  vit. B tabs           
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Ascorbic acid Tabs; capsules;  Spect. determ.*at (510 nm) 20-300 ppm <1.2 20 [83] 
(Vitamin C) Eff. tablets      
       
Ascorbic acid Tablets;   Oxidation by Ce(IV)  30-200 ppm <1.2 120 [84] 
(Vitamin C) drops  Spect. determ.*at (410 nm)     
       
Ascorbic acid Tablets Redox reaction between ascorbic      
(Vitamin C)  acid and permanganate in acidic  0-1200mg/l 2.9 60 [85] 
  medium,      
   Spect. determ.*at (525 nm)     
       
Ascorbic acid Eff. Tablets; Absorbance of redox indicator 2.5x10-3- 1x10-1mol/l <2 17 [86] 
(Vitamin C) liquids ferroin incorporated into the     
  membrane,     
  (redox optical sensor- optode)     
  Chemiluminescence 5x10-8-1x10-5mol/l <4 180 [87] 
       
Zinc Supplement, Reaction with xylenol orange, 10-60 mg/ml <1 30 [88] 
 energy-boosting  Spect. determ.*at (568 nm)     
 Tablets      
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A review of SI techniques applied to pharmaceutical analysis [34] 
Table 1.2 Electrochemical methods  
Analyte  Matrix Detection method Linear range R.S.D.% Sample   Ref. 
          
 
frequency 
h-1   
Azidothymidine Capsules Amperiometric immunosensor, 80-2000 nmol/l 1 38 [87] 
   graphite paste with anti-AZT     
       
R-captopril Spiked samples  Amperiometric biosensor  120-950 nmol/l  <0.1 34 [88] 
   100-1000 nmol/l  <0.1  38 [89] 
       
S-captopril Spiked samples  Amperiometric biosensor 0.4-1.6 µmol/l   <0.1  34 [90] 
  Tablets Amperiometric biosensor  0.05-1.5 µmol/l    <0.2  80 [88] 
 Spiked samples   Ion selective electrode  1-1000 µmol/l  <0.1  34 [89] 
       
Captopril Tablets Ion selective electrode    
2x10-4- 1.4x10-3 
mol/l   >1  5 [91] 
       
Chloride  Pharmaceutical Optode 1x10-3-1 mol/l <1  14 [92] 
  formulations  Ion selective electrode    1x10-5-1x10-2mol/l  <0.6  60 [92] 
       
Clavulanate Tablets Ion selective electrode    2x10-3-1x10-1 mol/l 0.6 55 [93] 
(Potassium)   Ion selective electrode    2x10-3-1x10-1 mol/l 0.5 53 [93] 
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Diclofenac   Tablets Potentiometric detection, 5x10-6-1x10-2 mol/l <0.4  33 [96] 
 Injections Ion selective electrode        
  Suppositories      
       
S-enalapril Raw material  Amperiometric biosensor 0.08-1.50ppm <0.1  75 [97] 
       
Penicillin-G Pharmaceutical Ion selective electrode    2x10-4-1x10-2mol/l 2 25 [98] 
       
S-pentopril Spiked samples   Amperiometric biosensor 0.2-6.0 µmol/l  <0.1 75 [97] 
       
S-perindopril Spiked samples   Amperiometric biosensor 60-800 nmol/l  <0.1 75 [97] 
       
R-perindopril Spiked samples   Amperiometric biosensor 60-900 nmol/l  <0.1 30 [97] 
       
S-ramipril Raw material  Amperiometric biosensor  0.12-0.60 µmol/l  <0.1 75 [97] 
       
L-thyroxine Tablets;  Amperiometric biosensor 10-780 ng/ml  <0.1 20 [99] 
 (L-T4)  injections      
       
D-thyroxine  Tablets;  Amperiometric biosensor 50-500 nmol/l  <0.1 20 [99] 
 (D-T4)  injections           
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L-
thriiodthyro Raw material  Amperiometric biosensor 15-380 ng/ml  <0.1 20 [99] 
nine (L-T3)       
       
Riboflavin Vitamin B tabs 
Adsorptive strip. 
voltammetry 0.0-0.8 µ mol/l 3 34 [100] 
(vitamin B2) Multivitamin 
 determination and 
photodeg-     
  radation study     
       
Vitamin B6 Multivitamin Ion selective electrode     1x10-4-1x10-2 mol/l <0.47 50 [101] 
  formulations  Potentiometric detection,     
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1.4 Automated process analysis in pharmaceutical production  
The analytical determinations carried out in monitoring the chemical and 
biochemical reactions involved in the production process should systematically 
supply quantitative measurements. These determinations must eliminate, or at 
least minimize, sampling steps to give a rapid report on the state of a production 
process. For its robustness, capacity to collect samples directly from the reaction 
medium and a possibility of determining different species, the SIA technique 
was found to be adequate to control industrial processes. The SIA systems were 
also applied in the monitoring of the production processes of some drugs [102-
105].  
 
1.5 Automated drug dissolution and drug release  
   The dissolution assays of pharmaceuticals are very important for quality 
control of pharmaceutical products. Since these tests supply detailed information 
on the dynamic characteristics of the dissolution process, they are so useful for 
studies accompanying the development of new dosage forms. The automated 
SIA systems have the advantages of direct sample collection in the dissolution 
medium, carrying out parallel tests in the dissolution vessels and applying 
chemometric methods for the determination of multicomponents [106-109]. 
 
1.6 Functional cellular assays   
Functional assays are designed to classify a drug as agonist or antagonist, 
depending on whether it induces or inhibits a biological response. If the binding 
of the drug to the receptor induces a cellular response, such response can be 
evaluated by monitoring suitable parameters like cytosolic Ca2+, pH, acid 
release, lactate extrusion, glucose consumption, or oxygen consumption. 
Automation of the biological assays by the SIA technique using reagents in the 
heterogeneous SI-BI phase was proposed using various cell lines and measuring 
various evaluation parameters of the cellular response [110-113]. 
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1.7   Chemometrics 
Chemometrics is a chemical discipline that uses mathematics and 
statistics, so as to design or to select optimal experimental conditions, to provide 
maximum chemical information and to get good knowledge about chemical 
systems. [114,115]. 
 
1.7.1 Experimental design 
 
1.7.1.1 Factorial design  
Factorial designs were widely used in experiments where different factors 
were involved. It is necessary to study the overall effect of these factors on the 
response. In factorial designs, in each sample or replication of the experiment, 
all possible combinations of the factors levels are studied. The effect of a factor 
is defined as the change in response produced by the change in the level of the 
factor and is called the main effect and will be represented as the difference 
between the average response at the first level of the factor and the average 
response at the second level of the factor. The term effect interaction is used 
when the difference in response between the levels of one factor is not the same 
at all levels of other factors. The most elementary class of factorial design is 2 k 
factorial, where the base 2 stands for variables level and k for the number of 
factors studied. When one fits a first order equation to a 2 k factorial experiment, 
it is often likely to code the variables with -1 for the lowest level of a variable 
and +1 for the highest. Consider a 2 k factorial design matrix in terms of coded 
variables along with treatment combinations and their consequent responses 
(table 1.3) [116]. 
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Table 1.3: treatment of coded factors and their responses 
X1 X2 X3 R 
-1 -1 -1 a 
-1 -1 +1 b 
-1 +1 +1 c 
+1 +1 +1 d 
+1 +1 -1 e 
+1 -1 -1 f 
-1 +1 -1 g 
+1 -1 +1 h 
 
Where X1, X2 and X3 are the factors studied and R is the response obtained. The 
treatment combinations order above may differ according to each individual 
design matrix run and the variables studied. 
 
1.7.1.2 The ANOVA method  
(ANOVA) or analysis of variance is a statistical technique used to analyze 
measurements depending on several simultaneously operating effects, and to 
know the importance of these effects and to estimate them. This analysis usually 
used to distinguish the sources of variability between laboratories, samples and 
replicates and to find out the influence of factors whether from humans, 
instruments or due to chemical factors on the results of chemical analysis. In 
ANOVA, one assumes that the errors are distributed, independent and having the 
same variance. ANOVA assumes that the variances of random variables, due to 
the effect of independent factors, are additive. Therefore, ANOVA can be used 
to break down the total variance into a sum of several components each 
corresponding to a source of variance [117]. 
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1.7.2 Chemometric optimization [118-120] 
The optimization of chemical systems using mathematical and statistical 
techniques in the chemical sciences has become widespread. It was used to relate 
some of the desired properties of materials to their composition. The desired 
properties are usually related to variables of composition by some functional 
mathematical form. Variables that affect the result interact in an unknown 
mathematical functional form and varieties of similar techniques are used to 
provide hints of the physical and chemical behavior of the system measurements 
to be used. Statistical and mathematical techniques are used to determine the 
importance of certain variables. 
In order to apply mathematical results and numerical techniques of 
optimization to chemical problems, it is important to set out the boundaries of 
the system to be optimized. The key element in choosing a problem for 
optimization is the selection of the independent variables that are adequate for 
characterization of the system operating conditions. It is worthy to distinguish 
between the variables that can be treated and fixed and those that have great 
impact on the response. It is necessary to formulate the optimization problem 
with a single performance criterion.  
After the performance criterion, boundary conditions and the independent 
variables have been selected, the coming step is to assemble a model that 
describes the manner in which the problems variables are related and the way in 
which the performance criterion is influenced by the independent variable. In 
general, optimization of chemical systems may be performed directly since the 
mathematical model that relates the independent variables to the performance 
criterion is unknown. Thus the independent variables of the system may be set to 
selected values, the system operated under those conditions and the system 
performance is evaluated using the observed performance. The method of 
optimization would be used to predict improved choices of the independent 
variables values. 
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1.7.3 The Simplex method  
Optimization of technical systems is the process that can be implied to 
adjust the control variables and to find the levels, through which the best 
possible response can be achieved; different responses must be optimized 
concurrently. Optimization is usually done by "trial and error" or by changing 
one control variable while keeping the other variables constant. These methods 
are time consuming and require a lot of experiments to be carried. Simplex 
methods were introduced to overcome such problems.  
The basic simplex method was introduced in 1962, by applying this 
method an optimum response could be achieved with fewer trials so that, it saves 
time and resources. In the modified simplex method, two major modifications 
were introduced to the original basic method that allows the expansion in the 
direction of favorable responses of contract than in the direction of unfavorable 
conditions. In the super modified simplex method the differences in the 
responses as the simplex vertexes are used to determine the vertex with a better 
response. The multisimplex method is a good example of implementation of the 
simplex optimization method. The user has a full control over the simplex 
optimization process and that is because of the pull-down menus. Interestingly 
enough, multisimplex has the ability to optimize several responses at the same 
time [121]. 
 
1.8 Chemometric optimization of the SIA methods 
Chemometrics, in general, was introduced in analytical chemistry almost 
at the same time with FIA [119,120]. The most interesting is that chemometric 
approaches were used in some cases in the development and validation of FIA 
methods, since they can save time during the method development, and the 
detectors used with those systems can provide analytically useful data [115]. In 
FIA usually what will be optimized of response function is the peak height so as 
to increase the detectability of the system, reagent consumption, delay time and 
sample frequency [115]. 
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Chemometrics was so successful for the optimization of chemical 
reactions in SIA procedures and was proven to be efficient enough when dealing 
with three or more interactive variables, as the utilized FI manifold or the 
chemical reaction-based assay were concerned. 
Many papers in this subject (chemometric optimization of SIA methods 
for pharmaceutical analysis) were published. The first papers published were the 
assay of bromazepam [49], ascorbic acid [84], Perphenazine [122], 
flouroquinolone antibiotics [53], promethazine hydrochloride [163] and 
promazine [193]. The same group adopted chemometrical optimization FIA 
methods for some pharmaceuticals such as chlorpromazine [123], medazepam 
[124], and perphenazine [125], norfloxacin [126], promethazine hydrochloride 
[78, 127], procainamide hydrochloride [128], promethazine, chlorpromazine, 
trimeprazine [162], ciprofloxacin [129] and tetracycline [130].   
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1.9 Differential Electrolytic Potentiometry (DEP) 
 
1.9.1 DEP historical background 
Potentiometry is the field of electroanalytical chemistry in which potential 
is measured under the conditions of no current flow. The measured potential 
may then be used to determine the analytical quantity of interest, generally the 
concentration of some component of the analyte solution. Potentiometry is the 
most obvious method of finding the end point in titrimetric methods (134).  
 Electrolytic potentiotitrimetry is defined as the monitoring of the 
potential of a chemical cell with liquid junction during the course of a titration 
when a current of a few microamps is made to flow through the cell. The method 
is first proposed in by P. Dutoit and G. Weise (135). In order to avoid the 
possibility of deleterious effects which might be caused by repeated passages of 
current through the reference electrode, a third auxiliary electrode is used to 
conduct the current. The corresponding technique of applying a small current 
through a concentration cell without liquid junction during the course of titration 
is termed differential electrolytic potentiotitrimetry, and was introduced in 1922 
(136). The recommended IUPAC nomenclature corresponding to the terms 
electrolytic potentiotitrimetry and differential electrolytic potentiotitrimetry are 
controlled current potentiometric titration and controlled current potentiometric 
titration with two indicator electrodes, respectively.  Differential electrolytic 
potentiometry has the term electrolytic which was suggested by Bishop (137), 
implying that electrolysis is proceeding under the influence of a minute heavily 
stabilized current. This electrolysis current is less than the diffusion current of 
the electroactive species and the solutions are normally stirred.  
Basically, differential electrolytic potentiometry (DEP) as detection 
technique utilizes two identical metals that are polarized by a heavily constant 
current, and the potential difference between these indicator electrodes is 
measured. At the end-point, this potential difference produces a sharp 
symmetrical peak. DEP technique doesn’t require a reference electrode and thus 
the difficulties of the salt bridge are eliminated. Moreover, polarization enhances 
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the response of the electrodes. This technique has been applied to various types 
of titrimetric reactions using different types of electrodes. Antimony electrodes 
have been used as indicating electrode for acid base reactions (138-141). Silver-
silver halide electrodes are suitable for precipitation reactions (142-144). 
Platinum electrodes have been applied in oxidation-reduction reactions (145-
147) and gold amalgam electrodes are appropriate for complexation reactions 
(148-150).  DEP has been applied to various types of titrimetric reactions in non-
aqueous media using different types of electrodes (151-155) 
Polarization of an electrode is defined in the means of passing current 
through it. The potential of the electrode will be changed and it will be different 
from that of the zero-current potential. Depending on the type of polarization the 
anodic polarization will make the potential of the electrode more positive than 
the zero current. In the case of cathodic polarization, the electrode will attain 
more negative potential than the zero current electrodes. The difference in 
potentials is due to the overpotential.  
 
Overpotential 
In the absence of net current flowing in the external circuit the sum of 
cathodic and anodic current is equal to zero i.e. , io represents the 
exchange current that flows continuously in the compact layer. 
When , the electrode potential will have the equilibrium zero-
current value, with respect to saturated hydrogen electrode. 
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When a net current is passing through the electrodes its potential will 
have a new value, which is the potential of the working electrode.  
The difference between and is called the 
overpotential i.e. , consists of three 
components, charge transfer or activation overpotential, 
the mass transfer or concentration overpotential and 
is the resistance potential, occurs due to the slowness 
of the electrode process, depending upon the nature of electrode surface, its 
surface conditions and the concentration of electroactive species present in the 
medium, arises when the passage of current causes a net reaction at 
the electrode surface and independent of the nature of electrode. This results in a 
difference in concentrations of reactants and products at the electrode surface 
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from those in the bulk of solution forming concentration gradients.  Hence 
reactants migrate towards and products migrate away from the electrode.  
As a result of the overpotential which is due to the polarization process, a 
potential difference will develop between the two electrodes. The anode will 
lead the zero-current electrode and the cathode will lag the potential of that 
electrode. Hence ∆E which is the difference between the potentials of the anode 
and that of the cathode will be measured during the course of the reaction. 
Finally, a plot between ∆E and the volume being added from the burette will be 
established and the end- point is calculated from this plot by considering the tip 
of the resulting peak. Different parameters such as the value of the current, the 
stirring rate, and the types of the electrodes and the geometry of the cell have to 
be optimized in order to get a symmetrical peak with a considerable height. 
The shapes of titration curves resulting from two identical indicator 
electrodes polarized at constant current are characteristics of the reversibility of 
both the titrant and titrand, because reversible couples produce a current-
potential curve whose reciprocal slope dE/di in the vicinity of zero current is 
relatively small. The maximal e.m.f. between the two electrodes at the 
equivalence point is approximately equal to the difference between the formal 
potentials of the two couples (curve 1 in Fig.1.6). If a titrand which establishes a 
reversible couple is titrated with a titrant which doesn’t function reversibly, the 
e.m.f. between the two identical polarized electrodes will follow the course 
indicated by (curve 2 in Fig.1.6).  The current potential curve of the irreversible 
titrand couple will have a large value of the reciprocal slope dE/di at zero current 
as shown in curve 3 in Fig.1.6.   
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Figure 1.6: Types of titration curves with two identical indicator electrodes 
polarized at constant current. (1) titrand and titrant couples both reversible. (2) 
Titrand couple reversible, but titrant couple irreversible. (3) Titrand couple 
irreversible, but titrant couple reversible. 
 
The use of polarized electrodes can entail an error corresponding to the 
amount of electrolysis at the electrode. This is always present with a single 
polarized electrode, and also occurs with two identical polarized electrodes 
whenever the reaction couple behaves irreversibly that occurs with two identical 
electrodes. The error can be reduced to negligible proportions by using small 
electrodes and a small electrolysis current. The main value of polarized indicator 
electrodes is for irreversible couples where an un-polarized electrode is often 
very slow in acquiring a constant potential whereas a polarized indicator 
electrode reaches a steady potential quickly at constant current, and large 
variations of potential are observed at the end point. 
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1.10 Objectives 
1.10.1 Objectives of the SIA method 
This study was conducted to fulfill the following objectives: 
1- To perform a comprehensive procedure for the oxidation of both 
chlorpheniramine maleate and verapamil hydrochloride by permanganate 
in sulphuric acid media utilizing SIA. 
2- To construct SIA manifolds suitable for the method of assay of 
chlorpheniramine maleate and verapamil hydrochloride. 
3- To establish appropriate SIA programs for controlling the newly adopted 
methods. 
4- To search for the optimum conditions for the assay methods. 
5- To conduct a chemometric optimization for the methods under study. 
6- To evaluate the linearity, accuracy, precision, repeatability, robustness 
and cost of the newly adopted method. 
7- To validate the newly adopted method by comparison with the BP 
standard method. 
 
1.10.2 Objectives of the DEP method 
This study was performed to fulfill the following objectives: 
1- To perform a comprehensive study for the oxidation of promethazine 
hydrochloride with Cerium (IV) in acidic medium and its applicability to 
electrochemical detection. 
2- To construct a system suitable for electrochemical detection. 
3- To search for the optimum conditions for the assay method. 
4- To establish a computer program that controls the syringe pump for the 
addition of appropriate volumes. 
5- To evaluate the accuracy, precision, repeatability, robustness and cost of 
the newly adopted method. 
6- To validate the newly adopted method by comparison with the BP 
standard method. 
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CHAPTER TWO 
MATERIALS AND METHODS 
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2.1 Instrumentation 
 
2.1.1 SI analyzer 
The SI analyzer manifold used in this work consisted of a sequential 
injection analyzer combined with a fiber optic spectrophotometer (fig 2.1). The 
SI analyzer system is an Alitea USA/FIALab 3000 (Medina, WA USA). The 
following sections present descriptions and specifications of the components of 
the SI analyzer system 
 
 
Fig. 2.1: Sequential injection analyzer manifold diagram, CA: carrier (water); P: 
syringe pump; HC: holding coil; MPV: multi-position valve; 1-8: ports; RC: 
reaction coil; RS: radiation source; Z: Z-flow cell; D: detector; PC: personal 
computer; Ws: waste.  
 
2.1.1.1 Syringe pump (P) 
Only one syringe pump is needed because SIA is operated as a single line 
system. The pump is operated in an intermittent forward and reverse mode. The 
24,000-step stepper motor driven syringe pump (with an optical encoder 
feedback and 1.5 seconds to 20 minutes per stroke) was connected to a multi-
position valve through a reaction coil. The glass syringe pump is interchangeable 
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with great ease and available in size from 100 micro liters up to 10 milliliters to 
allow aspiration of adequate volumes of carrier, to deliver solutions and to flush 
the system. The volume of the syringe pump used is 2500 micro liters. 
 
2.1.1.2 Multi-position valve (MPV) 
The MPV used has eight ports with standard pressure of 250 psi (gas)/600 
psi (liquid); zero dead volume. It is chemically inert. Port selection is controlled 
automatically through a software program. 
 
2.1.1.3 Pump tubing 
It is a 0.30,, ID Teflon type supplied by Upchurch Scientific, Inc. (Oak     
Harbor, WA USA). It is used for the connection of the different units of the SIA   
manifold and for making coils. 
 
2.1.1.4 Coils 
Coils were manually prepared by coiling a pump tubing of 0.30,, ID 
Teflon type. The following sections describe the coils of the SIA manifold. 
 
2.1.1.4.1 Holding coil (HC) 
The HC was placed between the central port of the MPV and the P. The 
aspirated solutions are held in this coil. Other processes like mixing, dilution and 
reaction take place. The mixture is dispensed directly to the Z-flow cell or 
through the reaction coil which is optional according to the type of reaction. The 
length of the pump tubing of the HC used in this work was 200 cm. 
   
2.1.1.4.2 Reaction coil (RC) 
 Some reactions applied to measurements require different conditions 
such heating, increasing delay time of reaction. In such cases an additional coil 
was added, and called the reaction coil (RC). The RC usually placed between 
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MPV and the Z-flow cell. The RC is helpful in kinetic-based reactions. The 
length of the pump tubing of the RC used in this work was 160 cm.  
 
2.1.2 Miniaturized spectrometer 
 The fiber optic spectrometer is composed of a light source, fiber optic 
connectors, Z-flow cell, windows and a detector. Specifications, descriptions and 
set up of the optic system are discussed below. 
 
2.1.2.1 Fiber optic SMA Z-flow cell 
  It is a 10 mm path length plexiglass compatible with standard SMA 
terminated fiber optic and contains fused silica windows as wetting surfaces at 
each fiber optic junction. The SMA Z-flow cell is designed to accommodate 
common optical measurements and to minimize bubble trapping in flow 
injection and sequential injection analysis. 
 
2.1.2.2 Windows 
 The windows used in this study are a UV fused silica grade. It is a hard 
and chemically resistant material which has a high UV through IR transmittance 
(170 nm through ~2000 nm). The windows are removable for cleaning or 
replacement with another material that has different optical band-pass properties.  
 
2.1.2.3 Radiation source 
  The radiation source used is a LS-1 tungsten halogen with the following 
specifications: 
Spectral range:  360 nm -2µm 
Dimensions:   9.0 cm × 5.0 cm × 3.2 cm 
Power output:  6.5 watts 
Power input:   12 VDC/800 mA 
Bulb life:   900 h 
Bulb color temp.:  3100 K 
Time to stabilize output: ~ 30 min 
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Stability:   after 100-h burn-in, decay rate is ~ 0.1%h 
Internal filter:  BG-34 conversion filter 
Connector:   SMA 905 
 
2.1.2.4 Detector  
The USB2000 fiber optic spectrometer was manufactured by Ocean 
Optics® and it was used in this work. The name and function of each component 
are presented in table 2.1. The following points describe the specifications of the 
spectrometer. 
Dimensions:   8.91 mm × 6.33 mm × 3.44 mm 
Detector range:  200 – 1100 nm 
Gratings:   14 gratings; UV through shortwave NIR 
Entrance apertures: 5, 10, 25, 50, 100 or 200 mm wide slits or fiber (no 
slits) 
Optical resolutions: ~0.3 – 10.0 nm FWHM 
Dynamic range: 2 × 108 (system); 2000:1 for a single scan 
Stray light: <0.05% at 600 nm; <0.10% at 435 nm; <0.10% at 
250 nm 
Sensitivity: (estimate) 400nm – 90 photons/count; 600 nm – 41 
photons/count; 800 nm – 203 photons/count 
Fiber optic connector: SMA 905 to single-strand optical fiber (0.22 NA) 
Data transfer rate: Full scans into memory every 13 milliseconds 
Integration Time: 3 milliseconds to 65 seconds 
 
2.1.3 Conventional spectrophotometer 
The UV/VIS spectrophotometer provided by Perkin Elmer, Lambda 
EZ210 was used for applying the BP standard methods.  
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2.1.4 Oscilloscope  
The oscilloscope provided by Tektronix model 2213A 60 MHz to show 
the frequency and square wave for both AC and DC current generated by the 
circuit. 
 
Table 2.1 Functions of the USB2000 fiber optic spectrometer 
Item Name Function 
      
1 SMA connector Light from the input fiber enters the spectrometer 
  through this connector. 
2 Slit Regulate the amount of light that enter the  
  spectrometer and controls spectral resolution. 
3 Filter Restricts the optical radiation to pre-determined 
  wavelength regions. 
4 Collimating  Focuses the entering light towards the grating. 
 mirror  
5 Grating Diffracts light  from the collimating mirror and 
  directs the diffracted light onto the focusing 
  mirror 
6 Focusing mirror Receives light reflected from the grating and focuses 
  the light onto the CCD detector and L2 detector  
  collection lens. 
7 L2 Detector Attaches to the CCD detector. It focuses light from 
 collection lens a tall slit onto the shorter CCD detector elements. 
8 CCD Detector Collects the light received from the focusing  
  mirror or L2 detector collection lens and   
  converts the optical signal to digital signal. 
      
 
2.1.5 Voltmeter 
A digital multimeter provided by Agilent model 34401A to measure the 
differential electrolytic potential between the two electrodes. 
 
2.1.6 Microameter 
This microameter is provided by Simpson co. model no. 374 to measure 
the current that polarizes the electrodes. 
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2.1.7 Potentiometer 
A potentiometer provided by MeasureNet Co. USA was used for applying 
the BP standard methods. 
 
2.1.8 Electronic circuit 
An electronic circuit was designed to generate an AC and DC current for 
the polarization of electrodes and the consequent measurement of the potential 
difference between them by a voltmeter attached to the unit as in figure 2.6. 
 
2.1.9 Platinum electrodes 
Two identical platinum electrodes were employed, and polarized by the 
passage of current through them, and therefore change of their potential from 
that at zero current.  
 
2.1.10 Glass cell 
A specific glass cell was designed with openings from the top; one slit is 
for the insertion of the Teflon coils and the other two for the electrodes. In this 
cell the reactants were mixed together and where electrolysis takes place. 
 
2.1.11 Programmable syringe pump (SP) 
A computer controlled programmable syringe pump supplied from J-
Kem, Scientific USA was used in the differential electrolytic potentiometric 
titration for promethazine hydrochloride to deliver the exact required volumes of 
the reactants in microliterers. 
 
2.1.12 Magnetic stirrer and magnets 
An electronic magnetic stirrer and small magnets were used for proper 
mixing of the reactants.   
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2.2 Software packages 
2.2.1 FIALab® 
The FIALab for windows version 5.5 from FIALab® (Medina, WA USA) 
was utilized for controlling the SIA system. 
 
2.2.2 OOIbase® 
Spectrophotometric data acquisition and treatment were performed by 
2.2.2 OOIbase® software version 2.0.1.2, driver version 4.07.00, 2002 supplied 
from Ocean Optic, Inc. The software calculates the absorbance (Aλ) at 
wavelength λ using equation 2.1. 
⎥⎦
⎤⎢⎣
⎡
−
−−= λλ
λλλ
DR
DSA 10log
   (2.1) 
 
Where Sλ is the sample intensity at the wavelength λ; Dλ is the dark intensity at 
the wavelength λ; Rλ is the reference intensity at the wavelength λ. 
 
2.2.3 SigmaPlot® 
SigmaPlot® supplied from Jandel Sceintific Corporation (1994) version 
1.02 for windows 3.95 enhanced modes was used for chemometric calculations 
and for drawing of the three dimensional graphs. 
 
2.2.4 Excel® 
Excel® for windows 2003 was used for plotting calibration curves and 
their related calculations. 
2.3 Chemicals and Reagents 
 
2.3.1 Promethazine hydrochloride 
Promethazine hydrochloride supplied by sigma P4651 was used for 
preparing 0.001 mol 1-1as primary standard solution. The primary standard 
solution and the working standard solutions were immediately prepared before 
use. 
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2.3.2 Chlorpheniramine maleate 
Chlorpheniramine maleate supplied by sigma C3025 was used for 
preparing 200 ppm as primary standard solution. The primary standard solution 
and the working standard solutions were immediately prepared before use. 
 
2.3.3 Verapamil hydrochloride 
Verapamil hydrochloride supplied by sigma V4629 was used for 
preparing 200 ppm as primary standard solution. The primary standard solution 
and the working standard solutions were immediately prepared before use. 
 
2.3.4 Potassium permanganate 
Potassium permanganate from Fisher Scientific Co. Fair Lawn, New 
Jersey USA was used to prepare a stock solution of 0.01mol 1-1. The stock 
solution was stored in a dark place and covered with aluminum foil and weekly 
standardized by sodium oxalate. Working solutions were prepared daily. 
 
2.3.5 Cerium (IV) ammonium sulphate 
Ammonium cerium sulphate-2-hydrate,CeNH4)4(SO4)4. 2H2O from 
BDH Chemicals LTD, Poole, England was used to prepare 0.1 mol 1-1 in 0.01 
mol 1-1 sulfuric acid. Standard working solutions were prepared after 
standardization of stock solution by sodium oxalate. 
 
2.3.6 Sulfuric Acid 
           95-98 % (W/V-1), 1.84 g 1-1, supplied from Fisher Scientific Co., Fair 
Lawn, New Jeresy USA was used to prepare working standard solutions. 
 
2.3.7 Hydrochloric Acid 
          31-32 %, Specific gravity 1.16 g 1-1, from BDH Chemicals LTD, Poole 
England was used to prepare working standard solutions. 
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2.3.8 Sodium hydroxide 
97% sodium hydroxide supplied from Montplet & Steban SA, Barcelona, 
Spain was used to prepare 1 mol 1-1 stock solution. Standard working solutions 
were prepared and standardized by potassium hydrogen phthalate. 
 
2.3.9 Nitric Acid 
64-66% nitric acid, 1.4g 1-1, from Fluka Chemie AG, CH-9470 Buchs 
and packed in Switzerland was used to prepare Aqua Ragia 
 
2.3.10 Perchloric Acid 
Perchloric acid supplied from Fluka Chemie AG, CH-9470 Buchs and 
packed in Switzerland was used in standard potentiometric titration for 
chlorpheniramine. 
 
2.3.11 Ether 
Ether supplied from BDH Chemicals LTD, Poole England was used in 
the official method for the determination of chlorpheniramine tablet form. 
 
2.4 Pharmaceutical samples  
To validate the newly adopted method, some of the available 
pharmaceutical formulations containing the drug under study were collected 
from drug stores. The SIA, DEP and BP standard methods were applied to the 
collected samples. 
 
2.5 Procedure 
2.5.1 Reagents and samples preparations 
Standard and reagent solutions were prepared in distilled water. Blank 
solutions were prepared in the same way as for that of working solutions. Tablets 
were prepared by triturating 20 tablets, and then the required amount of powder 
was dissolved in water and filtered. The filterate was diluted to the required 
volume. 
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2.5.2 Parameters of the USB2000 fiber optic spectrometer  
The following sections describe the spectrometer setup adjusted for all 
measurements performed in the SIA work [131]. 
 
2.5.2.1 Integration time 
 Integration time represents the CCD charge time that will elapse before 
the A/D conversion. A time of 5 milliseconds was used throughout this study 
and gave acceptable results. Usually maximum signal is obtained by increasing 
integration time. 
 
2.5.2.2 Detector to average 
It describes many adjacent CCD pixel signals that are to be added 
together for a boxcar average, which will be assigned to a single A/D value. 
Increasing the number of detector to average loses the overall resolution of 
spectrum, but it decreases the noise of a spectrum. There were three levels 1, 3 
and 5. The medium level of detector to average 3 was the one to be used. 
 
2.5.2.3 Sample to average 
Sample averaging will average several spectra to produce an average 
spectrum over a given period of time. Its advantage is to reduce the noise by 
square root of the number of averages without affecting the spectral resolution, 
but it may affect temporal (time) resolution and may lower sampling rate. 
 
2.5.2.4 Sample rate 
Sample rate is the rate of spectra acquisition and it was adjusted to 4 Hz. 
An ideal rate of 4-Hz collects spectra every 250 ms. In practice, the actual 
sampling rate may be significantly slower than what is selected when high 
integration time is used. In most cases, 4 to 8 Hz is the maximum. 
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2.5.3 Preparation of SI analyzer manifold 
2.5.3.1 Fiber optic spectrometer setup 
Usually, spectrometer setup should not be changed unless instrumental 
malfunctioning took place. However before starting analysis, some parameters 
should be adjusted as shown in figure 2.2. The following sections describe the 
spectrometer setup and those parameters could be adjusted. 
 
2.5.3.1.1 Dark baseline 
Prior to data acquisition and before switching on the lamp, to reset all 
setup parameters and take a dark baseline, the spectrometer was logon and 
concomitantly a dark scan was performed. Figure 2.3 shows the line of the dark 
scan.    
 
 
 
Figure 2.2: Parameters of USB2000 fiber optic spectrometer adjusted for the 
current work 
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2.5.3.1.2 Reference scan 
After updating a dark background, to get a raw light input, the reference 
scan was performed after putting on the lamb and allowing it to warm for 30 
minutes. In most cases the reference scan gives spectrum as shown by figure 2.4. 
The ideal reference scan should be not less than 500 and not greater than 4095 
 
2.5.3.2 Washing the channels of SI analyzer 
Before loading solutions to the SIA system, the syringe, the main channel, 
holding coil, reaction coil and tubes connected to the MPV were washed with 
water. A fully automated program was written to control the washing process. 
The program is presented in appendix 1. 
 
 
 
Figure 2.3: Spectrometer dark background 
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Figure 2.4: Spectrometer reference background 
 
 
2.5.4 The BP standard methods   
To validate the newly adopted methods (SIA and DEP) the BP standard 
methods were applied for the assay of pharmaceuticals under study. 
 
2.5.4.1 Promethazine hydrochloride tablets analysis 
20 tablets were weighed and powdered. A powder containing 50 mg of 
promethazine hydrochloride was dissolved in 10 ml of 2 mol l-1 hydrochloric 
acid and then 200 ml of water was added. The mixture was shaken for 15 
minutes and sufficient volume of water was added to produce 500ml. 50ml of 
the mixture was centrifuged. 10 ml of 0.1 mol l-1 hydrochloric acid was added 
and sufficient volume of water was added to produce 100 ml. The absorbance of 
the resulting solution was measured at 249 nm. 
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2.5.4.2.1 Chlorpheniramine tablet analysis 
20 tablets were weighed and powdered. A powder containing 3 mg of 
chlorpheniramine was shaken with 20 ml of 0.05 mol l-1 sulfuric acid for 5 
minutes 20 ml of ether was added and shaken, the acid layer was filtered. The 
ether layer was extracted with two 10 ml quantities of 0.05 mol l-1 sulfuric acid. 
Each acid layer was filtered and washed with 0.05 mol l-1 sulfuric acid. The 
combined extract and the washings were made just alkaline to litmus with 1 mol 
l-1 sodium hydroxide, 2 ml in excess of sodium hydroxide were added and the 
mixture was extracted with two 50 ml quantities of ether. The ether extract was 
washed with 20 ml of water and with 20, 20 and 5 ml of 0.25 mol l-1 sulfuric 
acid respectively. The combined extracts were diluted to 50 ml with 0.25 mol l-1 
sulfuric acid, then 10 ml was diluted to 25 ml with a 0.25 mol l-1 sulfuric acid. 
The absorbance of the resulting solution was measured at 265 nm. 
 
2.5.4.2.2 Chlorpheniramine injection analysis 
A volume of injection containing 10 mg chlorpheniramine was diluted to 
500 ml with 0.25 mol l-1 sulfuric acid. The absorbance of the resulting solution 
was measured at 265 nm. 
  
2.5.4.3.1 Verapamil tablet analysis 
20 tablets were weighed and powdered. A powder containing 100 mg of 
verapamil hydrochloride was shaken with 150 ml of 0.1mol l-1 hydrochloric acid 
for 10 minutes. Sufficient volume of 0.1 mol l-1 hydrochloric acid was added to 
produce 200 ml and then the mixture is filtered. 10 ml of the filterate was diluted 
to 100 ml with water. The absorbance of the resulting solution was measured at 
278 nm. 
 
2.5.4.3.2 Verapamil injection analysis 
To a volume containing 5 mg of verapamil hydrochloride, 100 ml of 
0.01mol l-1 hydrochloric acid was added. The absorbance of the resulting 
solution was measured at 278 nm. 
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2.6 Promethazine Hydrochloride Assay 
 
2.6.1 Introduction 
Promethazine hydrochloride is chemically named as 10-N, N-dimethyl-1-
(10H-phenothiazine-10-yl)propan-2-amine hydrochloride or 10H-phenothiazine-
10-ethanamine, N, N, a-trimethyl-,monohydrochloride (figure 2.5). It is white or 
faintly yellowish crystalline powder, very soluble in water, freely soluble in 
alcohol and in methylene chloride [132] 
 
 
Figure 2:5 Promethazine hydrochloride structure 
 
 
Phenothiazines form a large class of basic drugs used primarily for the 
treatment of moderate to severe mental disorders. They can also be used as anti-
emetics, sedatives, antipruritics, antidyskinetics, analegesics and antihistaminics 
[134]. Promethazine hydrochloride is one of the most important drugs of the 
phenothiazine group. As an antihistamine with H1-receptor antagonism 
promethazine can be used for the symptomatic relief of hypersensitivity 
reactions [132, 135]. Promethazine hydrochloride is usually available as mono 
component in dosage forms involving injections, oral suspensions, tablets, 
suppositories and syrup [132, 133].  
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2.6.2 Assay methods of promethazine hydrochloride in pharmaceutical         
formulations 
Many analytical methods for the assay of promethazine hydrochloride in 
pharmaceutical preparations were established. Several methods were proposed 
involving official standard methods as well as non-official standard methods. 
The sections below describe the advantages and disadvantages of some proposed 
methods. 
 
2.6.2.1 Official standard methods 
The BP [132] method for the assay of promethazine hydrochloride in the 
generic form is a potentiometric titration with sodium hydroxide after dissolving 
the sample in ethanol and hydrochloric acid. A direct spectrophotometric method 
is provided for the injection form, the absorbance is measured at wavelength 249 
nm after a series of dilutions with hydrochloric acid. For oral solution form, 
sodium hydroxide is added to the sample, shaken for 1 minute, the mixture is 
extracted with chloroform and the combined extract is evaporated to dryness at 
30ºC under pressure 2 kPa. The residue is dissolved in hydrochloric acid and 
diluted with water. The absorbance is measured at wavelength 336 nm. It is clear 
that in this method lengthy extraction processes were applied and it consumes 
time and resources. The tablet form is assayed in the same way as the injection 
form; the sample is triturated with 2mol l-1 hydrochloric acid and shaken well for 
15 minutes and then centrifuged and diluted with 0.1 mol l-1 hydrochloric acid, 
the absorbance is measured at wavelength 249nm. This method is lengthier 
compared with that of the injection form. 
In the USP monograph [133], promethazine hydrochloride generic form is 
assayed by titration with perchloric acid in the presence of glacial acetic acid and 
mercuric acetae using crystal violet as an indicator. For injection form an HPLC 
method is used. The mobile phase is composed of sodium 1-pentanesulfonate, 
acetonitrile and glacial acetic acid. The method involves filtration and degassing 
which imply tedious sample treatments; in addition to that it is a lengthy 
procedure. Spectrophotometric method is provided for suppositories, the 
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palladium reagent is prepared by dissolving palladium chloride in hydrochloric 
acid and the mixture is warmed in a steam bath and diluted slowly. To part of the 
palladium reagent solution, sodium acetate is added and the pH is adjusted. The 
melted sample is dissolved in hexane and then hydrochloric acid is added. 
Promethazine hydrochloride is extracted by hydrochloric acid, shaken, diluted 
and finally filtered. The absorbance of the solution is measured at wavelength 
450nm. Spectrophotometric method of analysis is provided for the oral solution 
and syrup forms of promethazine hydrochloride, the sample is alkalized to 
promethazine base and extracted by chloroform, the combined chloroform 
extract is then washed by hydrochloric acid and evaporated on a steam bath with 
the aid of air current. The residue is warmed and dissolved in sulfuric acid, 
cooled and diluted by sulfuric acid and filtered. The absorbance of the resulting 
solution is measured at wavelength 289 nm. 
 
2.6.2.2 Other non-official methods 
There are many methods adopted for the assay of promethazine 
hydrochloride in pharmaceutical preparations including titrimetric [134,135], 
spectrophotometric [136-144], flourimetric [145-148], and chemiluminescence 
[149].In addition to high performance liquid chromatography [150,151], 
voltammetric [152,153], potentiometric [154,155], electrophoresis [156-159] and 
coductimetric [160]. Recently, flow injection analysis combined with different 
detectors including spectrophotometry [75, 161-165], chemiluminescence [79, 
166], spectroelectoanalysis [167] and turbidimetry [168] have been extensively 
studied for the assay of promethazine hydrochloride in pharmaceutical products.  
Many of the above mentioned methods were indirect, with narrow 
linearity and employing conventional spectrophotometric techniques. Others are 
lengthy. 
 
2.6.3 Construction and programming of electrochemical system 
A suitable electrochemical system was constructed (figure 2.6) for the 
purpose of performing a newly adopted method for the assay of promethazine 
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hydrochloride. For the oxidation of promethazine by cerium IV in acidic 
medium, a suitable program was written to control the whole process. The 
system involves the employment of a programmable syringe pump to deliver the 
exact volumes into the glass cell where the electrolysis occurs by the aid of 
polarized identical platinum electrodes. The polarization of the electrodes 
happens when a minute current passes through them; the current was generated 
by the electronic circuit and measured by the microameter. The voltammeter was 
used to measure the potential difference between the two electrodes and the 
oscilloscope to show the status of the current whether it is a DC or an AC. 
The program controlling the assay of promethazine hydrochloride is 
simple and as follows: 
1. The system was set as shown in figure 2.6  
2. The syringe pump was homed  
3. Each reagent was connected to a specified port; port 1 for promethazine, 
port 2 for the acid and port 3 for CeIV. 
4. A known volume in microliters of promethazine was first delivered into 
the glass cell, and then the supporting electrolyte which was sulfuric acid 
was added and stirred with magnetic stirrer and then titrated against 
CeIV. 
5. The endpoint was detected potentiometrically. 
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Figure 2.6: Electrochemical system; EC: electronic circuit; V: voltmeter; OS: 
oscilloscope; AM: microameter; PC: personal computer; SP: programmable 
syringe pump; MPV: multiposition valve; H: sulfuric acid; Ce: ceriumIV; PR: 
promethazine hydrochloride; WE: wire with two electrodes; G: glass cell; MS: 
magnetic stirrer. 
 
2.7 Chlorpheniramine maleate Assay 
2.7.1 Introduction 
Chlorpheniramine maleate is chemically named as 3-(4-chlorophenyl)-N-
N-dimethyl-3-pyrid-2-ylpro-panamine hydrogen (2)-butenedioate (figure 2.7). It 
is a white, crystalline powder, freely soluble in water, soluble in alcohol and 
slightly soluble in ether [132] 
 
Fig. 2.7 Chlorpheniramine maleate structure 
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Chlorpheniramine maleate, an alkylamine derivative, is a sedating 
antihistamine that causes a moderate degree of sedation; it also has 
antimuscarinic activity. It is used for the symptomatic relief of allergic 
conditions including urticaria and angioedema, rhinitis and conjunctivitis, and in 
pruritic skin disorders. It is a common ingredient of compound preparations for 
symptomatic treatment of coughs and common cold [169]. 
            
2.7.2 Assay methods of chlorpheniramine maleate in pharmaceutical          
formulations 
Many analytical methods for the assay of chlorpheniramine maleate in 
pharmaceutical preparations were established. Several methods were reported 
involving official standard methods as well as non-official standard methods. 
The sections below describe the advantages and disadvantages of some methods. 
 
2.7.2.1 Official standard methods 
The BP [132] method for the assay of chlorpheniramine maleate in the 
generic form is a potentiometric titration with perchloric acid after dissolving the 
sample in anhydrous acetic acid. A direct spectrophotometric method is provided 
for the injection form, the absorbance is measured at wavelength 265 nm after 
dilution with 0.25 mol l-1 sulphuric acid. For oral solution form, gas 
chromatography is employed to determine the content of chlorpheniramine 
maleate in the sample. For the tablet form 0.05 mol l-1 sulphuric acid is added to 
the sample, shaken for 5 minutes, then ether is added to the mixture. The acid 
layer is then filtered; the ether layer is extracted with two quantities of 0.05 mol 
l-1 sulphuric acid and then filtered and washed with more 0.05 mol l-1 sulphuric 
acids. The combined acid washings and extracts are made just alkaline to litmus 
paper by adding 1 mol l-1 sodium hydroxide, then 2 ml of sodium hydroxide are 
added in excess. This is followed by extraction with two quantities of ether and 
washing of each extract with water followed by successive extraction with three 
quantities of 0.25 mol l-1 sulphuric acid and a series of dilutions with more 0.25 
 57
mol l-1 sulphuric acid. The absorbance is measured at wavelength 265 nm. It is 
clear that in this method a lengthy extraction procedure is followed. 
 
2.7.2.2 Other non-official methods 
Several analytical methods adopted for the determination of 
chlorpheniramine in pharmaceutical formulations were found in the literature 
including, polarography [170], spectrophotometry [171, 172], infra red 
spectroscopy [173], micellar liquid chromatography [174, 175], capillary 
electrophoresis [176, 177], HPLC and capillary electrophoresis [178], ion-
selective sensors [179], HPLC [180- 183], HPLC and spectroscopy [184] and 
atomic emission spectrophotometry [185]. Most of the methods mentioned 
above have some drawbacks. Generally, they are lengthy procedures and 
consume a lot of reagents and time. It is therefore necessary to find a more 
effective, economical, automated and specific method as an alternative.   
 
2.7.3 The proposed SIA method 
An automated and cost-effective SIA method was proposed for the assay 
of chlorpheniramine maleate in pharmaceutical formulations. The method was 
based on the oxidation of chlorpheniramine by potassium permanganate in 
sulphuric acid media. The highly controlled conditions of the method made the 
spectrophotometric measurements easier to be performed. This method was 
accompanied by a complete chemometric optimization of the variables to help 
perform a comprehensive procedure for the drug. 
 
2.7.4 SIA program controlling chlorpheniramine assay 
A suitable SIA manifold for the oxidation of chlorpheniramine was 
constructed (figure 2.8), and the appropriate SIA protocol to execute the 
procedure was programmed (Appendix 7). The points below describe the 
consequent steps followed to execute the SIA method. 
1. Water was linked to the syringe pump through in-position mode to push 
reagents to the required part of the SIA manifold. 
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2. Sulphuric acid, permanganate, chlorpheniramine and water were linked to 
the selector valve through ports 2, 3, 4 and 5 respectively. 
3. The syringe was filled with 1500 µl of water by directing the bi-
directional valve to the in-position mode with flow rate of 150 µl s-1. 
4. The Teflon tubes were filled with their respective reagents by performing 
aspirations runs and directing the bi-directional valve to the out-position 
mode. 
5. With the same fast flow rate, the syringe was emptied and step 3 was 
repeated. 
6. 35 µl of sulphuric acid, 30 µl of permanganate and 50 µl of water were 
sequentially aspirated into the holding coil and short reverse strokes were 
performed three times to allow the mixing of the reagents to take place at 
flow rate 25 µl s-1. 
7. With a flow rate of 50 µl s-1, 250 µl volumes was dispensed to the 
reaction coil and the mixture was delayed for the required time to allow 
the reaction to take place. 
8. 1200 µl volume was dispensed with a flow rate of 25 µl s-1 to the Z-flow 
cell passing through the reaction coil and at the same time to the reference 
and absorbance scan were carried out at wavelength 507, 526, and 546 
nm, and the maximum absorbance was recorded as the value a1. 
9. The syringe is emptied and refilled with 1500 µl of water. 
10. To ensure the repeatability of dispersion and mixing, steps 6, 7, 8 and 9 
were repeated three times and the average of a1 (last two measurements) 
was calculated as A1. 
11. 35 µl of sulphuric acid, 30 µl of permanganate, 30 µl of chlorpheniramine 
and 20 µl of water were sequentially aspirated into the holding coil and 
short reverse strokes were performed three times to allow the mixing of 
the reagents at flow rate 25 µl s-1. 
12. With a flow rate of 50 µl s-1, 250 µl volumes was dispensed to the 
reaction coil and the mixture was delayed for the required time to allow 
the reaction to take place.  
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13. 1200 µl volume was dispensed with a flow rate of 25 µl s-1 to the Z-flow 
cell passing through the reaction coil and at the same time to the reference 
and absorbance scan were carried out at wavelength 507, 526, and 546 
nm and the maximum absorbance was recorded as the value a2. 
14. The syringe is emptied and refilled with 1500 µl of water. 
15. To ensure the repeatability of monitoring the reaction, steps 11, 12, 13 
and 14 were repeated three times and the average of a2 (last two 
measurements) was calculated as A2. 
The response R of the reaction was calculated using equation 2.2. 
 
R = A1 – A2                    (2.2) 
 
 
Fig. 2.8: Sequential injection analyzer manifold diagram (CH), CA: carrier 
(water); P: syringe pump; HC: holding coil; H+: sulphuric acid; Pmg: potassium 
permanganate; CH: Chlorpheniramine analyte; MPV: multi-position valve; 1-8: 
ports; RC: reaction coil; SP: spacer (water) RS: radiation source; Z: Z-flow cell; 
D: detector; Ws: waste; PC: personal computer.  
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2.8 Verapamil hydrochloride Assay 
2.8.1 Introduction 
Verapamil hydrochloride is chemically named as 2-(3, 4-
dimethoxyphenyl)-5-[{2-(3, 4-dimethoxyphenyl) ethyl} (methyl) amino]-2-( 1-
methylethyl)pentanenitrile hydrochloride (figure 2.9). It is a white, crystalline 
powder, soluble in water, sparingly soluble in alcohol and freely soluble in 
methanol [132] 
 
Figure 2.9.: Verapamil hydrochloride structure 
 
Verapamil is a calcium-channel blocker and a class IV antiarrythmic 
drug. Verapamil slows conduction through the atrioventricular node, and thus 
slows the increased ventricular response rate that occurs in atrial fibrillation and 
flutter. A decrease in both coronary and peripheral vascular resistance together 
with a sparing effect on myocardial intracellular oxygen consumption appears to 
be the modes of action in angina. The decreased peripheral vascular resistance 
may explain the antihypertensive effect of verapamil. It is used in the control of 
supraventricular arrhythmias and in the management of angina pectoris and 
hypertension. It may also be used in the management of myocardial infarction. 
Verapamil hydrochloride is usually available as mono component in dosage 
forms containing injections and tablets [169].  
 
2.8.2 Assay methods of verapamil hydrochloride in pharmaceutical         
formulations 
Many analytical methods for the assay of verapamil hydrochloride in 
pharmaceutical preparations were established. Several methods were proposed 
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involving official standard methods as well as non-official standard methods. 
The sections below describe the advantages and disadvantages of some used 
methods. 
 
2.8.2.1 Official standard methods 
The BP [132] method for the assay of verapamil hydrochloride in the 
generic form is a potentiometric titration with sodium hydroxide after dissolving 
the sample in ethanol and hydrochloric acid. A direct spectrophotometry is 
provided for the injection form; the absorbance is measured at wavelength 278 
nm after dilution with a 0.01 mol l-1 hydrochloric acid. The tablet form is 
assayed by shaking verapamil with 0.1mol l-1 hydrochloric acid for 10 minutes 
and then adding sufficient 0.1 mol l-1 hydrochloric acid and dilution of the 
filterate with water. The absorbance is measured at wavelength 278nm. This 
method is lengthier compared with that of the injection form. 
 
2.8.2.2 Other non-official methods 
Some analytical methods adopted for the determination of verapamil in 
pharmaceutical formulations were reported in the literature including, 
spectrophotometry [186], HPLC [187], atomic emission spectrophotometry 
[188], adsorptive stripping voltammetry [189], flow injection and pulse 
amperometric [190], micellar liquid chromatography [191], ion-selective 
electrode [192], and Resonance Rayleigh scattering with flow injection [193]. 
Most of these methods have some limitations. They are rather lengthy and 
consume a lot of reagents and time. So, it is advantageous to find a more 
effective, economical, automated and specific method. 
 
2.8.3 The proposed SIA method 
An automated and cost-effective SIA method was proposed for the assay 
of verapamil hydrochloride in pharmaceutical formulations. The method was 
based on the oxidation of verapamil by potassium permanganate in sulphuric 
acid media. The highly controlled conditions of the method made the 
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spectrophotometric measurements much easier to be performed. This method 
was accompanied by a complete chemometric optimization of the variables to 
help perform a comprehensive assay procedure for proper determination of the 
drug under study. 
 
2.8.4 SIA program controlling verapamil hydrochloride assay 
A suitable SIA manifold for the oxidation of verapamil hydrochloride was 
constructed (figure 2.10), and the appropriate SIA protocol to execute the 
procedure was programmed (Appendix 6). The points below describe the 
consequent steps followed to execute the SIA method. 
1. Water was linked to the syringe pump through in-position mode to push 
reagents to the required part of the SIA manifold.  
2. Sulphuric acid, permanganate, verapamil and water were linked to the 
selector valve through ports 2, 3, 4 and 5 respectively. 
3. The syringe was filled with 1500 µl of water by directing the bi-
directional valve to the in-position mode with flow rate of 150 µl s-1. 
4. The Teflon tubes were filled with their respective reagents by performing 
aspirations runs and directing the bi-directional valve to the out-position 
mode. 
5. With the same fast flow rate, the syringe was emptied and step 3 was 
repeated. 
6. 35 µl of sulphuric acid, 30 µl of permanganate and 50 µl of water were 
sequentially aspirated into the holding coil and short reverse strokes were 
performed three times to allow the mixing of the reagents to take place at 
flow rate 25 µl s-1. 
7. With a flow rate of 50 µl s-1, 250 µl volumes was dispensed to the 
reaction coil and the mixture was delayed for the required time to allow 
the reaction to take place. 
8. 1200 µl volume was dispensed with a flow rate of 25 µl s-1 to the Z-flow 
cell passing through the reaction coil and at the same time to the reference 
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and absorbance scan were carried out at wavelength 507, 526, and 546 
nm, and the maximum absorbance was recorded as the value a. 
9. The syringe is emptied and refilled with 1500 µl of water. 
10. To ensure the repeatability of dispersion and mixing, steps 6, 7, 8 and 9 
were repeated three times and the average of the last two measurements 
was calculated as A. 
11. 35 µl of sulphuric acid, 30 µl of permanganate, 30 µl of verapamil and 20 
µl of water were sequentially aspirated into the holding coil and short 
reverse strokes were performed three times to allow the mixing of the 
reagents at flow rate 25 µl s-1. 
12. With a flow rate of 50 µl s-1, 250 µl volumes was dispensed to the 
reaction coil and the mixture was delayed for the required time to allow 
the reaction to take place.  
13. 1200 µl volume was dispensed with a flow rate of 25 µl s-1 to the Z-flow 
cell passing through the reaction coil and at the same time to the reference 
and absorbance scan were carried out at wavelength 507, 526, and 546 
nm, and the maximum absorbance was recorded as the value b. 
14. The syringe is emptied and refilled with 1500 µl of water. 
15. To ensure the repeatability of monitoring the reaction, steps 11, 12, 13 
and 14 were repeated three times and the average of b (last two 
measurements) was calculated as B 
The response R of the reaction was calculated using equation 2.3. 
 
R = A – B                    (2.3) 
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Fig. 2.10: Sequential injection analyzer manifold diagram (VR), CA: carrier 
(water); P: syringe pump; HC: holding coil; H+: sulphuric acid; Pmg: potassium 
permanganate; VR: Verapamil analyte; MPV: multi-position valve; 1-8: ports; 
RC: reaction coil; SP: spacer (water) RS: radiation source; Z: Z-flow cell; D: 
detector; Ws: waste; PC: personal computer.  
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CHAPTER THREE 
 
RESULTS AND DISCUSSION
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3.1 Chlorpheniramine maleate assay 
The utilization of SIA for the assay of chlorpheniramine in 
pharmaceutical formulations adopted spectrophotometric method of detection 
that is, by measuring the absorbance difference as explained by equation 2.2. In 
the following sections the results obtained are discussed and justified. 
    
3.1.1 Optimization of variables 
Key parameters that influence the performance of the proposed SIA 
method were studied in order to establish the optimum working conditions. Both 
physical and chemical parameters were studied. 
 
3.1.1.1 Physical parameters 
Physical parameters of the SIA system control the extent of the reaction 
and the degree of dispersion of a product of a reaction between the analyte and 
the colored reagent before it reaches the detector. This is important because the 
response is directly proportional to the concentration of the product passing 
through the flow cell. These parameters are responsible for delivering 
appreciable amount of the product for detection. 
  
3.1.1.1.1 Wavelength determination  
In order to obtain results with minimum interferences, it will be better to 
identify the wavelength which is optimum for giving reasonable peak height. 
The proposed system relies mainly on the measurements of these peak heights. 
In permanganate spectrum wavelengths of 507nm, 526nm and 546nm 
respectively were found to show some absorbance. The wavelength of 546nm 
gave the best results and was the one to be used. 
 
3.1.1.1.2 Time 
The reaction between chlorpheniramine and permanganate in acidic 
medium was based on the oxidation of chlorpheniramine by permanganate and 
consequent measurement of the absorbance differences between the blank which 
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is permanganate alone and after adding the analyte as explained by equation 2.2. 
Since this reaction is not fast enough, therefore the time must be optimized. A 
chemometric optimization for time was done as shown in figures 3.3, 3.4, 3.5 
and 3.6, and 4 minutes time was found to be the best. 
 
3.1.1.1.3 Flow rate 
The flow rate should be optimized so that the contact period is sufficient. 
The best flow rate was found to be 50µl s-1 for the carrier solution and 25µl s-
1from the multiposition valve to the holding coil on the reverse direction towards 
the detector and through the reaction coil. 
 
3.1.1.1.4 Volume 
The volumes of the reagents and analyte used throughout the method 
were kept constant; 30µl chlorpheniramine, 30µl permanganate; 35µl acid and 
20µl of spacer solution.  
 
3.1.1.1.5 Effect of HC and RC dimensions 
The dimensions of the holding coil have a limited effect once this coil can 
accommodate the volumes without diffusion into the carrier stream. The reaction 
coil dimensions have an influence on the dispersion degree and the extent of the 
reaction whether it was fast or slow because the zones are propelled through it 
and towards the detector and the length of 160 cm was used. 
 
3.1.1.2 Chemical parameters 
The proposed SIA system for the determination of chlorpheniramine is 
based on the reaction with potassium permanganate in acidic medium at 
wavelength 546 nm. The concentrations of each of these chemicals determine 
the limit of detection and the linear range of this system that can be used for 
quantitative analysis 
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3.1.1.2.1 Effect of sulphuric acid concentration 
Preliminary studies showed that sulphuric acid gave the best results; these 
results are evaluated and it was found that the optimum concentration ranges 
between 1×10-3mol l-1 and 1×10-2mol l-1. The higher concentration gave better 
results, but it seems to interfere somehow in the reaction, that the peak heights 
tend to get shorter as the time passes, which were supposed to be of the same 
height. The concentration of 1×10-3mol l-1 was used. A complete chemometric 
optimization of the effect of acid was done as shown in figures 3.1, 3.2, 3.3 and 
3.4.  
 
3.1.1.2.2 Effect of permanganate concentration 
Permanganate seems to have a profound effect on the process and as it 
has strong oxidizing capabilities and high molar absorptivity, it was used with 
success in this system with concentrations ranging from 5×10-4 to 5×10-3mol l-1. 
The reproducible and best results were found to be between 5×10-4 and 1×10-3 
mol l-1.  A concentration of 1×10-3mol l-1 was used. A complete chemometric 
optimization of the effect of permanganate was performed as shown in figures 
3.1, 3.2, 3.5 and 3.6. 
 
3.1.2 Sequential chemometric optimization 
Sequential chemometric optimization was employed to find out the 
optimum operating conditions of the proposed system and to check the 
parameters which substantially affected the efficiency of the method. 
 
3.1.2.1 The Experimental Design 
The experimental design approach was employed and 2k factorial design 
was run where 2 stands for variable levels considering the higher and lower 
values and k is the number of factors studied. Three factors were studied 
including sulphuric acid and permanganate concentrations and the delay time. 
The highest and lowest values were determined and assigned +1 and -1 coded 
levels respectively, and the matrix was arrayed as shown in table 3.1. The lowest 
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and the highest values were determined based on the same criteria discussed 
above. Eight experiments as a result of a 23 factorial design were arranged and 
the original levels and their responses were introduced as shown in table 3.2. 
 
3.1.2.1.1 The response surface method 
The results obtained from the factorial design were interpolated and 
plotted using SigmaPlot® software package. The surface plot of the response as 
a function of sulphuric acid concentration and permanganate concentration 
levels were plotted as in figure 3.1and 3.2. It was obvious that the surface 
response increases as the concentration of permanganate increases and to some 
extent as the concentration of acid increases. The figures indicate that the effect 
of permanganate concentration on the response was more than that of the acid 
concentration. The surface plot as a function of sulphuric acid concentration and 
delay time is presented in figures 3.3. It shows that at low acid concentration 
there is slight effect on response, but high acid concentration the response 
increases as time decreases. Figure 3.4 shows that at high and low acid 
concentrations response increases as time increases, but the effect on the 
response was higher at high acid concentration. Figure 3.5 and figure 3.6 show 
the surface plot of the response as a function of permanganate concentration and 
delay time. The effect of permanganate concentration on the response increases 
as the delay time increases.    
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Table3.1:       
Full treatment combinations of the coded values of parameters 
controlling the assay method of chlorpheniramine   
     
Exp.  H2SO4  KMnO4 Time Response 
Number         
     
1 +1 +1 -1 0.1960 
2 +1 +1 +1 0.2285 
3 -1 +1 -1 0.1705 
4 -1 +1 +1 0.1895 
5 -1 -1 -1 0.1045 
6 -1 -1 +1 0.1010 
7 +1 -1 -1 0.1230 
8 +1 -1 +1 0.1145 
          
     
 
 
 
Table3.2:      
Response obtained with the full treatment combinations of the original  
values of parameters controlling the assay method of chlorpheniramine  
     
Exp.  H2SO4 KMnO4 Time Response 
Number.         
     
1 0.01 0.001 2 min 0.1960 
2 0.01 0.001 4 min 0.2285 
3 0.001 0.001 2 min 0.1705 
4 0.001 0.001 4 min 0.1895 
5 0.001 0.0005 2 min 0.1045 
6 0.001 0.0005 4 min 0.1010 
7 0.01 0.0005 2 min 0.1230 
8 0.01 0.0005 4 min 0..1145 
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Fig. 3.1: Response surface plot of acid concentration (mol l-1) against    
permanganate concentration (mol l-1) for chlorpheniramine (time 2 min) 
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             Fig. 3.2: Response surface plot of acid concentration (mol l-1) against 
permanganate concentration (mol l-1) for chlorpheniramine (time 4 min) 
 
 
 
 
 
 
 
 
 
 73
0.095
0.100
0.105
0.110
0.115
0.120
0.125
-1
0
1
-1
0
1
R
esponse
Ac
id 
co
nc
en
tra
tio
n (
M
)
Time (min)
  
             Fig. 3.3: Response surface plot of acid concentration (mol l-1) against 
time for chlorpheniramine (permanganate 5×10-4 mol l-1) 
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             Fig. 3.4: Response surface plot of acid concentration (mol l-1) against 
time for chlorpheniramine (permanganate 1×10-3 mol l-1) 
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             Fig. 3.5: Response surface plot of permanganate concentration (mol l-1) 
against time for chlorpheniramine (acid 1×10-3 mol l-1) 
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               Fig. 3.6: Response surface plot of permanganate concentration (mol l-1) 
against time for chlorpheniramine (acid 1×10-2 mol l-1) 
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3.1.2.1.2 The Estimation of Effects 
Another method of the ANOVA approach was applied i.e. the effect 
factor (Ef) on the response. The main factor of a variable explains the level of 
effect on the response of a system. It is calculated as the difference between the 
average of the response of the highest levels (+1) and the average of the response 
of the lowest levels (-1) as presented in Eq. 3.1. Therefore a 23 factorial design 
was adopted to calculate the effect factors. The interaction effect factor explains 
the level of the interaction effect between variables on the response of a system. 
In this respect, the encoded levels of each experiment are multiplied and then 
calculated as in Eq. 3.1. Table 3.3 shows a 23 factorial design matrix and the 
multiplication of the encoded levels of the variables. The main and interaction 
effect factors were calculated and the results obtained were introduced in table 
3.4. The main effect factors show that permanganate concentration had a 
significant effect on the response more than the effect of acid concentration or 
delay time. The two-variable interaction effect factor between permanganate 
concentration and delay time was higher than that between acid concentration 
and permanganate concentration or time. The three-variable interactions effect 
was lower than permanganate concentration and delay time, acid and 
permanganate concentrations and higher than that of acid and delay time 
interaction effect. These findings strengthen what was explained by the surface 
plot that permanganate concentration and delay time strongly interacted with 
each other than with acid concentration.   
 
( ) ( )
n
Y
n
Y
Ef ∑∑ −−+= 11     3.1 
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Table 3.3         
A 23 factorial design matrix and variables interaction   
         
                  
Exp. 
No. A P T AP AT PT APT Response
                  
         
1 +1 +1 -1 + - - - 0.1960 
2 +1 +1 +1 + + + + 0.2285 
3 -1 +1 -1 - + - + 0.1705 
4 -1 +1 +1 - - + - 0.1895 
5 -1 -1 -1 + + + - 0.1045 
6 -1 -1 +1 + - - + 0.1010 
7 +1 -1 -1 - - + + 0.1230 
8 +1 -1 +1 - + - - 0.1145 
                  
         
A: acid concentration, P: permanganate concentration, T: delay time, 
R: response       
 
 
 
 
Table 3.4   
The effect of variables on the response  
   
      
Effect factor       Variable Value 
      
Main effect              A 0.0242 
              P 0.0853 
              T 0.0098 
Two-variable interaction              AP 0.0081 
              AT 0.0021 
              PT 0.0158 
Three-variable 
interaction             APT 0.0046 
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3.1.3 Analytical appraisals 
The developed method was validated in order to evaluate if adequate 
linearity, repeatability, recovery, precision and accuracy had been achieved. The 
linearity of the proposed SIA system for the determination of chlorpheniramine 
maleate was evaluated under the optimum conditions. A series of standard 
solutions of chlorpheniramine were prepared and applied. Figure 3.7 shows the 
calibration plot of chlorpheniramine by the four standard solutions with the 
concentrations of 20, 50, 100 and 150 ppm. Beer's law was obeyed for this 
concentration range. The regression calibration equation obtained under 
optimum conditions was  
   
R = 0.0016C+ 0.0064       3.2 
Where R is the response calculated by the equation 2.1 and C is the unknown 
concentration of chlorpheniramine maleate as ppm. The correlation coefficient r 
was found to be 0.9998 indicating good linearity.  
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Figure 3.7 SIA calibration plot of Chlorpheniramine 
                (1×10-3 mol l-1) M H2SO4, (1×10-3 mol l-1) KMnO4, 4min) 
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3.1.4 Application 
The optimized SIA method was applied for the assay of chlorpheniramine 
maleate in pharmaceutical preparations collected from drug stores. Starch as one 
of the expected additive was examined to make sure that it did not to interfere 
with the process of determination of the analyte. Blank measurements using only 
the oxidizing agent which is permanganate and after adding 10 ppm starch were 
conducted and the absorbance difference was calculated as shown in equation 
2.1. This revealed that the excipient added showed negligible interference with 
the whole process. The mean recovery and the RSD% (relative standard 
deviation) are presented in table 3.5. The results obtained showed acceptable 
accuracy and repeatability. 
 
Table 3.5 Results obtained by the SIA and BP methods for the analysis of 
chlorpheniramine maleate synthetic sample, tablets and injections 
Chlorpheniramine 
sample 
SIA BP Official range* Recovery 
% 
R. S. D. ♠ 
% 
Synthetic  
sample 
99.8% 98% 98-101% 101.8% ± 1.8% 
Allerfin 10mg 
injection 
   96% 95% 90-110% 101% ± 1% 
Anallerg 4 mg 
tablets 
  97.25% 98.3% 92.5-107.5% 98.9% ± 1.1% 
 
*The official range of the content of a drug specified by the BP. 
♠The R. S. D. of n =7  
 
 
 
 
 
 
 
 81
3.2 Verapamil hydrochloride Assay 
3.2.1 Optimization of variables 
Key parameters that influence the performance of the proposed SIA 
method were studied in order to establish the optimum working conditions. Both 
physical and chemical parameters were studied 
 
3.2.1.1 Physical parameters 
Physical parameters of the SIA system control the extent of the reaction 
and the degree of dispersion of a product of a reaction between the analyte and 
the colored reagent before it reaches the detector. This is important because the 
response is directly proportional to the concentration of the product passing 
through the flow cell. These parameters are responsible for delivering 
appreciable amount of the product for detection.  
 
3.2.1.1.1 Wavelength determination 
In order to obtain results with minimum interferences, it will be best to 
identify the optimum wavelength that for giving reasonable peak height, since 
the proposed system relies mainly on the measurements of these peak heights. In 
permanganate spectrum wavelengths of 507nm, 526nm and 546nm respectively 
were found to show some absorbance. The wavelength of 546nm gave the best 
results and it was the one to chosen. 
 
3.2.1.1.2 Time 
The reaction between verapamil and permanganate in acidic medium is 
based on the oxidation of verapamil by permanganate and consequent 
measurement of the absorbance differences between the blank which is 
permanganate alone and after the addition of the analyte as explained by 
equation 2.3. For this reaction the time must be optimized. A chemometric 
optimization for time was done as shown in figures 3.10, 3.11, 3.12 and 3.13 and 
2 minutes time was the best to be used since delay time of 4 minutes did not 
improve the peak heights and were almost the same as for that of 2 minutes.  
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3.2.1.1.3 Flow rate 
The flow rate should be optimized so that the contact period is sufficient 
and the best flow rate was found to be 50µl s-1 for the carrier solution and 25µl s-
1from the multiposition valve to the holding coil on the reverse direction towards 
the detector and through the reaction coil. 
 
3.2.1.1.4 Volume  
The volume of the reagents and the analyte used throughout the method 
was kept constant; 30µl verapamil, 30µl permanganate; 35µl acid and 20µl of 
spacer solution which was water.  
 
3.2.1.1.5 Effect of HC and RC dimensions 
The dimensions of the holding coil have a limited effect once this coil can 
accommodate the volumes without diffusion into the carrier stream. The reaction 
coil dimensions have an influence on the dispersion degree and the extent of the 
reaction whether it was fast or slow because the zones are propelled through it 
and towards the detector and its length was 160 cm. 
 
3.2.1.2 Chemical parameters 
The proposed SIA system for the determination of verapamil is based on 
the reaction with potassium permanganate in acidic medium at wavelength 
546nm.The concentrations of each of these chemicals determine the limit of 
detection and the linear range of this system that can be used for quantitative 
analysis 
 
3.2.1.2.1 Effect of sulphuric acid concentration: 
Preliminary studies showed that sulphuric acid gave the best results. 
These results are evaluated and it was found that the optimum concentration 
ranges between 1×10-3mol l-1 and 1×10-2mol l-1. The higher concentration gave 
better results, but it seems to interfere somehow in the reaction so that the peak 
heights tend to get shorter as the time passes, though supposed to be of the same 
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height. The concentration of 1×10-3mol l-1 was selected. A complete 
chemometric optimization of the effect of acid was done as shown in the figures, 
3.8, 3.9, 3.10 and 3.11.  
 
3.2.1.2.2 Effect of permanganate concentration: 
Permanganate seems to have a profound effect on the process since it has 
enjoying strong oxidizing capabilities and high molar absorptivity; it is used 
with success in this system with concentrations ranging from 1×10-3 to 3×10-
3mol l-1. The reproducible and best results were found to be between 1×10-3 and 
2×10-3 mol l-1.  A concentration of 2×10-3mol l-1 was the one used in this assay 
method. A complete chemometric optimization of the effect of permanganate 
was performed as shown in figure 3.8, 3.9, 3.12 and 3.13. 
 
3.2.2 Sequential chemometric optimization 
Sequential chemometric optimization was employed to find out the 
optimum operating conditions of the proposed system and to check the 
parameters which substantially affected the efficiency of the method. 
 
3.2.2.1 Experimental design 
Experimental design is a powerful tool when used in part of optimization. 
Ruggedness testing and modeling of chemical analysis procedures were usually 
employed to understand the relationship between experimental factors and their 
corresponding responses, as well as the determination of the optimum working 
conditions at which minor changes of these factors can be tolerated. 
Experimental design approach along with response surface modeling were 
employed and 2k factorial design was run where 2 stands for variable levels 
considering the higher and lower values and k is the number of factors studied. 
Three factors were studied including sulphuric acid and permanganate 
concentrations and the delay time. The highest and lowest values were 
determined and assigned +1 and -1 coded levels respectively, and the matrix was 
arrayed as shown in table 3.6. The lowest and the highest values were 
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determined based on the same criteria discussed above. Eight experiments as a 
result of a 23 factorial design were arranged and the original levels and their 
respective responses were introduced as shown in table 3.7. 
 
3.2.2.1.1 The surface response method 
The results obtained from the factorial design were interpolated and 
graphed using SigmaPlot® software package. The surface plot of the response as 
a function of sulphuric acid concentration and permanganate concentration 
levels were plotted as in figure 3.8 and 3.9. In figure 3.8 it was obvious that the 
surface response increases as the concentration of permanganate increases and to 
some extent as the concentration of acid increases. Figure 3.9 shows that at high 
acid concentration there is slight increase in the response, but at low acid 
concentration there is a significant increase in response. The figures indicate that 
the effect of permanganate concentration on the response was more than that of 
the acid concentration. The surface plot as a function of sulphuric acid 
concentration and delay time is presented in figures 3.10 and 3.11. In figure 3.10 
there is slight increase of response with respect to acid concentration and delay 
time. Figure 3.11at high acid concentration and time did not show any effect 
while at low acid concentration the response increases with the increase of delay 
time. Figure 3.12 and figure 3.13 show the surface plot of the response as a 
function of permanganate concentration and delay time. In figure 3.12 the effect 
of delay time on the response is higher than that of permanganate concentration.   
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Table3.6      
Full treatment combinations of the coded values of parameters 
controlling the assay method of verapamil hydrochloride   
     
Exp.  H2SO4  KMnO4 Time Response 
Number         
     
1 -1 -1 -1 0.1009 
2 -1 -1 +1 0.1175 
3 -1 +1 -1 0.1755 
4 -1 +1 +1 0.2160 
5 +1 -1 -1 0.1455 
6 +1 -1 +1 0.1620 
7 +1 +1 -1 0.2435 
8 +1 +1 +1 0.2400 
          
 
 
 
 
Table3.7     
Response obtained with the full treatment combinations of the original  
values of parameters controlling the assay method of verapamil 
hydrochloride  
     
Exp.  H2SO4 KMnO4 Time Response 
Number.         
     
1 0.001 0.001 2 min 0.1009 
2 0.001 0.001 4 min 0.1175 
3 0.001 0.002 2 min 0.1755 
4 0.001 0.002 4 min 0.2160 
5 0.01 0.001 2 min 0.1455 
6 0.01 0.001 4 min 0.1620 
7 0.01 0.002 2 min 0.2435 
8 0.01 0.002 4 min 0.2400 
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               Fig. 3.8: Response surface plot of acid concentration (mol l-1) against 
permanganate concentration (mol l-1) for verapamil (time 2 min) 
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             Fig. 3.9: Response surface plot of acid concentration (mol l-1) against 
permanganate concentration (mol l-1) for verapamil (time = 4 min)   
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             Fig.3.10: Response surface plot of acid concentration (mol l-1) against 
time for verapamil (permanganate 1×10-3 mol l-1) 
 
 89
0.17
0.18
0.19
0.20
0.21
0.22
0.23
0.24
0.25
-1
0
1
-1
0
1
R
esponse
Ac
id 
co
nc
en
tra
tio
n 
(M
)
Time (min)
 
               Fig. 3.11: Response surface plot of acid concentration (mol l-1) against 
time for verapamil (permanganate 2×10-3 mol l-1)  
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Figure.3.12: Response surface plot of permanganate concentration 
(mol l-1) against time for verapamil (acid 1×10-3 mol l-1) 
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               Figure: 3.13: Response surface plot of permanganate concentration 
(mol l-1) against time for verapamil (acid 1×10-2 mol l-1) 
 
 
 
 
 
 
 
 
 
 
 
 92
3.2.2.1.2 Estimation of Effects 
Another method of the ANOVA approach was applied i.e. the effect 
factor (Ef) on the response. The main factor of a variable explains the level of 
effect on the response of a system. It is calculated as the difference between the 
average of the response of the highest levels (+1) and the average of the response 
of the lowest levels (-1) as presented in Eq. 3.1. Therefore a 23 factorial design 
was adopted to calculate the effect factors. The interaction effect factor explains 
the level of the interaction effect between variables on the response of a system. 
In this respect, the encoded levels of each experiment are multiplied and then 
calculated as in Eq. 3.1. Table 3.8 shows a 23 factorial design matrix and the 
multiplication of the encoded levels of the variables. The main and interaction 
effect factors were calculated and the results obtained were introduced in table 
3.9. The main effect factors show that permanganate concentration had a more 
significant effect on the response more than the effect of acid concentration or 
delay time respectively. The two-variable interaction effect factor between acid 
concentration and time was higher than that between acid and permanganate 
concentrations and delay time, permanganate concentration and time and acid 
and permanganate respectively. However, the effect factor study exhibits 
positive effect for all factors except for acid time and acid permanganate time 
which have negative effect. These findings strengthen what was explained by the 
surface plot that permanganate concentration and delay time strongly interacted 
with each other than with acid concentration.   
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Table 3.8         
A 23 factorial design matrix and variables interaction   
         
                  
Exp. 
No. A P T AP AT PT APT Response
                  
         
1 -1 -1 -1 + + + - 0.1009 
2 -1 -1 +1 + - - + 0.1175 
3 -1 +1 -1 - + - + 0.1755 
4 -1 +1 +1 - - + - 0.2160 
5 +1 -1 -1 - - + + 0.1455 
6 +1 -1 +1 - + - - 0.1620 
7 +1 +1 -1 + - - - 0.2435 
8 +1 +1 +1 + + + + 0.2400 
                  
         
A: acid concentration, P: permanganate concentration, T: delay time, 
R: response       
 
 
Table 3.9   
The effect of variables on the response  
   
      
Effect factor Variable Value 
      
Main effect A 0.0452 
 P 0.0873 
 T 0.0173 
Two-variable interaction AP 0.00072 
 AT -0.011 
 PT 0.00098 
Three-variable interaction APT -0.0109 
      
 
 
 
 94
3.2.3 Analytical appraisals 
The developed method was validated in order to evaluate if adequate 
linearity, repeatability, recovery, precision and accuracy had been achieved. The 
linearity of the proposed SIA system for the determination of verapamil 
hydrochloride was evaluated under the optimum conditions. A series of standard 
solutions of the analyte were prepared and applied. Figure 3.10 shows the 
calibration plot of verapamil by the four standard solutions with the 
concentrations of 50, 100, 150 and 200 ppm. Beer's law was obeyed for this 
concentration range. The regression calibration equation obtained under 
optimum conditions was  
   
R = 0.0018C+ 0.005         3.3 
 
Where R is the response calculated by equation 2.1 and C is the unknown 
concentration of verapamil hydrochloride as ppm. The correlation coefficient r 
was found to be 0.9978 indicating good linearity.  
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Figure 3.10: SIA calibration plot of Verapamil 
(1×10-3mol l-1 H2SO4, 2×10-3mol l-1 KMnO4, 2min) 
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3.2.4 Application 
The accuracy of the proposed SIA method was evaluated by comparing 
the results obtained for samples with the proposed SIA method with those 
performed with BP standard method. The % R.S. D. (relative standard deviation) 
and the mean recovery of verapamil hydrochloride are presented in table 3.10. 
The results from both methods were found to be comparable and show 
acceptable accuracy and repeatability. Verapamil hydrochloride is available in 
pharmaceutical formulations as a mono drug, so only excipients such as starch, 
talc or maltose could be present in a typical pharmaceutical formulation. A blank 
measurement was run with permanganate alone and after adding 10 ppm starch 
to examine the interference of excipients. The absorbance of the blank was 
almost the same as that after adding starch.   
   
Table 3.10 Results obtained by the SIA and BP methods for the analysis of 
verapamil hydrochloride synthetic sample, tablets and injections 
Verapamil  
sample 
SIA BP Official* 
range  
recovery 
% 
R. S. D. ♠ 
% 
Synthetic  
sample 
99.8% 101% 99-101% 98.81 ±1.2 
Manidon 5 mg 
 injection 
101% 102% 90-110% 99.01 ±0.98 
Isoptin 40 mg 
 tablets 
98.89 96% 92.5-107.5% 103 ±3.01 
 
*The official range of the content of a drug specified by the BP. 
♠The R. S. D. n =7  
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3.3 Promethazine hydrochloride Assay 
Promethazine hydrochloride assay was based on its oxidation by cerium 
(IV) in sulfuric acid medium. Many factors may affect this process including 
supporting electrolye concentration, current, flow rate and type of electrodes. 
The potential of polarized electrode will be changed and will be different from 
that at zero current. Anodic polarization will make the potential more positive 
than zero current, while cathodic polarization results in negative potential. This 
difference in potential is due to overpotential. 
For oxidation-reduction (redox) reactions, the indictor electrode is usually 
a noble metal of the platinum group, gold or silver under limited conditions. This 
electrode will serve to transfer electrons from the solution to the external circuit 
without being oxidized itself. Optimization of factors that affect electrolysis will 
lead to a good detection. 
 
3.3.1 Optimization of variables 
Key parameters that influence the performance of the proposed DEP 
method were studied in order to establish the optimum working conditions.  
  
3.3.1.1 Flow rate 
The flow rate should be optimized so that the contact period is sufficient 
and the best flow rate was found to be 20µl s-1 for the addition of the reagent into 
the glass cell. 
 
3.3.1.2 DC Current 
The current needed to polarize the electrodes was optimized and the best 
current to be used was 5µA which was kept constant throughout the analysis.  
 
3.3.1.3 Type of electrodes 
Two identical platinum electrodes were used. They were fixed in specific 
position in the glass cell and immersed in the solution in a way not to touch the 
bottom of the cell to avoid acquiring any kind of resistance. The electrodes were 
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connected to electronic circuit and ammeter, and then the differential electrolytic 
potential between the two polarized electrodes was measured by the voltmeter. 
 
3.3.1.4.1Effect of sulphuric acid concentration 
Preliminary studies showed that sulphuric acid as supporting electrolyte 
gave the best results as it facilitates transfer of electrons during electrolysis. 
Adding supporting electrolyte in a proper concentration is sufficient to lower the 
resistance potential to an insignificant value. Rapid stirring of solution results in 
a uniform concentration in the bulk. Since ions carry the current, 
electromigration of reacting species will occur.  The addition of a background 
electrolyte minimizes such migration which depends upon the conductivity of 
the electrolyte solution and the amount of current flowing but not on 
electrochemical processes. These results are evaluated and it was found that the 
optimum concentration ranges between 1×10-3mol l-1 and 1×10-2mol l-1.  
 
3.3.1.5 Effect of Cerium (IV) concentration: 
Cerium (IV) in sulfuric acid seems to have a profound effect on the 
process and since it has strong oxidizing capabilities, it is used with great 
success in this system with concentrations ranging from 5×10-5 to 1×10-3mol l-1 
with respect to different concentrations of the analyte. The procedure was based 
on the oxidization of promethazine hydrochloride by cerium (IV) in acidic 
medium and generation of a potential difference between the two indicator 
electrodes in the electrolyte solution which is detected electrically by a voltmeter 
connected to the system as shown in figure 2.6.  
 
3.3.2 DEP Titration curves 
Unlike normal potentiometric titrations in which the endpoint is 
determined by plotting the potential against the volume or the ratio of ∆E/∆V 
against the volume as in figure 3.15, in DEP (differential electrolytic 
potentiometric) titration curves the endpoint will be determined directly at the 
highest point of the curve of differential potentiometric potential against volume.  
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Fig. 3.15: A typical potentiometric titration curve of promethazine hydrochloride     
against NaOH 
 
3.3.2.1 Determination of the end point 
To determine the end point for each titration, a DEP titration curve was 
graphed by plotting the volume of cerium (IV) in microliters against the DE 
potential in millivolts, the highest point of the curve corresponding to the highest 
potential reading will be the endpoint and the volume corresponding to this 
potential will be read from the graph (figure 3.16.) Usually we are concerned 
with the volume near the end point. 
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Fig.3.16: DEP titration curve of 1 ml of 5×10-4mol l-1 promethazine with 1×10-
3mol l-1of Ce (IV) and 2ml of 5×10-3mol l-1 H2SO4    
 
   
3.3.2.2 Determination of Cerium (IV) volume 
The determination of Cerium (IV) volume will lead in turn to the 
determination of the number of moles of cerium (IV) that reacted with 
promethazine hydrochloride. To do this a number of DEP titrations were 
performed under different conditions. The differential electrolytic potential was 
recorded and graphed against the volume of cerium (IV). 
 
3.3.2.3 Analytical calculations 
To calculate the number of moles of cerium (IV) that reacted with 
promethazine, first the volume reading was taken from the graph, and then the 
rule in equation 3.4 was applied.  
  3.4 
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To calculate the number of moles for Ce (IV) and for promethazine 
hydrochloride reacted with each other.  
(1) In figure 3.17: 
For Ce (IV), 8×10-4mol l-1 × 0.7(ml)/1000 = 5.6 x 10-7 moles 
For promethazine HCl, 5×10-4mol l-1 x 1(ml)/1000 =5×10-7moles  
  
     
 
 
Fig.3.17: DEP titration curve of 1 ml of 5×10-4mol l-1 promethazine with 8×10-
4mol l-1of Ce (IV) and 2ml of 5×10-3mol l-1 H2SO4  
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(2) In figure 3.18: 
For Cerium (IV), 4×10-4mol l-1 × 0.9(ml)/1000 = 3.6 x 10-7 moles 
For promethazine HCl, 5×10-4mol l-1 x 1(ml)/1000 =5×10-7moles  
 
 
 
 
 
   
Fig.3.18: DEP titration curve of 1 ml of 5×10-4mol l-1 promethazine with 4×10-
4mol l-1of Ce (IV) and 2ml of 5×10-3mol l-1 H2SO4    
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(3) In figure 3.19: 
For Cerium (IV), 2.5×10-4mol l-1 × 0.5(ml)/1000 = 1.25 x 10-7 moles 
For promethazine HCl, 1.25×10-4mol l-1 x 1(ml)/1000 =1.25×10-7moles  
 
 
 
 
 
 
 
 
 
Fig.3.19: DEP titration curve of 1 ml of 1.25×10-4mol l-1 promethazine with 
2.5×10-4mol l-1of Ce (IV) and 2ml of 1×10-3mol l-1 H2SO4    
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(4) In figure 3.20: 
For Cerium (IV), 2.5×10-4mol l-1 × 0.5(ml)/1000 = 1.25 x 10-7 moles 
For promethazine HCl, 1.25×10-4mol l-1 x 1(ml)/1000 =1.25×10-7moles  
  
 
 
 
 
 
 
 
 
 
 
 
Fig.3.20: DEP titration curve of 1 ml of 1.25×10-4mol l-1 promethazine with 
2.5×10-4mol l-1of Ce (IV) and 2ml of 5×10-3mol l-1 H2SO4    
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 (5) In figure 3.21: 
For Cerium (IV), 2.5×10-4mol l-1 × 0.6(ml)/1000 = 1.5 x 10-7 moles 
For promethazine HCl, 2.5×10-4mol l-1 x 0.5(ml)/1000 =1.25×10-7moles  
 
 
 
 
 
 
 
 
 
 
 
Fig.3.21: DEP titration curve of 0.5 ml of 2.5×10-4mol l-1 promethazine with 
2.5×10-4mol l-1of Ce (IV) and 2ml of 1×10-3mol l-1 H2SO4   
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(6) In figure 3.22: 
For Cerium (IV), 5×10-5mol l-1 × 0.8(ml)/1000 = 4 x 10-8 moles 
For promethazine HCl, 3×10-5mol l-1 x 1(ml)/1000 =3×10-8moles  
 
 
Figure 3.22: DEP titration curve of 1 ml of 3×10-5mol l-1 promethazine with 
5×10-5mol l-1of Ce (IV) and 2ml of 1×10-3mol l-1 H2SO4   
 
3.3.2.4 Impression 
Promethazine hydrochloride was found to be oxidizable by cerium (IV) in 
sulfuric acid media resulting in a free radical form [161] and it was shown in 
(figure 3.23). In this study and from the above findings it was obvious that one 
mole of cerium (IV) reacted with one mole of promethazine hydrochloride. 
 
 
 
 Fig.2.23: The proposed reaction scheme of the promethazine oxidation by 
acidified cerium (IV) 
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Fig.3.24: DEP titration curve of 1 ml of 3.8×10-4mol l-1 Histolac tablets with 
1×10-3mol l-1of Ce (IV) and 2ml of 1×10-3mol l-1 H2SO4   
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3.3.3 Application 
The DEP system for the assay of promethazine hydrochloride in 
pharmaceutical formulations collected from drug stores was successfully applied 
under the optimum conditions and validated in order to evaluate the precision, 
recovery, repeatability and accuracy of the method.  The optimum conditions of 
supporting electrolyte concentration ranges from 1×10-3mol l-1- 1×10-2mol l-1, a 
DC current of 5µA, 20 µl s-1 flow rate and cerium IV concentration ranges from 
5×10-5mol l-1-1×10-3mol l-1 .The mean recovery and the R. S. D. (relative 
standard deviation) are presented in table 3.11. The results obtained show 
acceptable precision, accuracy and reproducibility.  
 
Table 3.11 Results obtained by DEP and BP methods for the analysis of 
promethazine in standard samples and tablets 
Promethazine 
sample 
DEP BP Official range* 
% 
Recovery 
% 
R. S. D.♠ 
% 
Standard 
sample 
100% 98% 99-101% 102% ± 2% 
Histolac 25 mg 
tablets 
95% 95.7% 95-105% 99.2% ± 0.7% 
 
*The official range of the content of a drug specified by the BP. 
♠The R. S. D. of n =5  
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Conclusion 
 
The sequential injection analysis (SIA) technique has been successfully 
employed for developing new methods for the assay of chlorpheniramine 
maleate and verapamil hydrochloride in pharmaceutical preparations with.  
• The construction of SIA manifolds suitable for the assay of some 
pharmaceuticals like chlorpheniramine and verapamil. 
• Appropriate programming of SIA software to effectively control the 
newly adopted methods. 
• Sequential chemometric optimization of the methods for the assay of 
chlorpheniramine and verapamil was successfully applied by the 
employment of the response surface plot and factorial design. 
• The newly adopted methods were validated compared to those methods of 
the BP. 
• The proposed SIA methods were successfully applied to pharmaceutical 
samples as well as for synthetic ones. 
• The performance of the newly adopted methods was studied and 
evaluated with respect to linearity, repeatability, reliability, selectivity, 
robustness, accuracy and precision. 
• The newly adopted methods have some advantages compared to that of 
the official method in being: 
a) Fully automated. 
b) Time saving. 
c) Economical, with respect to the consumption of reagents. 
d) Safe, with respect to solution handling and to the environment. 
For electrochemical method applied for the assay of promethazine 
hydrochloride in pharmaceutical formulations the following should be noted. 
• The system used was easy to construct and simple to operate. 
• The program controlling pump was simple with clear and direct 
commands to run the titration smoothly. 
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• The method basically relies on the oxidation of promethazine with CeIV 
in acidic medium, and the detection of the endpoint potentiometirically. 
• The detection of the endpoint was based on applying DEP (differential 
electrolytic potential) theory which was novel. 
• The newly adopted method was validated compared to that of the BP. 
• The proposed electrochemical method was successfully applied to 
pharmaceutical samples as well as for synthetic ones. 
• The newly adopted method has the advantages of being automated, safe 
and economical. 
• The performance of the method was studied and evaluated with respect 
to selectivity, sensitivity, accuracy and precision.   
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Recommendations 
 
In pharmaceutical laboratories where quality control and assurance take 
place; a huge amount of chemical waste is generated and accumulated day by 
day. This may eventually lead to harmful consequences on the environment and 
in turn on humans where personal safety is critically affected. In addition, 
minimizing of operational costs necessitates the introduction of new methods to 
be applied with great success along with the conventional analytical procedures, 
but with many advantages over them. This situation implies intensifying the 
research in this vital field of sciences. The SIA methodology as a modern 
analytical technique, can contribute largely to solve many of the problems of 
traditional analytical laboratories such as waste minimization, cost-effectiveness, 
speed and automation. Pharmaceutical laboratories can make use of this 
technology and be applied for routine analysis. The introduction of SIA 
technique to the analytical chemistry few years ago still being unexplored and a 
lot have to be done to validate its potentiality in the area of titrimetry.  
The adopted SIA titrimetric methods for the assay of chlorpheniramine 
and verapamil in pharmaceutical formulations have good performance 
characteristics such as accuracy and precision as well as automation with respect 
to conventional titrimetric ones. SIA versatility allows almost all titrimetric 
approaches such as spectrophotometric and potentiometric to be conducted 
successfully. Hence, it is recommended to adapt SIA technique to conduct the 
official other than the non-official standard titrimetric methods. 
The results of present adopted SIA methods for the assay of 
chlorpheniramine and verapamil in pharmaceutical formulations showed that 
experimental design and variable screening can substantially reduce the time 
needed for method development. So it is recommended to employ chemometrics 
approach in the development of SIA method. 
As far as the electrochemical determination of promethazine 
hydrochloride is concerned, it is worthy to mention that the application of novel 
(DEP) detection method was simple, sensitive, economical, and easy to perform. 
Unlike normal potentiometric it is easy to detect the end point directly from the 
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DEP titration curves. More work need to be done for more improvement since 
only a few researchers deal with this vital topic. Hence, it is recommended to 
adapt the newly introduced DEP method for the determination of 
pharmaceuticals.      
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Appendices 
 
1. SIA program for washing all channels  
'Flushing syringe  
 132
SyringePump Flowrate (microliter/sec) 150 
Valve port 1  
SyringePump Valve Out  
SyringePump Empty  
SyringePump Delay Until Done  
'Washing the main channel  
SyringePump Valve In  
SyringePump Fill  
SyringePump Delay Until Done  
SyringePump Valve Out  
SyringePump Empty  
SyringePump Delay Until Done  
 
'Washing tube connected with port 2 
Valve port 2  
SyringePump Aspirate (microliter) 1500 
Valve port 1  
SyringePump Empty  
SyringePump Delay Until Done  
 
'Washing tube connected with port 3 
Valve port 3 
SyringePump Aspirate (microliter) 1500 
Valve port 1  
SyringePump Empty  
SyringePump Delay Until Done 
 
 'Washing tube connected with port 4 
Valve port 4  
SyringePump Aspirate (microliter) 1500 
Valve port 1  
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SyringePump Empty  
SyringePump Delay Until Done 
 'Washing tube connected with port 5 
Valve port 5  
SyringePump Aspirate (microliter) 1500 
Valve port 1  
SyringePump Empty  
SyringePump Delay Until Done 
 'Washing tube connected with port 6 
Valve port 6  
SyringePump Aspirate (microliter) 1500 
Valve port 1  
SyringePump Empty  
SyringePump Delay Until Done  
'Washing tube connected with port 7 
Valve port 7  
Syringe Pump Aspirate (microliter) 1500 
Valve port 1  
Syringe Pump Empty  
Syringe Pump Delay Until Done  
'Washing tube connected with port 8 
Valve port 8  
Syringe Pump Aspirate (microliter) 1500 
Valve port 1  
Syringe Pump Empty  
Syringe Pump Delay Until Done 
 
2. SIA program for washing port 2  
'Washing port 2 
 
SyringePump Flowrate (microliter/sec) 150 
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SyringePump Valve Out  
SyringePump Empty  
SyringePump Delay Until Done  
 
SyringePump Flowrate (microliter/sec) 150 
SyringePump Valve In  
SyringePump Aspirate (microliter) 1500 
SyringePump Delay Until Done  
 
'Sulphuric acid 
 
SyringePump Flowrate (microliter/sec) 150 
SyringePump Valve Out  
Valve port 2  
SyringePump Aspirate (microliter) 100 
SyringePump Delay Until Done  
 
SyringePump Flowrate (microliter/sec) 150 
Valve port 1  
SyringePump Empty  
SyringePump Delay Until Done  
 
 
 
 
 
 
3. SIA program for washing port 3  
'Washing port 3 
 
SyringePump Flowrate (microliter/sec) 150 
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SyringePump Valve Out  
SyringePump Empty  
SyringePump Delay Until Done  
 
SyringePump Flowrate (microliter/sec) 150 
SyringePump Valve In  
SyringePump Aspirate (microliter) 1500 
SyringePump Delay Until Done  
 
'Permanganate 
 
SyringePump Flowrate (microliter/sec) 150 
SyringePump Valve Out  
Valve port 3  
SyringePump Aspirate (microliter) 100 
SyringePump Delay Until Done  
 
SyringePump Flowrate (microliter/sec) 150 
Valve port 1  
SyringePump Empty  
SyringePump Delay Until Done  
 
 
 
 
 
 
4. SIA program for washing port 4  
'Washing port 4 
 
SyringePump Flowrate (microliter/sec) 150 
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SyringePump Valve Out  
SyringePump Empty  
SyringePump Delay Until Done  
 
SyringePump Flowrate (microliter/sec) 150 
SyringePump Valve In  
SyringePump Aspirate (microliter) 1500 
SyringePump Delay Until Done  
 
'Analyte 
 
SyringePump Flowrate (microliter/sec) 150 
SyringePump Valve Out  
Valve port 4  
SyringePump Aspirate (microliter) 100 
SyringePump Delay Until Done  
 
SyringePump Flowrate (microliter/sec) 150 
Valve port 1  
SyringePump Empty  
SyringePump Delay Until Done 
 
  
 
 
 
 
5. SIA program for washing and loading the channels 
'Washing the main channel 
SyringePump Flowrate (microliter/sec) 150 
SyringePump Valve Out  
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SyringePump Empty  
SyringePump Delay Until Done  
 
SyringePump Flowrate (microliter/sec) 150 
SyringePump Valve In  
SyringePump Fill  
SyringePump Delay Until Done   
 
SyringePump Flowrate (microliter/sec) 150 
Valve port 1  
SyringePump Valve Out  
SyringePump Empty  
SyringePump Delay Until Done  
 
SyringePump Flowrate (microliter/sec) 150 
SyringePump Valve In  
SyringePump Aspirate (microliter) 1500 
SyringePump Delay Until Done  
 
'Loading channels 
'Sulfuric acid 
SyringePump Flowrate (microliter/sec) 100 
SyringePump Valve Out  
Valve port 2  
SyringePump Aspirate (microliter) 50 
SyringePump Delay Until Done 
 
'Permanganate 
SyringePump Flowrate (microliter/sec) 100 
Valve port 3  
SyringePump Aspirate (microliter) 50 
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SyringePump Delay Until Done  
 
'Chlorpheniramine  
SyringePump Flowrate (microliter/sec) 100 
Valve port 4  
SyringePump Aspirate (microliter) 50 
SyringePump Delay Until Done  
 
  
'Spacer and Blank solution 
SyringePump Flowrate (microliter/sec) 100 
Valve port 5  
SyringePump Aspirate (microliter) 50 
SyringePump Delay Until Done  
 
 
SyringePump Flowrate (microliter/sec) 150 
Valve port 1  
SyringePump Empty  
SyringePump Delay Until Done  
 
 
 
 
 
 
 
6. SIA program for controlling Verapamil  
'Washing the main channel 
SyringePump Flowrate (microliter/sec) 150 
SyringePump Valve Out  
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SyringePump Empty  
SyringePump Delay Until Done  
 
SyringePump Flowrate (microliter/sec) 150 
SyringePump Valve In  
SyringePump Fill  
SyringePump Delay Until Done   
 
SyringePump Flowrate (microliter/sec) 150 
Valve port 1  
SyringePump Valve Out  
SyringePump Empty  
SyringePump Delay Until Done  
 
SyringePump Flowrate (microliter/sec) 150 
SyringePump Valve In  
SyringePump Aspirate (microliter) 1500 
SyringePump Delay Until Done  
 
'Loading channels 
'Sulfuric acid 
SyringePump Flowrate (microliter/sec) 50 
SyringePump Valve Out  
Valve port 2  
SyringePump Aspirate (microliter) 50 
SyringePump Delay Until Done 
 
'Permanganate 
SyringePump Flowrate (microliter/sec) 50 
Valve port 3  
SyringePump Aspirate (microliter) 50 
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SyringePump Delay Until Done  
 
'Chlorpheniramine 
SyringePump Flowrate (microliter/sec) 50 
Valve port 4  
SyringePump Aspirate (microliter) 50 
SyringePump Delay Until Done  
 
'Spacer and Blank solution 
SyringePump Flowrate (microliter/sec) 50 
Valve port 5  
SyringePump Aspirate (microliter) 50 
SyringePump Delay Until Done  
 
SyringePump Flowrate (microliter/sec) 150 
Valve port 1  
SyringePump Empty  
SyringePump Delay Until Done  
 
'Blank 1 
 
SyringePump Flowrate (microliter/sec) 150 
SyringePump Valve In 
SyringePump Aspirate (microliter) 1500  
SyringePump Delay Until Done   
 
 
SyringePump Flowrate (microliter/sec) 50 
SyringePump Valve Out 
Valve port 2   
SyringePump Aspirate (microliter) 35 
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SyringePump Delay Until Done  
 
SyringePump Flowrate (microliter/sec) 50 
Valve port 3 
SyringePump Aspirate (microliter) 30   
SyringePump Delay Until Done  
 
SyringePump Flowrate (microliter/sec) 50 
Valve port 5  
SyringePump Aspirate (microliter) 50 
SyringePump Delay Until Done  
 'Mixing reagents 
SyringePump Flowrate (microliter/sec) 25 
Valve port 1  
SyringePump Dispense (microliter) 10 
Delay (sec) 1 
SyringePump Aspirate (microliter) 10 
Delay (sec) 1 
SyringePump Dispense (microliter) 10 
Delay (sec) 1 
SyringePump Aspirate (microliter) 10 
Delay (sec) 1 
SyringePump Dispense (microliter) 10 
Delay (sec) 1 
SyringePump Aspirate (microliter) 10 
Delay (sec) 1 
 
SyringePump Flowrate (microliter/sec) 50 
Valve port 1 
SyringePump Dispense (microliter) 250  
SyringePump Delay Until Done  
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'Resident time 
Delay (sec) 120 
 
SyringePump Flowrate (microliter/sec) 25 
SyringePump Dispense (microliter) 1200 
Delay (sec) 1 
Spectrometer Reference Scan  
Delay (sec) 1 
Spectrometer Absorbance Scanning 
SyringePump Delay Until Done  
Spectrometer Stop Scanning  
 
SyringePump Flowrate (microliter/sec) 150 
SyringePump Empty  
SyringePump Delay Until Done   
'Blank 2 
SyringePump Flowrate (microliter/sec) 150 
SyringePump Valve In 
SyringePump Aspirate (microliter) 1500  
SyringePump Delay Until Done  
  
SyringePump Flowrate (microliter/sec) 50 
SyringePump Valve Out 
Valve port 2  
 SyringePump Aspirate (microliter) 35 
SyringePump Delay Until Done  
SyringePump Flowrate (microliter/sec) 50 
Valve port 3 
SyringePump Aspirate (microliter) 30   
SyringePump Delay Until Done  
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SyringePump Flowrate (microliter/sec) 50 
Valve port 5  
SyringePump Aspirate (microliter) 50 
SyringePump Delay Until Done  
 
 'Mixing reagents 
SyringePump Flowrate (microliter/sec) 25 
Valve port 1  
SyringePump Dispense (microliter) 10 
Delay (sec) 1 
SyringePump Aspirate (microliter) 10 
Delay (sec) 1 
SyringePump Dispense (microliter) 10 
Delay (sec) 1 
SyringePump Aspirate (microliter) 10 
Delay (sec) 1 
SyringePump Dispense (microliter) 10 
Delay (sec) 1 
SyringePump Aspirate (microliter) 10 
Delay (sec) 1 
 
SyringePump Flowrate (microliter/sec) 50 
Valve port 1 
SyringePump Dispense (microliter) 250  
SyringePump Delay Until Done  
 
'Resident time 
Delay (sec) 120 
 
SyringePump Flowrate (microliter/sec) 25 
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SyringePump Dispense (microliter) 1200 
Delay (sec) 1 
Spectrometer Reference Scan  
Delay (sec) 1 
Spectrometer Absorbance Scanning 
SyringePump Delay Until Done  
Spectrometer Stop Scanning  
 
SyringePump Flowrate (microliter/sec) 150 
SyringePump Empty  
SyringePump Delay Until Done   
 
'Blank 3 
 
SyringePump Flowrate (microliter/sec) 150 
SyringePump Valve In 
SyringePump Aspirate (microliter) 1500  
SyringePump Delay Until Done   
 
 
SyringePump Flowrate (microliter/sec) 50 
SyringePump Valve Out 
Valve port 2   
SyringePump Aspirate (microliter) 35 
SyringePump Delay Until Done  
 
 
SyringePump Flowrate (microliter/sec) 50 
Valve port 3 
SyringePump Aspirate (microliter) 30   
SyringePump Delay Until Done  
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SyringePump Flowrate (microliter/sec) 50 
Valve port 5  
SyringePump Aspirate (microliter) 50 
SyringePump Delay Until Done  
 
 'Mixing reagents 
SyringePump Flowrate (microliter/sec) 25 
Valve port 1  
SyringePump Dispense (microliter) 10 
Delay (sec) 1 
SyringePump Aspirate (microliter) 10 
Delay (sec) 1 
SyringePump Dispense (microliter) 10 
Delay (sec) 1 
SyringePump Aspirate (microliter) 10 
Delay (sec) 1 
SyringePump Dispense (microliter) 10 
Delay (sec) 1 
SyringePump Aspirate (microliter) 10 
Delay (sec) 1 
 
SyringePump Flowrate (microliter/sec) 50 
Valve port 1 
SyringePump Dispense (microliter) 250  
SyringePump Delay Until Done  
 
'Resident time 
Delay (sec) 120 
 
SyringePump Flowrate (microliter/sec) 25 
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SyringePump Dispense (microliter) 1200 
Delay (sec) 1 
Spectrometer Reference Scan  
Delay (sec) 1 
Spectrometer Absorbance Scanning 
SyringePump Delay Until Done  
Spectrometer Stop Scanning  
 
SyringePump Flowrate (microliter/sec) 150 
SyringePump Empty  
SyringePump Delay Until Done   
'Sample Meas. 1 
SyringePump Flowrate (microliter/sec) 150 
SyringePump Valve In 
SyringePump Aspirate (microliter) 1500  
SyringePump Delay Until Done   
 
SyringePump Flowrate (microliter/sec) 50 
SyringePump Valve Out 
Valve port 2   
SyringePump Aspirate (microliter) 35 
SyringePump Delay Until Done  
 
SyringePump Flowrate (microliter/sec) 50 
Valve port 3 
SyringePump Aspirate (microliter) 30   
SyringePump Delay Until Done  
SyringePump Flowrate (microliter/sec) 50 
Valve port 4 
SyringePump Aspirate (microliter) 30   
SyringePump Delay Until Done  
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SyringePump Flowrate (microliter/sec) 50 
Valve port 5  
SyringePump Aspirate (microliter) 20 
SyringePump Delay Until Done  
 
'Mixing reagents 
SyringePump Flowrate (microliter/sec) 25 
Valve port 1  
SyringePump Dispense (microliter) 10 
Delay (sec) 1 
SyringePump Aspirate (microliter) 10 
Delay (sec) 1 
SyringePump Dispense (microliter) 10 
Delay (sec) 1 
SyringePump Aspirate (microliter) 10 
Delay (sec) 1 
SyringePump Dispense (microliter) 10 
Delay (sec) 1 
SyringePump Aspirate (microliter) 10 
Delay (sec) 1 
'Pushing reagents to the reaction coil 
SyringePump Flowrate (microliter/sec) 50 
Valve port 1 
SyringePump Dispense (microliter) 250  
SyringePump Delay Until Done  
Delay (sec) 5 
'Resident time 
Delay (sec) 120 
 
SyringePump Flowrate (microliter/sec) 25 
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SyringePump Dispense (microliter) 1200 
Delay (sec) 1 
Spectrometer Reference Scan  
Delay (sec) 1 
Spectrometer Absorbance Scanning 
SyringePump Delay Until Done  
Spectrometer Stop Scanning  
 
SyringePump Flowrate (microliter/sec) 150 
SyringePump Empty  
SyringePump Delay Until Done   
'Sample Meas. 2 
SyringePump Flowrate (microliter/sec) 150 
SyringePump Valve In 
SyringePump Aspirate (microliter) 1500  
SyringePump Delay Until Done   
 
SyringePump Flowrate (microliter/sec) 50 
SyringePump Valve Out 
Valve port 2   
SyringePump Aspirate (microliter) 35 
SyringePump Delay Until Done  
 
SyringePump Flowrate (microliter/sec) 50 
Valve port 3 
SyringePump Aspirate (microliter) 30   
SyringePump Delay Until Done  
SyringePump Flowrate (microliter/sec) 50 
Valve port 4 
SyringePump Aspirate (microliter) 30   
SyringePump Delay Until Done  
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SyringePump Flowrate (microliter/sec) 50 
Valve port 5  
SyringePump Aspirate (microliter) 20 
SyringePump Delay Until Done  
 
'Mixing reagents 
SyringePump Flowrate (microliter/sec) 25 
Valve port 1  
SyringePump Dispense (microliter) 10 
Delay (sec) 1 
SyringePump Aspirate (microliter) 10 
Delay (sec) 1 
SyringePump Dispense (microliter) 10 
Delay (sec) 1 
SyringePump Aspirate (microliter) 10 
Delay (sec) 1 
SyringePump Dispense (microliter) 10 
Delay (sec) 1 
SyringePump Aspirate (microliter) 10 
Delay (sec) 1 
'Pushing reagents to the reaction coil 
SyringePump Flowrate (microliter/sec) 50 
Valve port 1 
SyringePump Dispense (microliter) 250  
SyringePump Delay Until Done  
Delay (sec) 5 
'Resident time 
Delay (sec) 120 
 
SyringePump Flowrate (microliter/sec) 25 
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SyringePump Dispense (microliter) 1200 
Delay (sec) 1 
Spectrometer Reference Scan  
Delay (sec) 1 
Spectrometer Absorbance Scanning 
SyringePump Delay Until Done  
Spectrometer Stop Scanning  
 
SyringePump Flowrate (microliter/sec) 150 
SyringePump Empty  
SyringePump Delay Until Done   
'Sample Meas. 3 
SyringePump Flowrate (microliter/sec) 150 
SyringePump Valve In 
SyringePump Aspirate (microliter) 1500  
SyringePump Delay Until Done   
 
SyringePump Flowrate (microliter/sec) 50 
SyringePump Valve Out 
Valve port 2   
SyringePump Aspirate (microliter) 35 
SyringePump Delay Until Done  
 
SyringePump Flowrate (microliter/sec) 50 
Valve port 3 
SyringePump Aspirate (microliter) 30   
SyringePump Delay Until Done  
SyringePump Flowrate (microliter/sec) 50 
Valve port 4 
SyringePump Aspirate (microliter) 30   
SyringePump Delay Until Done  
 151
 
SyringePump Flowrate (microliter/sec) 50 
Valve port 5  
SyringePump Aspirate (microliter) 20 
SyringePump Delay Until Done  
'Mixing reagents 
SyringePump Flowrate (microliter/sec) 25 
Valve port 1  
SyringePump Dispense (microliter) 10 
Delay (sec) 1 
SyringePump Aspirate (microliter) 10 
Delay (sec) 1 
SyringePump Dispense (microliter) 10 
Delay (sec) 1 
SyringePump Aspirate (microliter) 10 
Delay (sec) 1 
SyringePump Dispense (microliter) 10 
Delay (sec) 1 
SyringePump Aspirate (microliter) 10 
Delay (sec) 1 
 
'Pushing reagents to the reaction coil 
SyringePump Flowrate (microliter/sec) 50 
Valve port 1 
SyringePump Dispense (microliter) 250  
SyringePump Delay Until Done  
Delay (sec) 5 
'Resident time 
Delay (sec) 120 
 
SyringePump Flowrate (microliter/sec) 25 
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SyringePump Dispense (microliter) 1200 
Delay (sec) 1 
Spectrometer Reference Scan  
Delay (sec) 1 
Spectrometer Absorbance Scanning 
SyringePump Delay Until Done  
Spectrometer Stop Scanning  
 
SyringePump Flowrate (microliter/sec) 150 
SyringePump Empty  
SyringePump Delay Until Done   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7. SIA program for controlling Chlorpheniramine  
'Washing the main channel 
SyringePump Flowrate (microliter/sec) 150 
Valve port 1  
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SyringePump Valve Out  
SyringePump Empty  
SyringePump Delay Until Done  
 
SyringePump Flowrate (microliter/sec)150 
SyringePump Valve In  
SyringePump Aspirate (microliter) 1500 
SyringePump Delay Until Done  
 
'Loading channels 
'Sulfuric acid 
SyringePump Flowrate (microliter/sec) 50 
SyringePump Valve Out  
Valve port 2  
SyringePump Aspirate (microliter) 50 
SyringePump Delay Until Done 
 
'Permanganate 
SyringePump Flowrate (microliter/sec) 50 
Valve port 3  
SyringePump Aspirate (microliter) 50 
SyringePump Delay Until Done  
'Chlorpheniramine 
SyringePump Flowrate (microliter/sec) 50 
Valve port 4  
SyringePump Aspirate (microliter) 50 
SyringePump Delay Until Done  
'Spacer and Blank solution 
SyringePump Flowrate (microliter/sec) 50 
Valve port 5  
SyringePump Aspirate (microliter) 50 
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SyringePump Delay Until Done  
 
SyringePump Flowrate (microliter/sec) 150 
Valve port 1  
SyringePump Empty  
SyringePump Delay Until Done 
  
'Blank 1 
 
SyringePump Flowrate (microliter/sec) 150 
SyringePump Valve In 
SyringePump Aspirate (microliter) 1500  
SyringePump Delay Until Done   
 
SyringePump Flowrate (microliter/sec) 50 
SyringePump Valve Out 
Valve port 2   
SyringePump Aspirate (microliter) 35 
SyringePump Delay Until Done  
 
SyringePump Flowrate (microliter/sec) 50 
Valve port 3 
SyringePump Aspirate (microliter) 30   
SyringePump Delay Until Done  
 
 
 
SyringePump Flowrate (microliter/sec) 50 
Valve port 5  
SyringePump Aspirate (microliter) 50 
SyringePump Delay Until Done  
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 'Mixing reagents 
 
SyringePump Flowrate (microliter/sec) 25 
Valve port 1  
SyringePump Dispense (microliter) 10 
Delay (sec) 1 
SyringePump Aspirate (microliter) 10 
Delay (sec) 1 
SyringePump Dispense (microliter) 10 
Delay (sec) 1 
SyringePump Aspirate (microliter) 10 
Delay (sec) 1 
SyringePump Dispense (microliter) 10 
Delay (sec) 1 
SyringePump Aspirate (microliter) 10 
Delay (sec) 1 
 
SyringePump Flowrate (microliter/sec) 50 
Valve port 1 
SyringePump Dispense (microliter) 250  
SyringePump Delay Until Done  
 
'Resident time 
Delay (sec) 240 
 
 
SyringePump Flowrate (microliter/sec) 25 
SyringePump Dispense (microliter) 1200 
Delay (sec) 1 
Spectrometer Reference Scan  
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Delay (sec) 1 
Spectrometer Absorbance Scanning 
SyringePump Delay Until Done  
Spectrometer Stop Scanning  
 
SyringePump Flowrate (microliter/sec) 150 
SyringePump Empty  
SyringePump Delay Until Done   
 
'Blank 2 
 
SyringePump Flowrate (microliter/sec) 150 
SyringePump Valve In 
SyringePump Aspirate (microliter) 1500  
SyringePump Delay Until Done   
 
SyringePump Flowrate (microliter/sec) 50 
SyringePump Valve Out 
Valve port 2   
SyringePump Aspirate (microliter) 35 
SyringePump Delay Until Done  
 
SyringePump Flowrate (microliter/sec) 50 
Valve port 3 
SyringePump Aspirate (microliter) 30   
SyringePump Delay Until Done  
 
SyringePump Flowrate (microliter/sec) 50 
Valve port 5  
SyringePump Aspirate (microliter) 50 
SyringePump Delay Until Done  
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 'Mixing reagents 
SyringePump Flowrate (microliter/sec) 25 
Valve port 1  
SyringePump Dispense (microliter) 10 
Delay (sec) 1 
SyringePump Aspirate (microliter) 10 
Delay (sec) 1 
SyringePump Dispense (microliter) 10 
Delay (sec) 1 
SyringePump Aspirate (microliter) 10 
Delay (sec) 1 
SyringePump Dispense (microliter) 10 
Delay (sec) 1 
SyringePump Aspirate (microliter) 10 
Delay (sec) 1 
 
SyringePump Flowrate (microliter/sec) 50 
Valve port 1 
SyringePump Dispense (microliter) 250  
SyringePump Delay Until Done  
 
'Resident time 
Delay (sec) 240 
 
 
 
SyringePump Flowrate (microliter/sec) 25 
SyringePump Dispense (microliter) 1200 
Delay (sec) 1 
Spectrometer Reference Scan  
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Delay (sec) 1 
Spectrometer Absorbance Scanning 
SyringePump Delay Until Done  
Spectrometer Stop Scanning  
 
SyringePump Flowrate (microliter/sec) 150 
SyringePump Empty  
SyringePump Delay Until Done   
 
'Blank 3 
 
SyringePump Flowrate (microliter/sec) 150 
SyringePump Valve In 
SyringePump Aspirate (microliter) 1500  
SyringePump Delay Until Done   
 
SyringePump Flowrate (microliter/sec) 50 
SyringePump Valve Out 
Valve port 2   
SyringePump Aspirate (microliter) 35 
SyringePump Delay Until Done  
 
SyringePump Flowrate (microliter/sec) 50 
Valve port 3 
SyringePump Aspirate (microliter) 30   
SyringePump Delay Until Done  
 
SyringePump Flowrate (microliter/sec) 50 
Valve port 5  
SyringePump Aspirate (microliter) 50 
SyringePump Delay Until Done  
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'Mixing reagents 
 
SyringePump Flowrate (microliter/sec) 25 
Valve port 1  
SyringePump Dispense (microliter) 10 
Delay (sec) 1 
SyringePump Aspirate (microliter) 10 
Delay (sec) 1 
SyringePump Dispense (microliter) 10 
Delay (sec) 1 
SyringePump Aspirate (microliter) 10 
Delay (sec) 1 
SyringePump Dispense (microliter) 10 
Delay (sec) 1 
SyringePump Aspirate (microliter) 10 
Delay (sec) 1 
 
SyringePump Flowrate (microliter/sec) 50 
Valve port 1 
SyringePump Dispense (microliter) 250  
SyringePump Delay Until Done  
 
'Resident time 
Delay (sec) 240 
 
 
SyringePump Flowrate (microliter/sec) 25 
SyringePump Dispense (microliter) 1200 
Delay (sec) 1 
Spectrometer Reference Scan  
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Delay (sec) 1 
Spectrometer Absorbance Scanning 
SyringePump Delay Until Done  
Spectrometer Stop Scanning  
 
SyringePump Flowrate (microliter/sec) 150 
SyringePump Empty  
SyringePump Delay Until Done   
 
'Sample Meas. 1 
SyringePump Flowrate (microliter/sec) 150 
SyringePump Valve In 
SyringePump Aspirate (microliter) 1500  
SyringePump Delay Until Done   
 
SyringePump Flowrate (microliter/sec) 50 
SyringePump Valve Out 
Valve port 2   
SyringePump Aspirate (microliter) 35 
SyringePump Delay Until Done  
 
SyringePump Flowrate (microliter/sec) 50 
Valve port 3 
SyringePump Aspirate (microliter) 30   
SyringePump Delay Until Done  
 
 
SyringePump Flowrate (microliter/sec) 50 
Valve port 4 
SyringePump Aspirate (microliter) 30   
SyringePump Delay Until Done  
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SyringePump Flowrate (microliter/sec) 50 
Valve port 5  
SyringePump Aspirate (microliter) 20 
SyringePump Delay Until Done  
 
'Mixing reagents 
SyringePump Flowrate (microliter/sec) 25 
Valve port 1  
SyringePump Dispense (microliter) 10 
Delay (sec) 1 
SyringePump Aspirate (microliter) 10 
Delay (sec) 1 
SyringePump Dispense (microliter) 10 
Delay (sec) 1 
SyringePump Aspirate (microliter) 10 
Delay (sec) 1 
SyringePump Dispense (microliter) 10 
Delay (sec) 1 
SyringePump Aspirate (microliter) 10 
Delay (sec) 1 
 
'Pushing reagents to the reaction coil 
SyringePump Flowrate (microliter/sec) 50 
Valve port 1 
SyringePump Dispense (microliter) 250  
SyringePump Delay Until Done  
'Resident time 
Delay (sec) 240 
 
SyringePump Flowrate (microliter/sec) 25 
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SyringePump Dispense (microliter) 1200 
Delay (sec) 1 
Spectrometer Reference Scan  
Delay (sec) 1 
Spectrometer Absorbance Scanning 
SyringePump Delay Until Done  
Spectrometer Stop Scanning  
 
SyringePump Flowrate (microliter/sec) 150 
SyringePump Empty  
SyringePump Delay Until Done   
'Sample Meas. 2 
SyringePump Flowrate (microliter/sec) 150 
SyringePump Valve In 
SyringePump Aspirate (microliter) 1500  
SyringePump Delay Until Done   
 
SyringePump Flowrate (microliter/sec) 50 
SyringePump Valve Out 
Valve port 2   
SyringePump Aspirate (microliter) 35 
SyringePump Delay Until Done  
 
SyringePump Flowrate (microliter/sec) 50 
Valve port 3 
SyringePump Aspirate (microliter) 30   
SyringePump Delay Until Done  
SyringePump Flowrate (microliter/sec) 50 
Valve port 4 
SyringePump Aspirate (microliter) 30   
SyringePump Delay Until Done  
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SyringePump Flowrate (microliter/sec) 50 
Valve port 5  
SyringePump Aspirate (microliter) 20 
SyringePump Delay Until Done  
 
'Mixing reagents 
SyringePump Flowrate (microliter/sec) 25 
Valve port 1  
SyringePump Dispense (microliter) 10 
Delay (sec) 1 
SyringePump Aspirate (microliter) 10 
Delay (sec) 1 
SyringePump Dispense (microliter) 10 
Delay (sec) 1 
SyringePump Aspirate (microliter) 10 
Delay (sec) 1 
SyringePump Dispense (microliter) 10 
Delay (sec) 1 
SyringePump Aspirate (microliter) 10 
Delay (sec) 1 
 
'Pushing reagents to the reaction coil 
SyringePump Flowrate (microliter/sec) 50 
Valve port 1 
SyringePump Dispense (microliter) 250  
SyringePump Delay Until Done  
'Resident time 
Delay (sec) 240 
 
SyringePump Flowrate (microliter/sec) 25 
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SyringePump Dispense (microliter) 1200 
Delay (sec) 1 
Spectrometer Reference Scan  
Delay (sec) 1 
Spectrometer Absorbance Scanning 
SyringePump Delay Until Done  
Spectrometer Stop Scanning  
 
SyringePump Flowrate (microliter/sec) 150 
SyringePump Empty  
SyringePump Delay Until Done   
'Sample Meas. 3 
SyringePump Flowrate (microliter/sec) 150 
SyringePump Valve In 
SyringePump Aspirate (microliter) 1500  
SyringePump Delay Until Done   
 
SyringePump Flowrate (microliter/sec) 50 
SyringePump Valve Out 
Valve port 2   
SyringePump Aspirate (microliter) 35 
SyringePump Delay Until Done  
 
SyringePump Flowrate (microliter/sec) 50 
Valve port 3 
SyringePump Aspirate (microliter) 30   
SyringePump Delay Until Done  
SyringePump Flowrate (microliter/sec) 50 
Valve port 4 
SyringePump Aspirate (microliter) 30   
SyringePump Delay Until Done  
 165
 
SyringePump Flowrate (microliter/sec) 50 
Valve port 5  
SyringePump Aspirate (microliter) 20 
SyringePump Delay Until Done  
 
'Mixing reagents 
SyringePump Flowrate (microliter/sec) 25 
Valve port 1  
SyringePump Dispense (microliter) 10 
Delay (sec) 1 
SyringePump Aspirate (microliter) 10 
Delay (sec) 1 
SyringePump Dispense (microliter) 10 
Delay (sec) 1 
SyringePump Aspirate (microliter) 10 
Delay (sec) 1 
SyringePump Dispense (microliter) 10 
Delay (sec) 1 
SyringePump Aspirate (microliter) 10 
Delay (sec) 1 
 
'Pushing reagents to the reaction coil 
SyringePump Flowrate (microliter/sec) 50 
Valve port 1 
SyringePump Dispense (microliter) 250  
SyringePump Delay Until Done  
'Resident time 
Delay (sec) 240 
 
SyringePump Flowrate (microliter/sec) 25 
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SyringePump Dispense (microliter) 1200 
Delay (sec) 1 
Spectrometer Reference Scan  
Delay (sec) 1 
Spectrometer Absorbance Scanning 
SyringePump Delay Until Done  
Spectrometer Stop Scanning  
 
SyringePump Flowrate (microliter/sec) 150 
SyringePump Empty  
SyringePump Delay Until Done   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
8. SIA program to expel the bubbles   
'Washing the main channel  
SyringePump Flowrate (microliter/sec) 150 
Valve port 1  
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SyringePump Valve Out  
SyringePump Empty  
SyringePump Delay Until Done  
 
SyringePump Flowrate (microliter/sec) 200 
SyringePump Valve In  
SyringePump Fill  
SyringePump Delay Until Done   
 
SyringePump Flowrate (microliter/sec) 200 
Valve port 1  
SyringePump Valve Out  
SyringePump Empty  
SyringePump Delay Until Done  
 
 
 
  
 
 
 
 
 
    
   
 
